-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E2ghIaZdb/NJIUYFkxmnmKv3kmKXfNRPkJFfOABqJ/mE95q4JTSP9GGSnn/K5aPX cxKTT5F0SuqYBY8cqdDpdQ== 0000950148-02-000393.txt : 20020414 0000950148-02-000393.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950148-02-000393 CONFORMED SUBMISSION TYPE: SC 13E3 PUBLIC DOCUMENT COUNT: 8 FILED AS OF DATE: 20020215 GROUP MEMBERS: CRAIG ENTERPRISES, INC. GROUP MEMBERS: DA HOLDINGS, INC. GROUP MEMBERS: GENEVIEVE CRAIG GROUP MEMBERS: SIDNEY CRAIG GROUP MEMBERS: SJF ENTERPRISES, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: JENNY CRAIG INC/DE CENTRAL INDEX KEY: 0000878865 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200] IRS NUMBER: 330366188 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13E3 SEC ACT: 1934 Act SEC FILE NUMBER: 005-42104 FILM NUMBER: 02552050 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVE STE 300 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 6192597000 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVENUE STREET 2: SUITE 300 CITY: DEL MAR STATE: CA ZIP: 92014 FORMER COMPANY: FORMER CONFORMED NAME: JCI HOLDINGS INC DATE OF NAME CHANGE: 19600201 FORMER COMPANY: FORMER CONFORMED NAME: CRAIG JENNY INC /DE DATE OF NAME CHANGE: 19930328 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JENNY CRAIG INC/DE CENTRAL INDEX KEY: 0000878865 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200] IRS NUMBER: 330366188 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13E3 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVE STE 300 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 6192597000 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVENUE STREET 2: SUITE 300 CITY: DEL MAR STATE: CA ZIP: 92014 FORMER COMPANY: FORMER CONFORMED NAME: JCI HOLDINGS INC DATE OF NAME CHANGE: 19600201 FORMER COMPANY: FORMER CONFORMED NAME: CRAIG JENNY INC /DE DATE OF NAME CHANGE: 19930328 SC 13E3 1 v79145orsc13e3.htm SCHEDULE 13E-3 JENNY CRAIG SCHEDULE 13E-3
Table of Contents

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13E-3
(Rule 13e-100)
Rule 13e-3 Transaction Statement Under Section 13(e) of the
Securities Exchange Act of 1934

Jenny Craig, Inc.
(Name of the Issuer)

Jenny Craig, Inc.
Sidney Craig
Genevieve Craig
Craig Enterprises, Inc.
SJF Enterprises, Inc.
DA Holdings, Inc.
(Name of Person(s) Filing Statement)

Common Stock, Par Value $.000000005 Per Share
(Title of Class of Securities)

22406 10 2
(CUSIP Number of Class of Securities)


Sidney Craig
11355 N. Torrey Pines Rd.
La Jolla, California 92037
(858) 812-7000

with copies to:

Thomas W. Dollinger
Proskauer Rose LLP
2049 Century Park E., #3200
Telephone: (310) 284-5630

(Name, Address and Telephone Numbers of Person Authorized to Receive Notices
and Communications on Behalf of the Person(s) Filing Statement)


 


Table of Contents

This statement is filed in connection with (check the appropriate box):

        a.      
[X] The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the Securities Exchange Act of 1934.
 
        b.       [   ] The filing of a registration statement under the Securities Act of 1933.
 
        c.       [   ] A tender offer.
 
        d.       [   ] None of the above.

     Check the following box if the soliciting materials or information statement referred to in checking box (a) are preliminary copies: [X]

     Check the following box if the filing is a final amendment reporting the results of the transaction: [   ]


CALCULATION OF FILING FEE

            
Transaction Valuation*   Amount of Filing Fee

 
$114,459,649     $10,531  


*         The transaction value was based upon the sum of (a) the product of 20,688,971 shares of Common Stock and the merger consideration of $5.30 per share and (b) the difference between the merger consideration of $5.30 per share and the exercise price per share of each of the 1,483,000 shares of Common Stock subject to outstanding options in which the exercise price per share is less than the merger consideration per share.

[X]     Check the box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

                 
Amount Previously Paid:     $10,531     Filing Party:   Jenny Craig, Inc.
Form or Registration No     Schedule 14A     Date Filed:   February 15, 2002

 


Item 1. Summary Term Sheet
Item 2. Subject Company Information.
Item 3. Identity and Background of Filing Person.
Item 4. Terms of the Transaction.
Item 5. Past Contacts, Transactions, Negotiations and Agreements.
Item 6. Purposes of the Transaction and Plans or Proposals.
Item 7. Purposes, Alternatives, Reasons and Effects.
Item 8. Fairness of the Transaction.
Item 9. Reports, Opinions, Appraisals and Negotiations.
Item 10. Source and Amounts of Funds or Other Consideration.
Item 11. Interest in Securities of the Subject Company.
Item 12. The Solicitation or Recommendation.
Item 13. Financial Statements.
Item 14. Persons/Assets, Retained, Employed, Compensated or Used.
Item 15. Additional Information.
Item 16. Exhibits.
SIGNATURE
EXHIBIT (B)(1)
EXHIBIT (B)(2)
EXHIBIT (B)(3)
EXHIBIT (C)(2)
EXHIBIT (D)(2)
EXHIBIT (D)(4)
EXHIBIT (D)(5)


Table of Contents

INTRODUCTION

     This Rule 13e-3 Transaction Statement on Schedule 13E-3 (this “Schedule 13E-3”) is being filed jointly by Jenny Craig, Inc., a Delaware corporation (“JCI”), Sidney Craig (“Mr. Craig”), Genevieve Craig (“Mrs. Craig”), Craig Enterprises, Inc., a Delaware corporation (“CEI”), SJF Enterprises, Inc., a Delaware corporation (“SJF”), and DA Holdings, Inc., a California corporation (“DAHI” and, together with Mr. Craig, Mrs. Craig, CEI and SJF, the “Craig Stockholders”), in connection with the Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 27, 2002, by and among JCI, J Holdings Corp. (“J Holdings”) and J Acquisition Corp. (“J Acquisition”). JCI and the Craig Stockholders are referred to herein as the “Filing Persons.” If the Merger Agreement is adopted and the Merger (as defined herein) is approved by JCI’s stockholders, J Acquisition will merge with and into JCI (the “Merger”), with JCI continuing as the surviving corporation. In the Merger, each outstanding share of common stock, par value $0.000000005 per share, of JCI (the “Common Stock”), other than shares of Common Stock held in JCI’s treasury, held by J Holdings or J Acquisition or held by stockholders who perfect their appraisal rights under Delaware law, will be converted into the right to receive $5.30 in cash, without interest, less any applicable withholding taxes.

     Information contained in this Schedule 13E-3 concerning JCI and its affiliates (except for information relating to the Craig Stockholders other than in their capacities as directors or officers of JCI) has been supplied by JCI, and information concerning the Craig Stockholders (except for information relating to the Craig Stockholders in their capacities as directors or officers of JCI) has been supplied by the Craig Stockholders.

     Concurrently with the filing of this Schedule 13E-3, JCI is filing a preliminary proxy statement (the “Proxy Statement”) pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), pursuant to which the JCI board of directors is soliciting proxies from stockholders of JCI in connection with the Merger. The cross reference sheet below is being supplied pursuant to General Instruction G to Schedule 13E-3 and shows the location in the Proxy Statement of the information required to be included in response to the items of this Schedule 13E-3. The information set forth in the Proxy Statement, including all appendices thereto, is hereby incorporated herein by this reference, and the responses to each item in this Schedule 13E-3 are qualified in their entirety by the information contained in the Proxy Statement and the appendices thereto. As of the date hereof, the Proxy Statement is in preliminary form and is subject to completion and amendment. Capitalized terms used but not defined in this Schedule 13E-3 shall have the meanings given to them in the Proxy Statement.

1


Table of Contents

Item  1.    Summary Term Sheet

Regulation M-A
Item 1001

The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER” and “SUMMARY TERM SHEET” is incorporated herein by reference.

Item  2.    Subject Company Information.

Regulation M-A
Item 1002

     
(a)   The information set forth in the Proxy Statement under the caption “SUMMARY TERM SHEET — The Companies” is incorporated herein by reference. JCI is the issuer of the class of equity securities which is the subject of the Rule 13e-3 transaction.
 
(b)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Special Meeting” and “INTRODUCTION — Voting Rights; Vote Required for Approval” is incorporated herein by reference.
 
(c)   The information set forth in the Proxy Statement under the caption “INTRODUCTION — Comparative Market Price Data” is incorporated herein by reference.
 
(d)   The information set forth in the Proxy Statement under the caption “INTRODUCTION — Dividends” is incorporated herein by reference.
 
(e)   Not applicable.
 
(f)   Not applicable.

Item  3.    Identity and Background of Filing Person.

Regulation M-A
Item 1003

     
(a)-(c)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Companies” is incorporated herein by reference.
 
    Mr. Craig, a citizen of the United States, has his principal business address at 11355 N. Torrey Pines Rd., La Jolla, California 92037. The principal occupation of Mr. Craig is to serve as the Chairman of the Board and Chief Executive Officer of JCI. Mr. Craig has been Chairman of the Company or its predecessors since 1983 and served as Chief Executive Officer from 1983 through April, 1994. In October 1997, Mr. Craig was appointed Chief Executive Officer of the Company.

2


Table of Contents

     
    Mrs. Craig, a citizen of the United States, has her business address at 11355 N. Torrey Pines Rd., La Jolla, California 92037. The principal occupation of Mrs. Craig is to serve as the Chairman of the Executive Committee of the Board of JCI. Mrs. Craig has served as Chairman of the Executive Committee since September 2000, as Vice-Chairman of JCI from September 1991 to September 2000, as President and Chief Operating Officer of JCI or its predecessors from 1983 to August 1991 and as a director of JCI or its predecessors from 1983 to date. Mrs. Craig served as President of JCI from October 1997 through December 1998. Mr. and Mrs. Craig are husband and wife.
 
    CEI, a Delaware corporation, has its principal business address at 16092 San Dieguito Rd., Rancho Santa Fe, California 92067. The business telephone number of CEI is (619) 756-6980. CEI’s principal business is investing in securities and business enterprises. Mr. and Mrs. Craig beneficially own all of the outstanding capital stock of CEI. Mr. and Mrs. Craig are the directors of CEI. Mr. Craig is the Chairman of the Board of CEI, Mrs. Craig is the President and Chief Financial Officer of CEI, and Marvin Sears is the Vice President and Secretary of CEI.
 
    SJF, a Delaware corporation, has its principal business address at 16092 San Dieguito Rd., Rancho Santa Fe, California 92067. The business telephone number of SJF is (619) 756-6980. SJF’s principal business is to hold shares of Common Stock. CEI beneficially owns all of the outstanding capital stock of SJF. Mr. and Mrs. Craig are the directors of SJF. Mr. Craig is the Chairman of the Board of SJF, Mrs. Craig is the President and Chief Financial Officer of SJF, and Marvin Sears is the Vice President and Secretary of SJF.
 
    DAHI, a California corporation, has its principal business address at 16092 San Dieguito Rd., Rancho Santa Fe, California 92067. The business telephone number of DAHI is (619) 756-6980. DAHI was incorporated on February 8, 1996 and has engaged in no activities other than issuance of shares of common stock of DAHI to SJF in exchange for shares of Common Stock. SJF beneficially owns all of the outstanding capital stock of DAHI. Mr. and Mrs. Craig are the directors of DAHI. Mr. Craig is the Chairman of the Board of DAHI, Mrs. Craig is the President and Chief Financial Officer of DAHI, and Marvin Sears is the Vice President and Secretary of DAHI.
 
    Directors and Executive Officers of JCI. Set forth below are the (i) name, (ii) address, (iii) current principal occupation or employment, and the name, principal business and address of any corporation or other organization in which the employment or occupation is conducted, and (iv) material occupations, positions, offices or employment during the past five years, and the name, principal business and address of any corporation or other organization in which the occupation, position, office or employment was carried on, of each of the directors and executive officers of JCI, except for Mr. and Mrs. Craig, whose information is provided above. Each person identified below is a United States citizen.
 
    Marvin Sears has his principal business address at 2049 Century Park East, Suite 3200, Los Angeles, California 90027. Mr. Sears has been a director of JCI since July 1989, has served as the Secretary of JCI since June 1991, and as Assistant Secretary of JCI from August 1985 to June 1991. Mr. Sears is a practicing attorney in Los Angeles, California.

3


Table of Contents

     
    where, since May 1989, he has been a partner in the law firm of Proskauer Rose LLP, counsel to the Company during fiscal 2001 and currently.
 
    Scott Bice has his principal business address at Room 434, University Park MC-0071, 699 Exposition Boulevard, Los Angeles, California 90089. Mr. Bice has served as a director of the Company since February 1995. Mr. Bice is the Robert C. Packard Professor of Law at the University of Southern California Law Center and served as Dean of the University of Southern California Law Center from 1980 until June 2000.
 
    Andrea Van de Kamp has her business address at 9665 Wilshire Blvd., Beverly Hills, California 90212. Ms. Van de Kamp has served as a director of the Company since August, 1994. Ms. Van de Kamp was Senior Vice President and Managing Director of West Coast Operations, Sotheby’s, from 1989 through May 1997 and has been Chairman, West Coast Operations of Sotheby’s since May 1997.
 
    Robert Wolf has his business address at 1880 Century Park East, Suite 611, Los Angeles, California 90067. Mr. Wolf has served as a director of the Company since February, 1995. Mr. Wolf is a Managing Partner of Bob Wolf Partners, a marketing and advertising consulting company. Mr. Wolf was the Chairman and Chief Executive Officer of Chiat/Day North America, an advertising firm, from 1989 through November 1995.
 
    Patricia Larchet has her business address at 11355 N. Torrey Pines Rd., La Jolla, California 92037. Ms. Larchet, a director of the Company since September 2000, has served as the President and Chief Operating Officer of the Company since December 1999. Prior to serving as the Company’s President, Ms. Larchet was General Manager of the Australian division of the Company. Ms. Larchet has worked for the Company since 1985.
 
    Duayne Weinger has his business address at 11355 N. Torrey Pines Rd., La Jolla, California 92037. Mr. Weinger has served as the Chief Administrative Officer of the Company since December, 1999, and as Vice-Chairman of the Company since September 2000. From 1994 until joining the Company, Mr. Weinger was a private investor. From 1987 until 1994, Mr. Weinger owned and operated franchised centres of the Company. Mr. Weinger is the son-in-law of Sidney and Jenny Craig.
 
    Barbara Barry has her business address at 11355 N. Torrey Pines Rd., La Jolla, California 92037. Ms. Barry has served as Vice President, Marketing since June 2000. From June 1999 until June 2000, Ms. Barry was Vice President of Sales, Marketing and Merchandising for 3 Day Blinds Inc., a custom manufacturer and retailer of hard window coverings. From June 1997 until June 1999, Ms. Barry was Director of Marketing for Smart and Final, a 220 store retail chain. From April 1994 until June 1997, Ms. Barry was Senior Brand Development Manager for Unocal 76 Products.
 
    James S. Kelly has his business address at 11355 N. Torrey Pines Rd., La Jolla, California 92037. Mr. Kelly has served as Vice President, Chief Financial Officer and Treasurer since June 1999 after having served as Vice President and Controller since 1993 and as Controller from 1989 through 1993. From January 1983 to January 1989,

4


Table of Contents

     
    Mr. Kelly was employed by KPMG LLP, an international accounting firm, most recently as an audit manager.
 
    Alan V. Dobies has his business address at 11355 N. Torrey Pines Rd., La Jolla, California 92037. Mr. Dobies has served as Vice President, Corporate Services since June 1990. From July 1988 to May 1990, Mr. Dobies was Vice President, Operations of Joico International, a manufacturer of professional hair-care products.
 
    During the last five years, none of the Filing Persons and none of the directors and executive officers of the Filing Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or was a party to any judicial or administrative proceeding (except for matters that were dismissed without sanction or settlement) that resulted in a judgment, decree or final order enjoining the person from future violations of, or prohibiting activities subject to, federal or state securities laws, or a finding of any violation of federal or state securities laws.

Item  4.    Terms of the Transaction.

Regulation M-A
Item 1004

     
(a)(1)   Not applicable.
 
(a)(2)(i)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET” and “INTRODUCTION — Proposal to be Considered at the Special Meeting” is incorporated herein by reference.
 
(a)(2)(ii)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “INTRODUCTION — Proposal to be Considered at the Special Meeting” and “THE MERGER — The Merger Agreement” is incorporated herein by reference.
 
(a)(2)(iii)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Purpose of the Merger,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger” and “SPECIAL FACTORS — The Continuing Stockholders’ Reasons for the Merger” is incorporated herein by reference.
 
(a)(2)(iv)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Special Meeting — Vote Required for Approval” and “INTRODUCTION — Voting Rights; Vote Required for Approval” is incorporated herein by reference.
 
(a)(2)(v)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Interests of Directors and Executive Officers in the Merger,” “SPECIAL FACTORS — Certain Effects of the Merger; Plans or Proposals After the Merger,”

5


Table of Contents

     
    “SPECIAL FACTORS — Interests of Executive Officers and Directors in the Merger” and “SPECIAL FACTORS — Certain Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders” is incorporated herein by reference.
 
(a)(2)(vi)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Accounting Treatment” and “THE MERGER — Accounting Treatment” is incorporated herein by reference.
 
(a)(2)(vii)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Material U.S. Federal Income Tax Consequences” and “SPECIAL FACTORS — Material U.S. Federal Income Tax Consequences of the Merger to JCI’s Stockholders” is incorporated herein by reference.
 
(c)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Interests of Directors and Executive Officers in the Merger,” “SPECIAL FACTORS — Certain Effects of the Merger; Plans or Proposals After the Merger,” “SPECIAL FACTORS — Interests of Executive Officers and Directors in the Merger” and “SPECIAL FACTORS — Certain Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders” is incorporated herein by reference.
 
(d)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Appraisal Rights” and “THE MERGER — Appraisal Rights” is incorporated herein by reference.
 
(e)   None.
 
(f)   Not Applicable.

Item  5.    Past Contacts, Transactions, Negotiations and Agreements.

Regulation M-A
Item 1005

     
(a)(1)   None.
 
(a)(2)   The information set forth in the Proxy Statement under the caption “OTHER MATTERS — Legal Counsel” is incorporated herein by reference. The information set forth under the headings “Compensation Committee Interlocks and Insider Participation” and “Certain Transactions” in the proxy statement filed by JCI on October 11, 2001 in connection with the 2001 Annual Meeting of Stockholders is incorporated herein by reference.
 
(b)-(c)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Interests of Directors and Executive Officers in the Merger,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Interests of Executive Officers and Directors in the Merger,” “SPECIAL FACTORS — Certain

6


Table of Contents

     
    Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders” and “OTHER MATTERS — Information Concerning Proposal by Craig Enterprises, Inc.” is incorporated herein by reference.
 
(e)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Interests of Directors and Executive Officers in the Merger,” “INTRODUCTION — Voting Rights; Vote Required for Approval,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Interests of Executive Officers and Directors in the Merger” and “SPECIAL FACTORS — Certain Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders” is incorporated herein by reference. The information set forth in Exhibits (d)(1), (d)(2), (d)(3), (d)(4), (d)(5) and (d)(6) is incorporated herein by reference.

Item  6.    Purposes of the Transaction and Plans or Proposals.

Regulation M-A
Item 1006

     
(b)   The information set forth in the Proxy Statement under the captions “SPECIAL FACTORS — Purpose and Structure of the Merger,” “SPECIAL FACTORS — Certain Effects of the Merger; Plans or Proposals After the Merger,” “SPECIAL FACTORS — Certain Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders “ and “THE MERGER — The Merger Agreement — Consideration to be Received by JCI Stockholders” is incorporated herein by reference.
 
(c)(1)-(8)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Effects of the Merger,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Certain Effects of the Merger; Plans or Proposals After the Merger,” “SPECIAL FACTORS — Interest of Executive Officers and Directors in the Merger” and “SPECIAL FACTORS — Certain Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders “ is incorporated herein by reference.

Item  7.    Purposes, Alternatives, Reasons and Effects.

Regulation M-A
Item 1013

     
(a)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Purpose of the Merger,” “SPECIAL FACTORS — Background of the Merger” and “SPECIAL FACTORS — Purpose and Structure of the Merger” is incorporated herein by reference.
 
(b)   The information set forth in the Proxy Statement under the captions “SPECIAL FACTORS — Background of the Merger” and “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger” is incorporated herein by reference.

7


Table of Contents

     
(c)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Purpose of the Merger,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger,” “SPECIAL FACTORS — JCI’s Reasons for the Merger,” “SPECIAL FACTORS — The Continuing Stockholders’ Reasons for the Merger” and “SPECIAL FACTORS — Purpose and Structure of the Merger” is incorporated herein by reference.
 
(d)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Effects of the Merger,” “SUMMARY TERM SHEET — The Merger — Interests of Directors and Executive Officers in the Merger,” “SUMMARY TERM SHEET — The Merger — Material U.S. Federal Income Tax Consequences,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger,” “SPECIAL FACTORS — Forecasts,” “SPECIAL FACTORS — Purpose and Structure of the Merger,” “SPECIAL FACTORS — Certain Effects of the Merger; Plans or Proposals After the Merger,” “SPECIAL FACTORS — Interests of Executive Officers and Directors in the Merger,” “SPECIAL FACTORS — Certain Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders,” “SPECIAL FACTORS — Material U.S. Federal Income Tax Consequences of the Merger to JCI Stockholders,” “THE MERGER — Payment of Merger Consideration and Surrender of Stock Certificates” and “THE MERGER — The Merger Agreement” is incorporated herein by reference.

Item  8.    Fairness of the Transaction.

Regulation M-A
Item 1014

     
(a)-(b)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Recommendations of the Special Committee and JCI’s Board of Directors,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Opinion of Houlihan Lokey,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger,” “SPECIAL FACTORS — Forecasts” and “SPECIAL FACTORS — The Continuing Stockholders’ Position as to the Fairness of the Merger” is incorporated herein by reference.
 
(c)   The information set forth in the Proxy Statement under the caption “INTRODUCTION — Voting Rights; Vote Required for Approval” is incorporated herein by reference.
 
(d)   The information set forth in the Proxy Statement under the captions “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Opinion of Houlihan Lokey,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger” and “SPECIAL FACTORS — The Continuing Stockholders’ Position as to the Fairness of the Merger” is incorporated herein by reference.

8


Table of Contents

     
(e)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Recommendations of the Special Committee and JCI’s Board of Directors,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger” and “SPECIAL FACTORS — The Continuing Stockholders’ Position as to the Fairness of the Merger” is incorporated herein by reference.
 
(f)   The information set forth in the Proxy Statement under the caption “SPECIAL FACTORS — Background of the Merger” is incorporated herein by reference.

Item  9.    Reports, Opinions, Appraisals and Negotiations.

Regulation M-A
Item 1015

     
(a)-(c)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Opinion of Houlihan Lokey,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Opinion of Houlihan Lokey,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger,” “SPECIAL FACTORS — Forecasts,” “SPECIAL FACTORS — The Continuing Stockholders’ Position as to the Fairness of the Merger,” “THE MERGER — Fees and Expenses of the Merger,” “OTHER MATTERS — Information Concerning Proposal by Craig Enterprises, Inc.” and “OTHER MATTERS — Information Incorporated By Reference” is incorporated herein by reference. The full text of the written opinion of Houlihan Lokey Howard & Zukin Financial Advisors, Inc. (“Houlihan Lokey”), dated January 27, 2002, is attached to the Proxy Statement as Appendix B. The written materials presented by Houlihan Lokey to the Special Committee and the JCI Board of Directors on January 25, 2002 are set forth as Exhibit (c)(2) hereto and are incorporated herein by reference.

Item  10.   Source and Amounts of Funds or Other Consideration.

Regulation M-A
Item 1007

     
(a)-(d)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Financing of the Merger,” “SPECIAL FACTORS — Financing of the Merger,” and “THE MERGER — Fees and Expenses of the Merger “ is incorporated herein by reference.

9


Table of Contents

Item  11.    Interest in Securities of the Subject Company.

Regulation M-A
Item 1008

     
(a)   The information set forth in the Proxy Statement under the captions “SUMMARY TERM SHEET — The Merger — Interests of Directors and Executive Officers in the Merger,” “INTRODUCTION — Voting Rights; Vote Required for Approval,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Interests of Executive Officers and Directors in the Merger,” “SPECIAL FACTORS — Certain Relationships Among ACI, DB Capital, J Holdings, J Acquisition and the Continuing Stockholders,” “THE MERGER — Voting Agreements” and “OTHER MATTERS — Security Ownership of Certain Beneficial Owners and Management” is incorporated herein by reference.
 
(b)(1)-(5)   Not applicable.

Item  12.    The Solicitation or Recommendation.

Regulation M-A
Item 1012

     
(d)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “INTRODUCTION — Voting Rights; Vote Required for Approval,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger,” “SPECIAL FACTORS — The Continuing Stockholders’ Reasons for the Merger” and “THE MERGER — Stockholders’ Voting Agreement” is incorporated herein by reference.
 
(e)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “SUMMARY TERM SHEET — The Merger — Recommendations of the Special Committee and JCI’s Board of Directors,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger” and “SPECIAL FACTORS — The Continuing Stockholders’ Reasons for the Merger” is incorporated herein by reference.

Item  13.    Financial Statements.

Regulation M-A
Item 1010

     
(a)   The information set forth in the Proxy Statement under the captions “INTRODUCTION — Selected Consolidated Financial Information,” “INTRODUCTION — Consolidated Ratios of Earnings to Fixed Charges and Book Value Per Share” and “OTHER MATTERS — Information Incorporated by Reference” is incorporated herein by reference.
 
(b)   Not applicable.

10


Table of Contents

Item  14.    Persons/Assets, Retained, Employed, Compensated or Used.

Regulation M-A
Item 1009

     
(a)-(b)   The information set forth in the Proxy Statement under the captions “QUESTIONS AND ANSWERS ABOUT THE MERGER,” “INTRODUCTION — Solicitation of Proxies; Expenses of Solicitation,” “SPECIAL FACTORS — Background of the Merger,” “SPECIAL FACTORS — Opinion of Houlihan Lokey,” “SPECIAL FACTORS — Reasons for the Recommendations of the Special Committee and JCI’s Board of Directors; Fairness of the Merger,” “SPECIAL FACTORS — Financing of the Merger” and “THE MERGER — Fees and Expenses of the Merger” is incorporated herein by reference.

Item  15.    Additional Information.

Regulation M-A
Item 1011

     
(b)   The information set forth in the Proxy Statement and appendices thereto is incorporated herein by reference.

Item  16.    Exhibits.

Regulation M-A
Item 1016

     
(a)(1)   Preliminary Proxy Statement of Jenny Craig, Inc. is incorporated herein by reference.
 
(a)(2)   Form of Proxy Card, filed with the Securities and Exchange Commission along with the Proxy Statement is incorporated herein by reference.
 
(a)(3)   Press Release dated January 28, 2002 (included as Exhibit 99.1 to the Report on Form 8-K filed by Jenny Craig, Inc. on January 29, 2002 and incorporated herein by reference).
 
(b)(1)   Senior Debt Commitment Letter, dated as of December 28, 2001, by and between Ableco Finance LLC and ACI Capital Co., Inc.
 
(b)(2)   Junior Subordinated Debt Commitment Letter dated January 27, 2002, by and between ACI Capital Co., Inc. and J Acquisition Corp.
 
(b)(3)   Sub Debt Commitment Letter dated January 27, 2002, by and among DB Capital Investors, L.P., J Holdings Corp., J Acquisition Corp. and ACI Capital Co., Inc.
 
(c)(1)   Opinion of Houlihan Lokey Howard & Zukin dated January 27, 2002 (included as Appendix B to the Proxy Statement and incorporated herein by reference).
 
(c)(2)   Materials presented by Houlihan Lokey Howard & Zukin to the Special Committee and the Jenny Craig, Inc. Board of Directors on January 25, 2002.

11


Table of Contents

     
(d)(1)   Agreement and Plan of Merger, dated as of January 27, 2002, by and among J Holdings Corp., J. Acquisition Corp. and Jenny Craig, Inc. (included as Appendix A to the Proxy Statement and incorporated herein by reference).
 
(d)(2)   Form of Stockholders’ Agreement by and among DB Capital Investors, L.P., ACI Capital Co., Inc., on behalf of ACI Entities and affiliates, Management Stockholders, SJF Enterprises, Inc., Sid Craig, Jenny Craig and Craig Enterprises, Inc.
 
(d)(3)   Stockholders’ Voting Agreement, dated as of January 27, 2002, by and among J Holdings Corp., J Acquisition Corp., Jenny Craig, Inc., Sidney Craig, Jenny Craig, Craig Enterprises, Inc., SJF Enterprises, Inc. and DA Holdings, Inc. (included as Exhibit 10.1 to the Report on Form 8-K filed by Jenny Craig, Inc. on January 29, 2002 and incorporated herein by reference).
 
(d)(4)   Equity Capital Commitment Letter dated January 27, 2002, by and between ACI Capital Co., Inc. and J Holdings Corp.
 
(d)(5)   Equity Commitment Letter dated January 27, 2002, by and among DB Capital Investors, L.P., J Holdings Corp., J Acquisition Corp. and ACI Capital Co., Inc.
 
(d)(6)   Equity Capital Commitment Letter, dated as of January 27, 2002, by and among SJF Enterprises, Inc. and J Holdings Corp. (included as Exhibit 10.2 to the Report on Form 8-K filed by Jenny Craig, Inc. on January 29, 2002 and incorporated herein by reference).
 
(f)   Section 262 of the Delaware General Corporation Law (included as Appendix C to the Proxy Statement and incorporated herein by reference).
 
(g)   Not applicable.

12


Table of Contents

SIGNATURE

     After due inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

         
JENNY CRAIG, INC.    
 
By:   /s/   PATRICIA LARCHET

Patricia Larchet, President and Chief Operating Officer
   
 
/s/   SIDNEY CRAIG

SIDNEY CRAIG
   
 
/s/   GENEVIEVE CRAIG

GENEVIEVE CRAIG
   
 
CRAIG ENTERPRISES, INC.
   
 
By:   /s/   SIDNEY CRAIG

Sidney Craig, Chairman
   
 
SJF ENTERPRISES, INC.    
 
By:   /s/   SIDNEY CRAIG

Sidney Craig, Chairman
   
 
DA HOLDINGS, INC.    
 
By:   /s/   SIDNEY CRAIG

Sidney Craig, Chairman
   
 
Dated:   February 15, 2002
   
EX-99.(B)(1) 3 v79145orex99-b1.txt EXHIBIT (B)(1) Exhibit (b)(1) ABLECO FINANCE LLC 450 Park Avenue, 28th Floor New York, New York 10022 December 28, 2001 Mr. Kevin S. Penn Mr. Ezra S. Field ACI Capital Co., Inc. 900 Third Avenue, 26th Floor New York, NY 10022 Re: Financing Commitment Gentlemen: An investor group formed by ACI Capital Co., Inc.("ACI Capital" and ACI Capital together with such investor group collectively, the "Investor") has advised Ableco Finance LLC (a special situations lending company hereinafter referred to as the "Lender") that the Investor is directly or through a wholly owned acquisition vehicle acquiring all of the capital stock of Jenny Craig, Inc. ("Jenny Craig") and its subsidiaries (the "Acquisition") (Jenny Craig and those of its subsidiaries designated by the Lender as borrowers collectively, the "Borrower"). The Investor has also advised the Lender that the Investor requires financing (i) to consummate the Acquisition, (ii) for the general working capital requirements of the Borrower and (iii) to pay fees and expenses related to the financing contemplated by this commitment letter. The Lender is pleased to advise you that the Lender hereby commits to provide the Borrower with a revolving credit and term loan facility totaling not more than $35 million at any one time outstanding (the "Financing Facility"), consisting of (A) a revolving credit facility in an aggregate principal amount outstanding not exceeding $5 million, (B) a tranche A term loan in an outstanding principal amount of $15 million and (C) a tranche B term loan in an outstanding principal amount of $15 million, all substantially on the terms and conditions set forth in the Outline of Terms and Conditions attached hereto as Exhibit A (the "Term Sheet"). The obligations of the Borrower under the Financing Facility will be secured by a first priority lien on, and security interest in, substantially all assets of the Borrower and its subsidiaries, in each case subject to such exclusions as the Lender (in its sole and absolute discretion) may agree. The Lender's commitment to provide the Financing Facility is subject in all respects to satisfaction of the terms and conditions contained in this commitment letter and in the Term Sheet. The Investor acknowledges that the Term Sheet is intended as an outline only and does not purport to summarize all the conditions, covenants, representations, warranties and other provisions which would be contained in definitive legal documentation for the Financing Facility. The loan documentation for the Financing Facility will include, in addition to the provisions that are summarized in this commitment letter and the Term Sheet, provisions that, in the reasonable opinion of the Lender, are customary or typical for this type of financing ACI Capital Co., Inc. December 28, 2001 Page 2 transaction and other provisions that the Lender reasonably requires in the context of the proposed transaction. By its execution hereof and its acceptance of the commitment contained herein, ACI Capital agrees to indemnify and hold harmless the Lender and each of its assignees, its affiliates and its directors, members, officers, employees and agents (each an "Indemnified Party") from and against any and all losses, claims, damages, liabilities or other expenses to which such Indemnified Party may become subject, insofar as such losses, claims, damages, liabilities (or actions or other proceedings commenced or threatened in respect thereof) or other expenses arise out of or in any way relate to or result from the Acquisition, this commitment letter or the extension of the Financing Facility contemplated by this commitment letter, or in any way arise from any use or intended use of this commitment letter or the proceeds of the Financing Facility contemplated by this commitment letter, and ACI Capital agrees to reimburse each Indemnified Party for any legal or other expenses incurred in connection with investigating, defending or participating in any such loss, claim, damage, liability or action or other proceeding (whether or not such Indemnified Party is a party to any action or proceeding out of which indemnified expenses arise), but excluding therefrom all expenses, losses, claims, damages and liabilities which are finally determined in a non-appealable decision of a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of the Indemnified Party. In the event of any litigation or dispute involving this commitment letter or the Financing Facility, the Lender shall not be responsible or liable to the Investor, the Borrower or any other person for any special, indirect, consequential, incidental or punitive damages. In addition, ACI Capital agrees to reimburse the Lender for all reasonable out-of-pocket fees and expenses (the "Expenses") incurred by or on behalf of the Lender in connection with the negotiation, preparation, execution and delivery of this commitment letter, the Term Sheet and any and all definitive documentation relating hereto and thereto, including, but not limited to, the reasonable fees and expenses of counsel to the Lender in connection with any due diligence, collateral reviews and field examinations. The obligations of ACI Capital under this paragraph shall remain effective whether or not definitive documentation is executed and notwithstanding any termination of this commitment letter, provided, that, if, after the Acquisition, the Borrower enters into definitive documentation for the Financing Facility, the obligations of ACI Capital under this commitment letter and the Term Sheet shall thereupon terminate and be superseded in all respects by the obligations of the Borrower to the Lender. On the date of execution hereof, ACI Capital agrees to pay to the Lender, in immediately available funds, a commitment fee equal to $525,000 (the "Commitment Fee"), which fee shall be earned in full and payable on the first date on or after the date ACI Capital accepts this commitment letter and the Term Sheet and that the Investor has executed a definitive merger agreement (the "Merger Agreement") for the Acquisition. In addition, ACI Capital agrees to pay to the Lender, promptly after its request, additional expense deposits if the Lender determines that the amount of Expenses incurred or to be incurred by the Lender in connection with the Financing Facility exceeds or will exceed the amount of any expense deposit previously paid to the Lender. ACI Capital Co., Inc. December 28, 2001 Page 3 The Lender's commitment to provide the Financing Facility is subject to (i) the negotiation, execution and delivery of definitive loan documentation in form and substance satisfactory to the Lender, the Borrower and their respective counsel, (ii) the satisfaction of the Lender that at all times prior to and including the date on which the transactions referred to hereunder close that there has not occurred or become known to the Lender any material adverse change with respect to the condition, financial or otherwise, business, operations, assets, liabilities or prospects of the Borrower, as determined by the Lender in its sole discretion (a "Material Adverse Change"), (iii) the absence of any material disruption or general adverse developments in the financial markets, as determined by the Lender in its sole discretion, and (iv) such other customary conditions as set forth in the Term Sheet. If at any time the Lender shall determine (in its sole discretion exercised reasonably) that either (A) the Investor or the Borrower will be unable to fulfill any condition set forth in this commitment letter or in the Term Sheet or (B) any Material Adverse Change has occurred, the Lender may terminate this commitment letter by giving notice thereof to ACI Capital (subject to the obligation of ACI Capital to pay all fees, costs, expenses and other payment obligations expressly assumed by ACI Capital hereunder, which shall survive the termination of this commitment letter). The Investor represents and warrants that (i) all written information and other materials concerning the Investor, the Borrower or the Acquisition (collectively, the "Information") which has been, or is hereafter, made available by, or on behalf of the Investor is, or when delivered will be, when considered as a whole, complete and correct in all material respects and does not, or will not when delivered, contain any untrue statement of material fact or omit to state a material fact necessary in order to make the statements contained therein not misleading in light of the circumstances under which such statement has been made and (ii) to the extent that any such Information contains projections, such projections were prepared in good faith on the basis of (A) assumptions, methods and tests stated therein which are believed by the Investor or Jenny Craig, as applicable, to be reasonable and (B) information believed by the Investor or Jenny Craig, as applicable, to have been accurate based upon the information available to the Investor at the time such projections were furnished to the Lender. This commitment letter is delivered to ACI Capital upon the condition that, prior to its acceptance of this offer and the payment of the Commitment Fee, neither the existence of this commitment letter or the Term Sheet, nor any of their contents, shall be disclosed by the Investor, except as may be compelled to be disclosed in a judicial or administrative proceeding, as otherwise required by law or, on a confidential and "need to know" basis, solely to the directors, officers, employees, advisors and agents of the Investor or the Borrower and its representatives. In addition, the Investor agrees that it will (i) consult with the Lender prior to the making of any filing in which reference is made to the Lender or the commitment contained herein, and (ii) obtain the prior approval of the Lender before releasing any public announcement in which reference is made to the Lender or to the commitment contained herein. The Investor acknowledges that the Lender and its affiliates may now or hereafter provide financing or obtain other interests in other companies in respect of which the Investor, the Borrower or their affiliates may be business competitors, and that the Lender and its affiliates will have no obligation to provide to the Investor, the Borrower or any of their affiliates any confidential ACI Capital Co., Inc. December 28, 2001 Page 4 information obtained from such other companies. The Lender agrees that it will not provide confidential information obtained from the Investor or the Borrower except (i) as may, be compelled to be disclosed in a judicial or administrative proceedings, (ii) as otherwise required by law, or (iii) on a confidential and "need to know" basis to its directors, officers, employees, advisors and agents and to prospective assignees or participants, provided such persons have been instructed to keep such information confidential. The offer made by the Lender in this commitment letter shall expire, unless otherwise agreed by the Lender in writing, at 5:00 p.m. (New York City time) on January 5, 2002, unless prior thereto the Lender has received a copy of this commitment letter, signed by ACI Capital accepting the terms and conditions of this commitment letter and the Term Sheet. The commitment by the Lender to provide the Financing Facility shall expire at 5:00 p.m. (New York City time) on May 31, 2002, unless prior thereto, definitive loan documentation shall have been agreed to in writing by all parties and the conditions set forth therein shall have been satisfied (it being understood that the obligation of ACI Capital to pay all amounts in respect of indemnification and Expenses shall survive termination of this commitment letter). If after the Acquisition, the Borrower enters into definitive documentation for the Financing Facility, the obligations of the Investor and ACI Capital under this commitment letter and the Term Sheet shall thereupon terminate and be superseded in all respects by the obligations of the Borrower to the Lender. Should the terms and conditions of the offer contained herein meet with your approval, please indicate your acceptance by signing and returning a copy of this commitment letter to the Lender. ACI Capital Co., Inc. December 28, 2001 Page 5 This commitment letter, including the attached Term Sheet (i) supersedes all prior discussions, agreements, commitments, arrangements, negotiations or understandings, whether oral or written, of the parties with respect thereto, (ii) shall be governed by the law of the State of New York, (iii) shall be binding upon the parties and their respective successors and assigns, (iv) may not be relied upon or enforced by any other person or entity, and (v) may be signed in multiple counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. If this commitment letter becomes the subject of a dispute, each of the parties hereto hereby waives trial by jury. This commitment letter may be amended, modified or waived only in a writing signed by the parties hereto. Very truly yours, ABLECO FINANCE LLC By: /s/ DANIEL E. WOLF -------------------------- Name: Daniel E. Wolf Title: VP Agreed and accepted as of 23 day of Dec. 2001: ACI CAPITAL CO., INC. By: /s/ EZRA FIELD -------------------------- Name: Ezra Field Title: VP EXHIBIT A JENNY CRAIG, INC. AND ITS SUBSIDIARIES OUTLINE OF TERMS AND CONDITIONS FOR PROPOSED FINANCING FACILITY This Outline of Terms and Conditions is part of the Commitment Letter, dated December 28, 2001 (the "Commitment Letter"), addressed to ACI Capital Co., Inc. ("ACI Capital") by Ableco Finance LLC (a special situations lending company hereinafter referred to as the "Lender") and is subject to the terms and conditions of the Commitment Letter. Capitalized terms used herein shall have the meanings set forth in the Commitment Letter unless otherwise defined herein. BORROWER: Jenny Craig and certain of its subsidiaries as required by the Lender (collectively the "Borrower"). GUARANTORS: All subsidiaries of the Borrower that are not a Borrower as required by the Lender (together with the Borrower, each a "Loan Party" and collectively, the "Loan Parties"). LENDER: The Lender or affiliates thereof, to be designated at closing. FINANCING FACILITY: A revolving credit and term loan facility totaling not more than $35 million at any one time outstanding (the "Maximum Credit"), consisting of (i) a revolving credit facility in an aggregate principal amount at any time outstanding not exceeding $5 million, (ii) a tranche A term loan in an outstanding principal amount of $15 million (the "Term Loan A") and (iii) a tranche B term loan in an outstanding principal amount of $15 million (the "Term Loan B" and, together with the Term Loan A, the "Term Loans"). Revolving Credit Facility Aggregate revolving credit loans under the Financing Facility ("Revolving Loans") will be limited to $5 million. Such Revolving Loans will be made to the Borrower on not less than two (2) days prior notice and shall be in minimum amounts of $100,000. Term Loan Facility A term loan facility, consisting of the Term Loan A and the Term Loan B. (The Term Loans and the Revolving Loans are, collectively, the "Loans".) The Term Loans will be fully funded on the Closing Date (as defined herein). TERM: The Financing Facility will have a term of two (2) years (the "Maturity Date"), provided, that, subject to the conditions set forth in the Term Loan B Extension Fee section of this Term Sheet, at the election of the Borrower, the Term Loan B may be extended for a period of one year. AMORTIZATION: The Revolving Loans, the Term Loans (except with respect to the amortization described below) and other obligations outstanding under the Financing Facility will be payable in full on the Maturity Date. The Term Loan A will amortize on a monthly basis in installments of $250,000 for the first 12 months after the Closing Date and $350,000 for months 13 through 24 after the Closing Date. MANDATORY Customary mandatory prepayments to be included AND OPTIONAL PREPAYMENT: in definitive loan documentation (e.g., issuance of equity, debt, sale of assets, tax refunds, casualty events, etc.)., provided, that, in the absence of a continuing event of default, prepayments will not be required from the proceeds of equity issuances. Mandatory prepayments shall be applied, first, to prepay the outstanding principal amount of the Term Loan A (applied to installments thereof as selected by the Borrower if no event of default is continuing or, if an event of default is continuing, in the inverse order of maturity), second, to prepay the outstanding principal amount of the Term Loan B, and, lastly, to reduce the outstanding principal of the Revolving Loans. In addition, a prepayment of the Loans will be required if the principal amount of the Loans exceeds the cash collections of the Borrower for a period of seventy (70) days, measured at the end of each 70 day period (any such excess of the principal amount of the Loans over the cash collections is hereinafter referred to as the "Excess"). If as a result of the occurrence of an Excess any such payment is required, the Borrower will have the option of (i) prepaying the Loans to a level that would eliminate the Excess or (ii) providing cash collateral to the Lender for an amount equal to the amount of the Excess. After the Excess is eliminated and if no event of default is continuing, the Lender shall release any cash collateral provided to the Lender in connection with the Excess. Optional prepayments on the Term Loan A and the Term Loan B will be permitted, provided that the Term Loan A is repaid in full prior to any optional prepayment of the Term Loan B. Optional payments shall be applied to the installments of the Term Loan A as selected by the Borrower if no event of default is continuing, or if an event of default is continuing, in the inverse order of maturity. Amounts repaid under the Revolving Credit Facility may be re-borrowed. Except as provided above, the Borrower shall be permitted to prepay the Loans in whole or in part at any time without penalty or premium. Termination of the Financing Facility prior to the Maturity Date would not result in a prepayment fee. 2 CLOSING DATE: The first date on which all definitive loan documentation satisfactory to the Lender (the "Loan Documents") is executed by the Loan Parties and the Lender, which date shall not be later than May 31, 2002, unless otherwise agreed in writing by the Lender and the Borrower. COLLATERAL: All obligations of the Loan Parties to the Lender shall be secured by a perfected, first priority lien on and security interest in substantially all of the now owned and hereafter acquired assets of the Loan Parties, including, but not limited to, accounts receivable, inventory, real property, machinery and equipment, trademarks and tradenames, copyrights, patents and other intellectual property, general intangibles, chattel paper, all shares of all capital stock of subsidiaries of the Loan Parties and all proceeds thereof, and such other assets, tangible or intangible, as may be required, in the Lender's opinion, to fully secure the contemplated Loans under the Financing Facility (the "Collateral"). All borrowings by the Borrower, all costs, fees and expenses of the Lender and all other obligations owed to the Lender shall be secured as described above and shall be charged to the loan account to be established under the Financing Facility. INTEREST: All Revolving Loans shall bear interest at the rate per annum equal to six percent (6%) above the Reference Rate from time to time in effect. The Term Loan A shall bear interest at the rate per annum equal to seven and one-half percent (7.5%) above the Reference Rate from time to time in effect. The Term Loan B shall bear interest at the rate per annum equal to nine and one-half percent (9.5%) above the Reference Rate from time to time in effect. At no time shall the Reference Rate referred to above be less than five percent (5.0%). As used herein, "Reference Rate" means the rate of interest publicly announced from time to time by JP Morgan Chase Bank in New York, New York as its prime rate. All interest and fees shall be computed on the basis of a year of 360 days for the actual days elapsed. If any Event of Default shall occur and be continuing, interest shall accrue at a rate per annum equal to 3% in excess of the rate of interest otherwise in effect. CASH MANAGEMENT: All proceeds of Collateral shall be deposited in cash management accounts under the sole dominion and control of the Lender. In the absence of a continuing event of default and if availability under the Revolving Credit Facility and unencumbered cash are greater than or equal to an amount to be agreed upon, all funds deposited in such cash management accounts shall be permitted to be transferred to the operating accounts of the Borrower and used by the Borrower in the 3 ordinary course of its business. At any time an event of default is continuing or if availability under the Revolving Credit Facility and unencumbered cash are less than an amount to be agreed upon, the Lender may require that thereafter all funds deposited in such cash management accounts will be transferred to the Lender on each business day and applied to repay the outstanding Revolving Loans. Collections will be credited to the obligations on the day received in the cash management accounts conditional on final payment to the Lender. FEES: Closing Fee: 3% of the Maximum Credit, earned in full, non-refundable and payable on the Closing Date less the amount of the Commitment Fee paid pursuant to the Commitment Letter. Facility Fee: 1.25% of the outstanding amount of the Term Loan B will be earned in full, non-refundable and payable at the end of each period of 90 days after the Closing Date (i.e. payable on the 90th day, 180th day, 270th day, etc.). Term Loan B 3% of the then outstanding Extension Fee: Term Loan B earned in full, non-refundable and payable upon the Borrower's election to extend the Term Loan B for a period of one year. Such extension shall be subject to (i) the Borrower's compliance with the terms and conditions of the Financing Facility and (ii) the repayment of all Revolving Loans and the Term Loan A on or prior to the Maturity Date. USE OF PROCEEDS: The Loans under the Financing Facility will be used, in conjunction with $42,500,000 in cash equity or other securities acceptable to the Lender, solely (i) to consummate the Acquisition, (ii) for the general working capital requirements of the Borrower and (iii) to pay fees and expenses related to the financing contemplated by the Commitment Letter. 4 CONDITIONS PRECEDENT: The obligation of the Lender to make any Loans under the Financing Facility will be subject to customary conditions precedent including, without limitation, the following initial conditions precedent: (a) Execution and delivery of appropriate legal documentation in form and substance satisfactory to and required by the Lender and its counsel (including, without limitation, the financing agreement, the security and pledge agreements, the mortgages and title insurance policies, the guaranties, the block account agreements and the landlord waivers (for the headquarters of the Borrower), and the satisfaction of the conditions precedent contained therein. (b) There shall have occurred no event or condition which has had, or is reasonably likely to have, a Material Adverse Change. (c) The Lender's completion of its legal due diligence, including, without limitation, all ERISA, environmental, tax, accounting and labor matters, with results are satisfactory to the Lender; all necessary governmental and third party consents and approvals necessary in connection with the Financing Facility and the transactions contemplated thereby shall have been obtained (without the imposition of any conditions that are not reasonably acceptable to the Lender) and shall remain in effect; and no law or regulation shall be applicable in the reasonable judgment of the Lender that restrains, prevents or imposes materially adverse conditions upon the Financing Facility or the transactions contemplated thereby. (d) The Lender shall have been granted a perfected, first priority lien on all Collateral, and shall have received UCC, tax and judgment lien searches and other appropriate evidence (including title reports and surveys relating to all owned real property comprising Collateral), evidencing the absence of any other liens on the Collateral, except existing liens acceptable to the Lender. (e) Opinions from the Loan Parties' counsel as to such matters as the Lender and counsel to the Lender may reasonably request. (f) The Lender shall be satisfied with the cash management system of the Borrower. 5 (g) Insurance satisfactory to the Lender; such insurance to include liability insurance for which the Lender will be named as an additional insured and property insurance with respect to the Collateral for which the Lender will be named as loss payee. (h) There shall exist no claim, action, suit, investigation, litigation or proceeding, pending or threatened in any court or before any arbitrator or governmental instrumentality which relates to the Acquisition or the Financing Facility or which, in the opinion of the Lender, has any reasonable likelihood of having a Material Adverse Change. (i) The Borrower shall have, on the Closing Date, unrestricted cash balances of at least $7,500,000, after giving effect to (A) the Term Loans made on the Closing Date and (B) the payment of all fees and expenses related to the Financing Facility and no Revolving Loans shall be made on the Closing Date. (j) The Lender shall be satisfied with the terms of the cash equity contribution (or other securities acceptable to the Lender) of at least $42,500,000 which will fund the Acquisition. The Lender shall be satisfied with the terms of the Merger Agreement. (k) The Lender's loan origination costs including, without limitation, audit fees, attorneys' fees, search fees, title fees, documentation and filing fees, shall have been paid by the Borrower. (l) The Lender shall have received such financial and other information regarding the Loan Parties as the Lender may reasonably request. REPRESENTATIONS Usual representations and warranties, AND WARRANTIES: including, but not limited to, corporate existence and good standing, authority to enter into loan documentation, governmental approvals, non-violation of other agreements, financial statements, litigation, compliance with environmental, pension and other laws, taxes, insurance, absence of Material Adverse Change, absence of default or unmatured default under the Financing Facility and priority of the Lender's liens. COVENANTS: Usual covenants, including, but not limited to, provision of financial statements, notices of litigation, defaults and unmatured defaults and other information, compliance with pension, environmental and other laws, inspection of properties, books and records, maintenance of insurance, limitations with respect 6 to liens and encumbrances, dividends and retirement of capital stock, guarantees, sale and lease back transactions, consolidations and mergers, investments, capital expenditures, loans and advances, indebtedness, operating leases, transactions with affiliates, prepayment of other indebtedness and amendments to material agreements. The financial covenants for the Financing Facility shall be as set forth on Annex I attached hereto. Financial reporting to include: (i) annual, audited financial statements, (ii) quarterly, internally prepared, financial statements, (iii) monthly, internally prepared, financial statements, (iv) annual projections, including monthly balance sheet, profit and loss and cash flow figures, and (v) other reporting as required by the Lender. EVENTS OF DEFAULT: Usual events of default, including, but not limited to, payment, cross-default, violation of covenants, breach of representations or warranties, bankruptcy or insolvency, judgment, ERISA, environmental and change of control. GOVERNING LAW: All documentation in connection with the Financing Facility shall be governed by the laws of the State of New York. ASSIGNMENTS, PARTICIPATIONS: The Lender may sell or assign its loans or commitments under the Financing Facility without the consent of the Loan Parties. The Lender may also sell participations in its loans and commitments under the Financing Facility without the consent of the Loan Parties, provided that such participants shall be limited to customary voting rights. OUT-OF-POCKET EXPENSES: All fees, including reasonable legal fees, costs and expenses of counsel to the Lender, and all reasonable out-of-pocket expenses associated with the transaction, are to be paid by the Loan Parties. 7 ANNEX I Financial Covenants
2nd Quarter Out/ At Close 1st Quarter Out Holding Level - ---------------------------------------------------------------------------------------- Minimum Adjusted EBITDA $13.9 $13.9 $13.9 Leverage Ratio 2.35x 2.30x 2.25x Fixed Charge Coverage 1.6x(*) 1.6x(*) 1.7x(*) Ratio ("FCCR")
Adjusted EBITDA EBITDA for the latest twelve months, treating any management fees and/or Jenny Craig consulting fees actually paid (after close) as operating expenses, and subject to the following adjustments: (i) Trailing adjustments - litigation judgment, excess executive compensation, and public company costs; (ii) Pro Forma adjustments from closing - litigation judgment, middle-east refund and Y2K expense. Net Interest Expense ("NIE") Interest on the Term Loans plus quarterly extension fee on the Term Loan B, net of interest income on cash. Scheduled Principal Payments Amortization on Term Loan A of $250,000 for months 1 through 12, and $350,000 for months 13 through 24. Total Debt Includes capital lease obligation ($1.5 mm), the Term Loans, and funded portion of Revolving Loans, if any. Net Debt Total Debt less cash on the balance sheet. Leverage Ratio Net Debt divided by Adjusted EBITDA. Fixed Charge Coverage Ratio Adjusted EBITDA less maintenance capital expenditures for the latest twelve months, divided by NIE plus Scheduled Principal Payments ("SPP"). For the purpose of this covenant, NIE and SPP during the first four (4) quarters after the Transaction closes shall be calculated on an annualized basis and thereafter on a trailing basis. - ------------------------------ (*) Notwithstanding the headings of the covenant table, the FCCR shall be 1.6x for the first four quarters, and then 1.7x thereafter. 8
EX-99.(B)(2) 4 v79145orex99-b2.txt EXHIBIT (B)(2) Exhibit (b)(2) January 27, 2002 J Acquisition Corp. 900 Third Avenue 26th Floor New York, New York 10022 Re: Junior Subordinated Debt Commitment Gentlemen: Reference is made to that certain Agreement and Plan of Merger (the "Agreement"), dated as of the date hereof, by and between J Holdings Corp., a Delaware corporation ("Parent"), J Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (the "Borrower"), and Jenny Craig, Inc., a Delaware corporation (the "Company"), which agreement contemplates the acquisition by Parent of 100% of the outstanding shares of the Company (such acquisition, together with agreements related thereto or contemplated thereby, representing the "Transaction"). In connection therewith and in order to finance in part the Transaction, ACI Capital Co., Inc. (the "Lender") is pleased to advise you that it hereby commits to provide the Borrower with a Junior Subordinated Debt Financing in an aggregate principal amount of $9 million (the "Subdebt Financing"). The obligations of the Borrower under the Subdebt Financing will be secured by a second priority lien on, and security interest in, substantially all assets of the Borrower (it being understood that the Company will become the Borrower upon consummation of the Acquisition), the Parent and all domestic subsidiaries of the Borrower, in each case subject to such exclusions as the Lender (in its sole and absolute discretion) may agree. The Lender's commitment to provide the Subdebt Financing is subject in all respects to satisfaction of the terms and conditions contained in this commitment letter and in the Outline of Terms and Conditions attached hereto as Exhibit A (the "Term Sheet"). The Borrower acknowledges that the Term Sheet is intended as an outline only and does not purport to summarize all the conditions, covenants, representations, warranties and other provisions which would be contained in definitive legal documentation for the Subdebt Financing. The loan documentation for the Subdebt Financing will include, in addition to the provisions that are summarized in this commitment letter and the Term Sheet, provisions that, in the reasonable opinion of the Lender, are customary or typical for this type of financing transaction and other provisions that the Lender reasonably requires in the context of the proposed transaction. The Lender's commitment to provide the Subdebt Financing is subject to (i) the negotiation, execution and delivery of definitive loan documentation in form and substance satisfactory to the Lender, the Borrower and their respective counsel, (ii) the satisfaction of the conditions precedent to the closing of the Transaction set forth in Sections 6.1 and 6.3 (other than Section 6.3(c) of the Agreement), (iii) all conditions precedent to the obligation of the Senior Lender (as defined in the Agreement) to consummate the Senior Financing (as defined in the Agreement) having been met and the Senior Lender shall intend to and shall be willing and prepared to consummate the Senior Financing, in each case other than with respect to any conditions relating to the debt capital investment contemplated by this commitment letter, the debt capital commitment letter of DB Capital Investors, L.P. of even date herewith or the equity capital commitment letter of SJF Enterprises, Inc., of even date herewith, and (iv) satisfaction of the conditions as set forth in the Term Sheet. The offer made by the Lender in this commitment letter is contingent upon execution of the Agreement, and should the Agreement be executed, the commitment by Lender to provide the Subdebt Financing shall expire immediately upon the earlier of (i) the termination of the Agreement and (ii) the Expiration Date (as defined in the Agreement), as may be extended in accordance with the terms of the Agreement. Should the terms and conditions of the offer contained herein meet with your approval, please indicate your acceptance by signing and returning a copy of this commitment letter to the Lender. This commitment letter, including the attached Term Sheet (i) supersedes all prior discussions, agreements, commitments, arrangements, negotiations or understandings, whether oral or written, of the parties with respect to the subject matter hereof and thereof, (ii) shall be governed by the law of the State of New York, (iii) shall be binding upon the parties and their respective successors and assigns, (iv) may not be relied upon or enforced by any other person or entity other than the parties hereto and Parent, and (v) may be signed in multiple counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. If this commitment letter becomes the subject of a dispute, each of the parties hereto hereby waives trial by jury. This commitment letter may be amended, modified or waived only in a writing signed by the parties hereto. 2 Please confirm that the foregoing is in accordance with your understanding by signing and returning to the Lender the enclosed copy of this Commitment Letter on or before the close of business on the date hereof, whereupon this Commitment Letter shall become a binding agreement between us. Very truly yours, ACI CAPITAL CO., INC. By: /s/ KEVIN S. PENN -------------------------- Name: Kevin S. Penn Title: Managing Director Agreed and accepted on this 27th day of January, 2002: J ACQUISITION CORP. By: /s/ KEVIN S. PENN ------------------------------ Name: Kevin S. Penn Title: President 3 EXHIBIT A OUTLINE OF TERMS AND CONDITIONS FOR PROPOSED SUBDEBT FINANCING This Outline of Terms and Conditions is part of the Commitment Letter, dated January 27, 2002 (the "Commitment Letter"), addressed to J Acquisition Corp. by ACI Capital Co., Inc. (together with the other lenders party to the definitive Subdebt Financing agreement, the "Lenders") and is subject to the terms and conditions of the Commitment Letter. Capitalized terms used herein shall have the meanings set forth in the Commitment Letter unless otherwise defined herein. BORROWER: J Acquisition Corp. Upon consummation of the Merger, Jenny Craig, Inc. and certain of its subsidiaries, as required by the Lenders (collectively the "Borrower"). GUARANTORS: All domestic subsidiaries of the Borrower that are not included in the "Borrower," as required by the Lenders (together with the Borrower, each a "Loan Party" and collectively, the "Loan Parties"). LENDERS: The Lenders or their respective affiliates thereof, to be designated at closing. FINANCING FACILITY: Junior Subordinated Debt Financing of up to $24 million (the "Subdebt Financing"). The Subdebt Financing will be funded in a single draw on the Closing Date (as defined below) and will be structured as a term loan which may not, once repaid, be drawn upon again. ACI will fund $9 million of the Subdebt Financing and DB Capital Investors, L.P. will fund $15 million thereof. TERM: The Subdebt Financing will have a term of five (5) years (the "Maturity Date"). AMORTIZATION: The Subdebt Financing will be payable in full on the Maturity Date. MANDATORY Customary mandatory prepayments to be included AND OPTIONAL PREPAYMENT: in definitive loan documentation (e.g., issuance of equity, debt, sale of assets, tax refunds, casualty events, etc.). Optional prepayments on the Subdebt Financing will be permitted in whole or in part, and from time to time. Prepayments will be subject to a one-year interest penalty in the first three years following the closing of the Transaction; a half-year interest penalty in the fourth year following the closing of the Transaction; and no prepayment penalty in the fifth year following the closing of the Transaction. Such penalties will be computed based on the interest rate in effect at the time of the prepayment. CLOSING DATE: On or prior to the closing date of, and immediately prior to, the Transaction (the "Closing Date"). COLLATERAL: All obligations of the Loan Parties to the Lenders shall be secured by a perfected, second priority lien on and security interest in substantially all of the now owned and hereafter acquired assets of the Loan Parties, including, but not limited to, accounts receivable, inventory, machinery and equipment, trademarks and tradenames, copyrights, patents and other intellectual property, general intangibles, chattel paper, all shares of all capital stock of domestic subsidiaries of the Borrower and 65% of the shares of capital stock 4 of all foreign subsidiaries of the Borrower, and all proceeds thereof, and such other assets, tangible or intangible, as may be required, in the Lenders' opinion, as security for the contemplated Subdebt Financing (the "Collateral"). All borrowings by the Borrower, all costs, fees and expenses of the Lenders and all other obligations owed to the Lenders shall be secured as described above and shall be charged to the loan account to be established under the Subdebt Financing. INTEREST: The Subdebt Financing shall bear interest at a rate calculated in the same manner as the rate payable on the Ableco Term B loan (including, for the purposes of determining the rate payable on the Ableco Term B loan, the facility fee payable thereunder). If the Ableco Term Loan B is no longer outstanding, the rate on the Subdebt Financing shall continue to be the rate that would have been payable had such Ableco Term Loan B continued to be outstanding. The interest shall be payable quarterly, and in-kind, in whole or in part, at the option of Borrower. All interest shall be computed on the basis of a year of 360 days for the actual days elapsed. If any Event of Default shall occur and be continuing, interest shall accrue at a rate per annum equal to 3% in excess of the prevailing rate. WARRANTS: In connection with and consideration for the Subdebt Financing, the Lenders shall be issued warrants (the "Warrants") to acquire 15% of the common equity of Parent on a fully diluted basis, at an exercise price per share equal to the price per share of the Parent's common stock. The Warrants shall be allocated to the Lenders ratably to their capital contributions to the Subdebt Financing. FEES: Closing Fee equal to 3% of the Subdebt Financing. USE OF PROCEEDS: The Loans under the Subdebt Financing will be used solely (i) to consummate the Transaction, (ii) for the general working capital requirements of the Borrower and (iii) to pay fees and expenses related to the Subdebt Financing. CONDITIONS PRECEDENT: The obligation of the Lenders to fund the Subdebt Financing on the Closing Date will be subject to customary conditions precedent including, without limitation, the following: 5 (a) Execution and delivery of appropriate legal documentation in form and substance satisfactory to and as required by the Lenders and their respective counsel (including, without limitation, the Subdebt Financing agreement, the security and pledge agreements, the mortgages and title insurance policies, the guaranties, the landlord waivers, other collateral access agreements, and the satisfaction of the conditions precedent contained therein). (b) Satisfaction of all conditions precedent to Parent's and Purchaser's obligations to close under the Agreement (other than the conditions set forth in Section 6.3(c) of the Agreement; provided, however, that all conditions precedent to the obligation of the Senior Lender (as defined in the Agreement) to consummate the Senior Financing (as defined in the Agreement) have been met and the Senior Lender shall intend to and shall be willing and prepared to consummate the Senior Financing, in each case other than with respect to any conditions relating to the debt capital investment contemplated by the Commitment Letter, the debt capital commitment letter of DB Capital Investors, L.P. of even date herewith, or the equity capital commitment letter of SJF Enterprises, Inc., of even date herewith). (c) The Lenders shall have been granted a perfected, second priority lien on all Collateral, and shall have received UCC, tax and judgment lien searches and other appropriate evidence (including title reports and surveys relating to all owned real property comprising Collateral), evidencing the absence of any other liens on the Collateral, except existing liens acceptable to the Lenders and the lien securing the Senior Financing. (d) Opinions from the Loan Parties' counsel as to such matters as the Lenders and the respective counsel to the Lenders may reasonably request. REPRESENTATIONS AND WARRANTIES: Bring-down of representations and warranties in the Agreement, plus authority to enter into Subdebt Financing documentation, non-violation of other agreements, and enforceability and priority of the Lenders' liens. COVENANTS: Usual covenants, including, but not limited to, provision of financial statements, notices of litigation, defaults and unmatured defaults and other information, compliance with pension, environmental and other laws, inspection of properties, books and records, maintenance of insurance, limitations with respect to liens and encumbrances, dividends and retirement of capital stock, guarantees, sale and lease back transactions, consolidations and mergers, investments, capital expenditures, loans and advances, indebtedness, operating leases, transactions with affiliates, prepayment of other indebtedness and amendments to material agreements. The loan documentation will contain the same financial covenants as those contained in the Senior Financing loan documents. Financial reporting to include: (i) annual, audited financial statements, (ii) quarterly, internally prepared, financial statements, (iii) monthly, internally prepared, financial statements, (iv) annual projections, including monthly balance sheet, profit and loss and cash flow figures, and (v) other reporting as required by the Lenders. 6 EVENTS OF DEFAULT: Usual events of default, including, but not limited to, payment, cross-default, violation of covenants, breach of representations or warranties, bankruptcy or insolvency, judgment, ERISA, environmental and change of control; provided, that so long as the Borrower has outstanding indebtedness under the Senior Financing and to the extent the Subdebt Financing is held by the original Lenders (or their respective affiliates), the only events of default that will permit the Lenders to exercise their rights to accelerate the maturity of the Subdebt Financing or foreclose on any security will be bankruptcy and insolvency and an event of default under Senior Financing pursuant to which the Senior Lender accelerates and forecloses on the security. GOVERNING LAW: All documentation in connection with the Subdebt Financing shall be governed by the laws of the State of New York. ASSIGNMENTS, PARTICIPATIONS: The Lenders may sell or assign their respective loans under the Subdebt Financing without the consent of the other Loan Parties. The Lenders may also sell participations in their respective loans under the Subdebt Financing without the consent of the other Loan Parties, provided that such participants shall be limited to customary voting rights. FEES & EXPENSES: Upon closing of the Transaction, the Borrower shall be fully obligated to pay, and shall immediately, reimburse the Lenders for all their out-of-pocket expenses incurred in connection with the Transaction and pay the Lenders a fee of 3% of the Subdebt Financing. 7 EX-99.(B)(3) 5 v79145orex99-b3.txt EXHIBIT (B)(3) EXHIBIT (b)(3) DB CAPITAL INVESTORS, L.P. 31 WEST 52ND STREET 26TH FLOOR NEW YORK, NEW YORK 10019 SUB DEBT COMMITMENT LETTER January 27, 2002 J Holdings Corp. J Acquisition Corp. ACI Capital Co., Inc. c/o ACI Capital Co., Inc. 900 Third Avenue 26th Floor New York, New York 10022 Ladies and Gentlemen: We are pleased to confirm the arrangements under which DB Capital Investors, L.P. ("DBCI") is committed to provide subordinated debt in connection with the transactions described herein in the amount, on the terms and subject to the conditions set forth in this letter (together, the "COMMITMENT LETTER") and the Fee Letter (as defined below). We understand that J Holdings Corp., a Delaware company ("PARENT", which is a newly formed, wholly owned subsidiary of ACI Capital Co., Inc. ("ACI")), and J Acquisition Corp., a Delaware company and a wholly owned subsidiary of Parent ("PURCHASER"), will sign, concurrently herewith, a merger agreement, dated the date hereof, and in the form attached hereto as EXHIBIT A (along with any other agreements or documents entered into in connection therewith or delivered pursuant thereto, the "ACQUISITION AGREEMENT") to acquire (the "ACQUISITION") all of the issued and outstanding common stock of Jenny Craig, Inc., a Delaware corporation (the "COMPANY"). In addition, in connection with the Acquisition, Parent, Purchaser, Sidney Craig, Jenny Craig, SJF Enterprises, Inc., DA Holdings, Inc., Craig Enterprises, Inc. and the Company will enter into a Stockholders' Voting Agreement, dated the date hereof and substantially in the form attached hereto as EXHIBIT B (along with any other agreements or documents entered into in connection therewith or delivered pursuant thereto, the "VOTING AGREEMENT"). We have confirmed that the total purchase price and financing requirements (including equity financing being provided by ACI, Company stockholders and management) for the Acquisition will be financed as set forth on EXHIBIT C hereto (the "FINANCINGS"). 1. Commitment. DBCI is pleased to confirm its commitment (the "COMMITMENT") to participate in Purchaser's Junior Subordinated Debt Financing (the "SUBDEBT Financing") in an aggregate principal amount of $15 million, on the terms and subject to the conditions contained in this Commitment Letter and in the outline of terms and conditions attached hereto as Exhibit D (the "TERM SHEET"). The obligations of Purchaser under the Subdebt Financing will be secured by a second priority lien on, and security interest in, substantially all assets of Purchaser (it being understood that the Company will become the borrower under the Subdebt Financing upon consummation of the Acquisition), Parent and all domestic subsidiaries of Purchaser, in each case subject to such exclusions as both of ACI and DBCI (in their sole and absolute discretion) may agree. DBCI's Commitment is subject, in its discretion, to the conditions set forth in this Commitment Letter and the Term Sheet and to the negotiation, execution and delivery of definitive documentation evidencing the Financings (along with any other agreements or documents entered into in connection therewith or delivered pursuant thereto, the "FINANCING AGREEMENTS"), satisfactory to DBCI and its counsel and the satisfaction of the terms, conditions and covenants contained therein. 2. Fees and Expenses. The fees for these services, among others, are to be set forth in a separate letter (the "FEE LETTER"), to be entered into prior to the closing of the Acquisition by and among ACI, DBCI, Parent and Purchaser. 3. Conditions Precedent. DBCI's obligations hereunder are conditioned on the following: a. The transactions contemplated by the Acquisition Agreement and the Voting Agreement shall have been consummated concurrently with, or shall be ready for consummation immediately after, DBCI's debt financing hereunder on the terms and conditions set forth in such agreements without modification, amendment or waiver, except as previously consented to in writing by DBCI. All conditions precedent to the obligations of Parent and Purchaser under such agreements (other than Section 6.3(c) of the Acquisition Agreement) shall have been satisfied without modification, amendment or waiver, except as previously consented to in writing by DBCI. b. The transactions contemplated by the Financing Agreements shall have been consummated prior to or concurrently with DBCI's debt financing hereunder in accordance with their terms, without modification, amendment or waiver, except as previously consented to in writing by DBCI. All conditions precedent to the obligations of the lenders or investors under the Financing Agreements shall have been satisfied, other than any conditions relating to the debt capital contemplated by this letter, the equity capital commitment letters from SJF Enterprises, Inc., ACI and DBCI and the junior subordinated debt commitment letter from ACI, each of even date herewith. 2 c. ACI, Parent and Purchaser shall have complied with their obligations hereunder. 4. Covenants. DBCI, ACI, Parent and Purchaser agree as follows: a. DBCI shall, and shall be permitted to, consummate the investment contemplated by the Commitment in accordance with the terms hereof. b. Parent and Purchaser shall, and ACI shall cause them to, consummate the transactions contemplated by the Acquisition Agreement and the Voting Agreement and satisfy their obligations thereunder, without amendment, modification or waiver except as previously consented to in writing by DBCI. c. ACI, Parent and Purchaser shall, and ACI shall cause Parent and Purchaser to, consummate the transactions contemplated by the Financing Agreements without amendment, modification or waiver, except as previously consented to in writing by DBCI. Without limiting the generality of the foregoing, there shall be no equity, debt or other financing of any type other than as set forth on EXHIBIT C hereto, without the prior written consent of DBCI. d. Parent and Purchaser shall, and ACI shall cause them to, to the extent commercially reasonable, enforce their respective rights and the obligations of the Company and other parties to the Acquisition Agreement or Voting Agreement (such other parties to the Voting Agreement, the "JC PARTIES"), including any rights to compensation or payments of any kind from any of the Company or the JC Parties whether or not the Acquisition is consummated, whether in respect of damages for breach, payments of termination fees, payments of expenses, gains owing under the Voting Agreement or otherwise. e. ACI, Parent and Purchaser shall promptly keep DBCI informed of, consult and confer with DBCI on all matters relating to the Acquisition, Acquisition Agreement, Voting Agreement, Financing and Financing Agreements and any discussions, communications or negotiations by and between ACI, Parent and Purchaser on the one hand and any of the Company or the JC Parties on the other hand in respect thereof. Such obligation shall include provision of copies of material correspondence, documents and other information and adequate notice and opportunity to attend conferences and meetings in respect thereof. In addition ACI, Parent and Purchaser shall apprise DBCI of, and consult with DBCI concerning all actions they may take or consider pursuant to or as contemplated by the Acquisition Agreement, Voting Agreement and Financing Agreements including exercise of rights thereunder regarding termination, information, further assurances, covenants, conditions, rights upon breach, enforcement of nonsolicitation and other rights. f. Without limiting DBCI's other rights in this Commitment Letter, in the event that an alternate bidder for the Company emerges or for some other reason an altered or improved bid for the Company is necessary or contemplated, DBCI will be 3 given the opportunity, but will not be obligated, to participate in any transactions contemplated in order to improve the terms of the Acquisition Agreement or make an alternative offer for the Company on the same percentage basis relative to ACI as the percentage resulting from dividing DBCI's original commitment to purchase debt and equity capital in Parent hereunder by ACI's original commitment to purchase debt and equity capital in Parent. 5. Acknowledgment. Each of ACI and DBCI has, independently and without reliance on the other party, based on such information and due diligence it has conducted as it has deemed appropriate, made its own analysis and decision to enter into its commitment to invest in Parent and to enter into the other documents and transactions contemplated by the Acquisition and the Acquisition Agreement. Each of ACI and DBCI will independently and without reliance upon the other party, continue to make its own decisions and to conduct its own due diligence with respect to the operation of the Company and the matters, transactions and any related agreements contemplated by the Acquisition and the Acquisition Agreement. ACI represents and warrants that it has made available to DBCI all the due diligence materials which ACI has received from the Company. 6. Confidentiality. Please note that this Commitment Letter, the Fee Letter, the transactions contemplated hereby and any written or oral information provided by DBCI in connection with this arrangement is exclusively for the information of ACI, Parent, Purchaser and the Company and may not be disclosed to any other party or circulated or referred to publicly without DBCI's prior written consent, except that you may disclose such information to your and the Company's officers, directors, agents and advisors who are directly involved in the consideration of the transactions contemplated hereby to the extent such persons are obligated to hold such advice in confidence or if otherwise required by law or in the event such information or documents are made public through no fault of ACI, Parent or Purchaser. 7. Assignment. None of DBCI, ACI, Parent or Purchaser may assign any of their respective rights or be relieved of any of their respective obligations hereunder without the prior written consent of the other parties hereto. 8. Termination. The Commitment will terminate upon the first to occur of (i) the closing of the Acquisition, (ii) the abandonment or termination of the Acquisition Agreement, (iii) a material breach by ACI, Parent or Purchaser under this Commitment Letter or the Fee Letter, provided, however, that DBCI shall notify ACI in writing of such breach, whereupon ACI shall have a commercially reasonable period of time (not to exceed twenty (20) calendar days) after ACI's receipt of such notice to cure such breach or (iv) the Expiration Date (as defined in the Acquisition Agreement), as may be extended in accordance with the terms of the Acquisition Agreement. 4 Please confirm that the foregoing is in accordance with your understanding by signing and returning to DBCI the enclosed copy of this Commitment Letter on or before the close of business on the date hereof, whereupon this Commitment Letter shall become a binding agreement among us. Very truly yours, DB CAPITAL INVESTORS, L.P. By: /s/ ROBERT SHARP --------------------------- Authorized Signatory Confirmed as of the date above: ACI CAPITAL CO., INC. By: /s/ KEVIN S. PENN ------------------------------ Name: Kevin S. Penn Title: Managing Director Confirmed as of the date above: J HOLDINGS CORP. By: /s/ KEVIN S. PENN ------------------------------ Name: Kevin S. Penn Title: President 5 Confirmed as of the date above: J ACQUISITION CORP. By: /s/ KEVIN S. PENN ----------------------------- Name: Kevin S. Penn Title: President 6 EXHIBIT D OUTLINE OF TERMS AND CONDITIONS FOR PROPOSED SUBDEBT FINANCING This Outline of Terms and Conditions is part of the Sub Debt Commitment Letter, dated January 27, 2002 (the "Commitment Letter"), addressed to J Holdings Corp., J Acquisition Corp. and ACI Capital Co., Inc. ("ACI") by DB Capital Investors, L.P. (together with the other lenders party to the definitive Subdebt Financing agreement, the "Lenders") and is subject to the terms and conditions of the Commitment Letter. Capitalized terms used herein shall have the meanings set forth in the Commitment Letter unless otherwise defined herein. BORROWER: J Acquisition Corp. Upon consummation of the Acquisition, Jenny Craig, Inc. and certain of its subsidiaries, as required by the Lenders (collectively the "Borrower"). GUARANTORS: All domestic subsidiaries of the Borrower that are not included in the "Borrower," as required by the Lenders (together with the Borrower, each a "Loan Party" and collectively, the "Loan Parties"). LENDERS: The Lenders or their respective affiliates thereof, to be designated at closing. FINANCING FACILITY: Junior Subordinated Debt Financing of up to $24 million (the "Subdebt Financing"). The Subdebt Financing will be funded in a single draw on the Closing Date (as defined below) and will be structured as a term loan which may not, once repaid, be drawn upon again. ACI will fund $9 million of the Subdebt Financing and DB Capital Investors, L.P. will fund $15 million thereof. TERM: The Subdebt Financing will have a term of five (5) years (the "Maturity Date"). AMORTIZATION: The Subdebt Financing will be payable in full on the Maturity Date. MANDATORY AND OPTIONAL PREPAYMENT: Customary mandatory prepayments to be included in definitive loan documentation (e.g., issuance of equity, debt, sale of assets, tax refunds, casualty events, etc.). Optional prepayments on the Subdebt Financing will be permitted in whole or in part, and from time to time. Prepayments will be subject to a one-year interest penalty in the first three years following the closing of the Acquisition; a half-year interest penalty in the fourth year following the closing of the Acquisition; and no prepayment penalty in the fifth year following the closing of the Acquisition. Such penalties will be computed based on the interest rate in effect at the time of the prepayment. CLOSING DATE: On or prior to the closing date of, and immediately prior to, the Acquisition (the "Closing Date"). COLLATERAL: All obligations of the Loan Parties to the Lenders shall be secured by a perfected, second priority lien on and security interest in substantially all of the now owned and hereafter acquired assets of the Loan Parties, including, but not limited to, accounts receivable, inventory, machinery and equipment, trademarks and tradenames, copyrights, patents and other intellectual property, general intangibles, chattel paper, all shares of all capital stock of domestic subsidiaries of the Borrower and 65% of the shares of capital stock 1 of all foreign subsidiaries of the Borrower, and all proceeds thereof, and such other assets, tangible or intangible, as may be required, in the Lenders' opinion, as security for the contemplated Subdebt Financing (the "Collateral"). All borrowings by the Borrower, all costs, fees and expenses of the Lenders and all other obligations owed to the Lenders shall be secured as described above and shall be charged to the loan account to be established under the Subdebt Financing. INTEREST: The Subdebt Financing shall bear interest at a rate calculated in the same manner as the rate payable on the Ableco Term B loan (including, for the purposes of determining the rate payable on the Ableco Term B loan, the facility fee payable thereunder). If the Ableco Term Loan B is no longer outstanding, the rate on the Subdebt Financing shall continue to be the rate that would have been payable had such Ableco Term Loan B continued to be outstanding. The interest shall be payable quarterly, and in-kind, in whole or in part, at the option of Borrower. All interest shall be computed on the basis of a year of 360 days for the actual days elapsed. If any Event of Default shall occur and be continuing, interest shall accrue at a rate per annum equal to 3% in excess of the prevailing rate. WARRANTS: In connection with and consideration for the Subdebt Financing, the Lenders shall be issued warrants (the "Warrants") to acquire 15% of the common equity of Parent on a fully diluted basis, at an exercise price per share equal to the price per share of the Parent's common stock. The Warrants shall be allocated to the Lenders ratably to their capital contributions to the Subdebt Financing. FEES: Closing Fee equal to 3% of the Subdebt Financing. USE OF PROCEEDS: The Loans under the Subdebt Financing will be used solely (i) to consummate the Acquisition, (ii) for the general working capital requirements of the Borrower and (iii) to pay fees and expenses related to the Subdebt Financing. CONDITIONS PRECEDENT: The obligation of the Lenders to fund the Subdebt Financing on the Closing Date will be subject to customary conditions precedent including, without limitation, the following: 2 (a) Execution and delivery of appropriate legal documentation in form and substance satisfactory to and as required by the Lenders and their respective counsel (including, without limitation, the Subdebt Financing agreement, the security and pledge agreements, the mortgages and title insurance policies, the guaranties, the landlord waivers, other collateral access agreements, and the satisfaction of the conditions precedent contained therein). (b) Satisfaction of all conditions precedent to Parent's and Purchaser's obligations to close under the Acquisition Agreement (other than the conditions set forth in Section 6.3(c) of the Acquisition Agreement; provided, however, that all conditions precedent to the obligation of the Senior Lender (as defined in the Acquisition Agreement) to consummate the Senior Financing (as defined in the Acquisition Agreement) have been met and the Senior Lender shall intend to and shall be willing and prepared to consummate the Senior Financing, in each case other than with respect to any conditions relating to the debt capital investment contemplated by the Commitment Letter, the debt capital commitment letter of ACI of even date herewith, or the equity capital commitment letter of SJF Enterprises, Inc., of even date herewith). (c) The Lenders shall have been granted a perfected, second priority lien on all Collateral, and shall have received UCC, tax and judgment lien searches and other appropriate evidence (including title reports and surveys relating to all owned real property comprising Collateral), evidencing the absence of any other liens on the Collateral, except existing liens acceptable to the Lenders and the lien securing the senior debt financing described in Section 4.5(a) of the Acquisition Agreement (the "Senior Financing.") (d) Opinions from the Loan Parties' counsel as to such matters as the Lenders and the respective counsel to the Lenders may reasonably request. REPRESENTATIONS AND WARRANTIES: Bring-down of representations and warranties in the Acquisition Agreement, plus authority to enter into Subdebt Financing documentation, non-violation of other agreements, and enforceability and priority of the Lenders' liens. COVENANTS: Usual covenants, including, but not limited to, provision of financial statements, notices of litigation, defaults and unmatured defaults and other information, compliance with pension, environmental and other laws, inspection of properties, books and records, maintenance of insurance, limitations with respect to liens and encumbrances, dividends and retirement of capital stock, guarantees, sale and lease back transactions, consolidations and mergers, investments, capital expenditures, loans and advances, indebtedness, operating leases, transactions with affiliates, prepayment of other indebtedness and amendments to material agreements. The loan documentation will contain the same financial covenants as those contained in the Senior Financing loan documents. 3 ' Financial reporting to include: (i) annual, audited financial statements, (ii) quarterly, internally prepared, financial statements, (iii) monthly, internally prepared, financial statements, (iv) annual projections, including monthly balance sheet, profit and loss and cash flow figures, and (v) other reporting as required by the Lenders. EVENTS OF DEFAULT: Usual events of default, including, but not limited to, payment, cross-default, violation of covenants, breach of representations or warranties, bankruptcy or insolvency, judgment, ERISA, environmental and change of control; provided, that so long as the Borrower has outstanding indebtedness under the Senior Financing and to the extent the Subdebt Financing is held by the original Lenders (or their respective affiliates), the only events of default that will permit the Lenders to exercise their rights to accelerate the maturity of the Subdebt Financing or foreclose on any security will be bankruptcy and insolvency and an event of default under the Senior Financing pursuant to which the Senior Lender accelerates and forecloses on the security. GOVERNING LAW: All documentation in connection with the Subdebt Financing shall be governed by the laws of the State of New York. ASSIGNMENTS, PARTICIPATIONS: The Lenders may sell or assign their respective loans under the Subdebt Financing without the consent of the other Loan Parties. The Lenders may also sell participations in their respective loans under the Subdebt Financing without the consent of the other Loan Parties, provided that such participants shall be limited to customary voting rights. FEES & EXPENSES: Upon closing of the Acquisition, the Borrower shall be fully obligated to pay, and shall immediately, reimburse the Lenders for all their out-of-pocket expenses incurred in connection with the Acquisition and pay the Lenders a fee of 3% of the Subdebt Financing. 4 EX-99.(C)(2) 6 v79145orex99-c2.txt EXHIBIT (C)(2) Exhibit (c)(2) [JENNY CRAIG LOGO] JENNY CRAIG, INC. PRESENTATION TO THE INDEPENDENT COMMITTEE OF THE BOARD OF DIRECTORS January 25, 2002 HOULIHAN LOKEY HOWARD & ZUKIN Financial Advisors 1930 Century Park West Los Angeles, California 90067 (310) 553-8871 - http://www.hlhz.com Los Angeles - New York - Chicago - San Francisco Washington, D.C. - Minneapolis - Dallas - Atlanta - Toronto [JENNY CRAIG LOGO] TABLE OF CONTENTS
SECTION ------- Engagement Overview ................................................... A Due Diligence ......................................................... B Company Overview and Other Information ................................ C Summary Conclusions ................................................... D Valuation Considerations and Issues ................................... E Auction Overview and the Purchasers' Offer ............................ F Fairness/Valuation Analysis ........................................... G Appendices Comparable Company Descriptions ................................ 1 Comparable Company Financial Information ....................... 2 Selected Comparable Transactions ............................... 3 Net Operating Loss Analysis .................................... 4 Termination Fee Study .......................................... 5 LBO Model ...................................................... 6 Valuation Summary .............................................. 7
Houlihan Lokey Howard & Zukin Financial Advisors i ENGAGEMENT OVERVIEW [JENNY CRAIG LOGO] ENGAGEMENT OVERVIEW ENGAGEMENT OVERVIEW OVERVIEW OF TRANSACTION - - We understand that the Board of Directors (the "Board") of Jenny Craig, Inc. (the "Company" hereinafter) has received a proposal from a newly formed company controlled by ACI Capital ("ACI") and DB Capital Partners LP (collectively, the "Purchasers") pursuant to which the Purchasers will acquire all of the outstanding shares of the Company at $5.30/share, except for certain shares held by Sid and Jenny Craig (collectively, the "Craigs"); - - We further understand that in connection with such transaction, the Craig's will rollover certain shares in the Company into certain equity securities (representing approximately 20 percent interest in the newly formed company); - - The Craig's currently own approximately 69 percent of the Company's common stock; - - The Purchasers' acquisition of the Company's stock, the Craig's equity rollover, and other related transactions disclosed to Houlihan Lokey are collectively referred to herein as the "Transaction"; - - We understand that the Board of Directors of the Company has formed the Independent Committee of the Board of Directors (the "Committee") to consider certain matters regarding the Transaction; ROLE OF HOULIHAN LOKEY - - The Committee has requested that Houlihan Lokey render an opinion (the "Opinion") as to the fairness, from a financial point of view, to the public stockholders of the Company of the consideration to be received by them in connection with the Transaction. - - The Opinion shall not address the Company's underlying business decision to effect the Transaction. Houlihan Lokey Howard & Zukin Financial Advisors 1 DUE DILIGENCE [JENNY CRAIG LOGO] DUE DILIGENCE In connection with this Opinion, we have made such reviews, analyses and inquiries as we have deemed necessary and appropriate under the circumstances. Among other things, we have: 1. reviewed the Company's annual reports on Form 10-K for the five fiscal years ended June 30, 2001 and quarterly report on Form 10-Q for the quarter ended September 30, 2001, and Company-prepared interim financial statements for the 5-months ended November 30, 2001, which the Company's management has identified as being the most current financial statements available; 2. met with certain members of the senior management of the Company to discuss the operations, financial condition, future prospects and projected operations and performance of the Company, and met with representatives of Koffler & Company ("Koffler"), the Company's investment bankers, to discuss certain matters; 3. visited the business offices of the Company in La Jolla, California; 4. reviewed the Company's Confidential Information Memorandum dated Summer 2001 and other information and correspondence provided to potential investors in connection with the proposed sale of the Company; 5. reviewed forecasts and projections prepared by the Company's management with respect to the Company for the years ended June 30, 2002 and 2003; 6. reviewed the historical market prices and trading volume for the Company's publicly traded securities, and reviewed publicly-available analyst reports, news articles, and press releases relating to the Company; 7. reviewed certain information, including a summary of offers received, in connection with the proposed sale of the Company, prepared by Koffler; 8. reviewed the latest available draft of the Stock Purchase Agreement regarding to the Transaction; 9. reviewed certain other publicly available financial data for certain companies that we deem comparable to the Company, and publicly available prices and premiums paid in other transactions that we considered similar to the Transaction; and 10. conducted such other studies, analyses and inquiries as we have deemed appropriate. Houlihan Lokey Howard & Zukin Financial Advisors 3 COMPANY OVERVIEW AND OTHER INFORMATION [JENNY CRAIG LOGO] COMPANY OVERVIEW AND OTHER INFORMATION COMPANY OVERVIEW AND OTHER INFORMATION - - The Company provides a comprehensive weight management program through a chain of 654 Company-owned and franchised weight loss centers; - - During the latest twelve months ended November 30, 2001, the Company reported revenues of $297 million; - - After several years of negative operating trends, the Company's prospects appear to be improving: - U.S. Operations appear to be "turning the corner" - Same-store sales growth in the 4th quarter of fiscal year 2001 (year ended June 30, 2001), - Improved marketing, - Successful introduction of Ultimate Choice, - Price increases implemented during the year, - Ongoing "re-imaging" of the Company as more service-oriented, - CEO believes she has the right "management team" in place. - The Australian operations appear to have stabilized - Operations are still cash flow positive, although substantially below historical profitability levels, - Several key management positions are still vacant. - IN SPITE OF THE POSITIVE DEVELOPMENTS ABOVE, IT REMAINS UNCLEAR AS TO WHETHER SUCH RECENT RESULTS REFLECT A TRUE TURNAROUND OF THE BUSINESS OR JUST A SHORT-TERM ABERRATION. - A KEY INDICATOR OF THIS POTENTIAL TURNAROUND WILL BE THE COMPANY'S PERFORMANCE IN THE THIRD QUARTER OF THE CURRENT FISCAL YEAR (JANUARY THROUGH MARCH 2002). Houlihan Lokey Howard & Zukin Financial Advisors 5 [JENNY CRAIG LOGO] COMPANY OVERVIEW AND OTHER INFORMATION - - Stock price performance - The Company's stock price dropped immediately in August 2000 after the announcement that the $3.75/share buyout offer was withdrawn by Craig. - Subsequently, the stock price has generally traded at or below approximately $2.00 per share.(1) - In May 2001, the Company disclosed the hiring of Koffler to explore alternatives to maximize shareholder value, including the possible sale of the Company. - Stock was delisted from the NYSE in August 2001 and is currently traded in the OTC market. - Current stock price appears to significantly under-value the Company's core operations. - - Other Information - A substantial portion of the litigation judgment relating to the lease of the Company's former headquarters was reversed in October 2001. - The sale of the Company's headquarters was completed in July 2001, providing net proceeds of $15 million, - The Company's primary shareholders (Sid and Jenny Craig), both nearing 70 years of age, are seeking to diversify their personal holding as they approach retirement. - ---------- (1) The Company's stock price recently "spiked" to approximately $3/share in the absence of any apparent significant announcement or market event. Houlihan Lokey Howard & Zukin Financial Advisors 6 [JENNY CRAIG LOGO] COMPANY OVERVIEW AND OTHER INFORMATION PRICE/VOLUME CHART [DAILY PRICE/VOLUME GRAPH] Houlihan Lokey Howard & Zukin Financial Advisors 7 [JENNY CRAIG LOGO] COMPANY OVERVIEW AND OTHER INFORMATION DAILY STOCK PRICE AND TRADING VOLUME BASED ON CLOSING PRICES FROM 01/24/01 TO 01/24/02 SUMMARY STATISTICS Closing Price on 01/24/02 (pre-Announcement) $3.00 High Closing Price $3.12 Low Closing Price $1.01 Average Closing Price $1.85 Median Closing Price $1.69 Total Volume 4,760,100 Average Daily Trading Volume 19,670 Source: Factset
Houlihan Lokey Howard & Zukin Financial Advisors 8 [JENNY CRAIG LOGO] COMPANY OVERVIEW AND OTHER INFORMATION ANALYSIS OF TRADING VOLUME BASED ON CLOSING PRICES FROM 01/24/01 TO 01/24/02 PERCENT OF VOLUME WHICH TRADED IN STOCK PRICE RANGE [GRAPH] PERCENT OF VOLUME WHICH TRADED AT OR BELOW STOCK PRICE [GRAPH] Houlihan Lokey Howard & Zukin Financial Advisors 9 [JENNY CRAIG LOGO] COMPANY OVERVIEW AND OTHER INFORMATION MAJOR SHAREHOLDERS(1)
INVESTOR COMMON SHARES % OF TOTAL - -------- ------------- ---------- Institutional Investors: Dimensional Fund 1,224,700 5.9% Yacktman Asset 580,000 2.8% Vanguard Group 203,800 1.0% Loeb Arbitrage 50,200 0.2% ---------- ----- Total Institutions 2,058,700 10.0% Sidney and Jenny Craig 14,212,500 68.7% Other Directors and Insiders 672,330 3.2% Total Insiders 14,884,830 71.9% Other Public Stock Holders 3,745,441 18.1% ---------- ----- Basic Shares(2) 20,688,971 100.0%
(1) Source: Bloomberg and Jenny Craig Definitive Proxy Statement dated 10/11/01. (2) Total shares outstanding as of November 12, 2001 per Jenny Craig's 10-Q dated 11/14/01. [PIE CHART] Other Public Stockholders 18% Total Institutions 10% Other Directors and Insiders 3% Sidney and Jenny Craig 69%
Houlihan Lokey Howard & Zukin Financial Advisors 10 SUMMARY CONCLUSIONS [JENNY CRAIG LOGO] SUMMARY CONCLUSIONS JENNY CRAIG, INC. SUMMARY VALUATION CONCLUSIONS [VALUATION APPROACH GRAPH] THE $5.30/SHARE OFFER FROM THE PURCHASERS IS GENERALLY ABOVE THE INDICATED VALUATION CONCLUSIONS AND, THEREFORE, APPEARS TO BE FAIR, FROM A FINANCIAL POINT OF VIEW. Houlihan Lokey Howard & Zukin Financial Advisors 12 VALUATION CONSIDERATIONS AND ISSUES [JENNY CRAIG LOGO] VALUATION CONSIDERATIONS AND ISSUES VALUATION CONSIDERATIONS AND ISSUES - - Very Comprehensive Auction Process Performed - Process publicly announced, - Provides convincing indication of fair market value across numerous offers, - The Company has achieved its projected financial results through November 2001; as a result, the latest twelve months EBITDA through November 2001 is substantially higher than the results through September 2001 (when final LOI's were received). - - Prior Offers for the Company - Offer to purchase common stock for $3.75/share by Craig received in June 2000; - Craig indicated they were not interested in selling their shares, effectively excluding other prospective buyers, - Offer subsequently withdrawn in August 2000. - - Public Stock Price - Lack of significant trading volume, - Lack of Wall Street coverage, - Significant "overhang" of Craig and institutional shareholders. Houlihan Lokey Howard & Zukin Financial Advisors 14 [JENNY CRAIG LOGO] VALUATION CONSIDERATIONS AND ISSUES - - Market Comparable Approach - Lack of comparable public companies and transactions, - Weight Watchers, while targeting same market/customer, has radically different business model than the Company. - - Discounted Cash Flow Approach - Variability in historical operating results, - "Credibility" of 2002E forecast, - Projected results relative to historical operating performance, - Inability of management to accurately forecast operating results historically, - The Company exceeded its FY 2001 projection, - The Company's operations are currently trending upwards, after a period of substantial declines. Houlihan Lokey Howard & Zukin Financial Advisors 15 AUCTION PROCESS AND THE PURCHASERS' OFFER [JENNY CRAIG LOGO] AUCTION PROCESS AND THE PURCHASERS' OFFER AUCTION PROCESS - - The Company retained Koffler & Co. in May 2001 to explore strategic alternatives, including a potential sale of the Company; - - Auction process appears to have been very thorough; - Over 300 potential investors, including both strategic and financial buyers, were contacted in connection with the sale process, - No restrictions placed on process by Sid & Jenny Craig nor the Company's management, - Potential sale of the Company was disclosed in various national media. - - Strong Response from Potential Investors; - 62 parties reviewed the Company's information memorandum, - 18 preliminary indications of interest received, - 12 management presentations held, - 8 Final offers received in late October, - Two additional rounds of "re-bidding" were held, - Ultimately, 3 final bids ranged from $5.25/share to $5.30/share. - The Company has elected to proceed with the Purchasers. Houlihan Lokey Howard & Zukin Financial Advisors 17 [JENNY CRAIG LOGO] AUCTION PROCESS AND THE PURCHASERS' OFFER THE PURCHASERS' OFFER - - Highlights of Purchasers' Offer - $5.30/share cash to all shareholders, - Equity roll-over of $4 million (total) for the Craigs and other management, - The Craig's will receive $600k annually for 5 years ($3 million in total) in connection with consulting/non- compete agreement. - - Rationale cited by the Company, Craig, and Koffler to proceed with the Purchasers: - Valuation: $5.30/share offer at top of range - Higher certainty of close - Willingness to commit significantly more equity capital (approximately $40 million) - Commitment letters in place from senior lenders - High degree of due diligence already completed - Subsequent discussions with other finalists - Koffler has held discussions with certain other potential buyers that submitted bids in the final round, - Such potential buyers were informed that the Company's performance is "at or slightly above budget", - No indications were made as to willingness to submit revised bids. Houlihan Lokey Howard & Zukin Financial Advisors 18 [JENNY CRAIG LOGO] AUCTION PROCESS AND THE PURCHASERS' OFFER ANALYSIS OF OFFER PRICE PREMIUM ANALYSIS Deal Price $ 5.30 Current Trading Price $ 3.00 Other Historical Price Information 20-day average $ 3.01 90-day average $ 2.74 6-month average $ 2.28 1-year average $ 1.80 PREMIUM Current Trading Price 76.7% 20-day average 75.9% 90-day average 93.4% 6-month average 132.9% 1-year average 194.2% IMPLIED VALUATION MULTIPLES Fully-diluted Shares outstanding 22,189,971 Offer Price $ 5.30 Implied Equity before Option Proceeds $ 117,607 Add: Transaction-related Expenses 8,000 -------------- Subtotal $ 125,607 Less: Assumed Option Proceeds upon Exercise 3,087 -------------- IMPLIED EQUITY VALUE $ 122,520 Adjustments to Arrive at Implied EV of Operations "Excess" Cash (40,000) Interest-bearing debt 1,394 NOL Value inherent in stock price (2,744) IMPLIED ENTERPRISE VALUE - OPERATIONS $ 81,170 Historical and Projected Operating Results LTM Adjusted EBITDA $ 14,522 FY 2002E Adjusted EBITDA 24,472 -------------- LTM Revenues 296,713 FY 2002E Revenues 308,146 Implied Multiples EV / LTM EBITDA 5.6 EV / FY 2002E EBITDA 3.3 EV / LTM Revenues 0.27 EV / FY 2002E Revenues 0.26
Houlihan Lokey Howard & Zukin Financial Advisors 19 [JENNY CRAIG LOGO] AUCTION PROCESS AND THE PURCHASERS' OFFER ANALYSIS OF THE BREAK-UP FEES AND RELATED ITEMS - - The Purchase Agreement calls for a break-up fee of $4.75 million in the event the Transaction is not consummated. - This amount represents 4% of the total Transaction value (including the cash on-hand) and 6% of the enterprise value of the Company (i.e. (excluding cash). - Houlihan Lokey conducted a study of disclosed termination (or break-up) fees in 144 publicly-announced M&A transactions in 2000 (see appendix), - For all 144 transactions in the study, termination fees as a percentage of transaction value ranged from a low 0.7% to a high of 6.6% with a median of 2.9%, - For transactions in the range of $50 million to $250 million (110 deals), the median termination fee was 3.3%. - While at the top of the range, the termination fee provision in the Transaction does not seem unreasonable. - - In addition to the above termination fees, the Purchase Agreement provides for an "upside" sharing agreement between the Purchasers and the Craigs in the event a better purchase offer is received (and accepted) by the Company; - Provision provides for the following "profit split": - 1(st) dollar above the current $5.30/share offer (i.e. new offers between $5.31 to $6.30) will be split 50/50 with the Purchasers. - Any amounts in excess of $6.30/share will be split 80/20 between Craig & the Purchasers. - Although such fees could "dis-incentive" the Craig's from accepting a superior offer, this arrangement does not directly impact the Company's other shareholders. Houlihan Lokey Howard & Zukin Financial Advisors 20 [JENNY CRAIG LOGO] AUCTION PROCESS AND THE PURCHASERS' OFFER ANALYSIS OF THE CRAIG'S EQUITY ROLL-OVER - - The current proposed deal structure calls for the Purchasers and other equity investors to acquire (i) $25 million of subordinated debt, (ii) $18 million of preferred stock, and (iii) $2 million of common stock in a "strip" on a pro-rata basis. - - The Purchasers' Offer requires the Craigs to roll-over approximately $4 million of their cash proceeds received in the Transaction. - The Craig's, at their option, elected to forego investment in the subordinated debt; rather, their entire $4 million roll-over will consist of preferred and common equity. - To the extent that the subordinated debt is "over-priced" (i.e. projected returns are below market norms), the Craig's equity roll-over could represent "hidden value" conveyed in the Transaction at the expense of the Company's minority shareholders. - - The projected returns on the subordinated debt (in the range of 20% to 25%)(1) appear to approximate market norms. - ---------- (1) Based on review of the terms of the various securities, discussions with the Company and Koffler & Co., and certain financial assumptions. Houlihan Lokey Howard & Zukin Financial Advisors 21 [JENNY CRAIG LOGO] AUCTION PROCESS AND THE PURCHASERS' OFFER ANALYSIS OF THE CRAIG'S NON-COMPETE/CONSULTING AGREEMENT Selected Going-Private Transactions Identified Between 02/01/95 to 12/01/01 ($ in Millions)
Individuals Deal Aggregate Percentage of Bound by Date Buyer Seller Consideration Non-Compete Consideration Term Agreement ---- ----- ------ ------------- ----------- ------------- ---- ----------- 7/15/01 Coca-Cola Amatil Ltd. San Miguel Corp. $ 2,700 $116.00 4.3% 10 yrs. Multiple 6/4/01 American Capital Strategies Ltd. Roy F. Weston, Inc. $ 66.00 $ 0.72 1.1% 3 yrs. Two 4/10/01 Vestar Capital and Goldner Hawn Michael Foods, Inc. $800.00 None 0.0% 2 yrs. Multiple Johnson & Morrison 11/5/99 Preferred Employers Holdings, Inc. 82% of Stockholders $ 16.12 None 0.0% 1 yr. Multiple 2/1/99 Saratoga Beverage Group Fresh Juice Company $ 19.80 $ 1.21 6.12% 2 & 3 yrs. Two 1/14/99 NNG Sahara $ 6.80 $ 0.15 2.21% N/A One 6/9/98 Fresh Foods, Inc. Tyson Foods, Inc. (Pierre Foods) $129.00 None 0.0% 1 yr. N/A 5/19/98 Coffee People Inc. The Coffee Plantation $ 8.20 None 0.00% 1.5 yrs. Multiple 1/5/98 Pacific Security Companies Minority Shareholders $ 1.84 $ 0.13 6.8% 5 yrs. One 10/21/97 Integrated Health Services, Inc. RoTech Medical Corporation $514.75 $ 5.00 1.0% N/A Multiple 8/28/97 Vermont Pure Hldg Excelsior Spring Water $ 3.32 $ 0.21 6.24% 5 yrs. One 3/1/97 Fresh Foods, Inc. 14 Franchised Restaurants $ 3.77 98,750 shares NA 15 yrs. One 5/2/96 BAB Holdings, Inc. Bagels Unlimited Inc. $ 1.54 $ 0.10 6.48% 6 yrs. Two 8/10/95 Triarc, Inc. Mistic $ 98.32 $ 3.00 3.05% 3 yrs. N/A 6/2/95 BAB Holdings, Inc. Greenberg's L.P. $ 2.00 $ 0.13 6.25% 5 yrs. N/A 2/1/95 Odwalla, Inc. J.S. Grants, Inc. $ 2.48 $ 0.89 35.89% 10 yrs. Two HIGH 6.80% 15 YRS. LOW 0.97% 1 YRS. MEDIAN 5.21% 4 YRS. MEAN 4.35% 5 YRS. NA ACI Capital Jenny Craig, Inc. $109.65 $ 3.00 2.74% 5 years Two Excluded from Range
BASED UPON THE ABOVE ANALYSIS, THE VALUE OF THE CRAIG'S CONSULTING / NON-COMPETE AGREEMENT DOES NOT APPEAR UNREASONABLE. Houlihan Lokey Howard & Zukin Financial Advisors 22 FAIRNESS/VALUATION ANALYSIS [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS VALUATION SUMMARY ($ in Thousands)
VALUATION CONCLUSIONS --------------------------------- Low High ------------ ------------ Valuation Approach Implied Public Market Valuation NMF NMF Market Approach $ 69,000 $ 80,000 Income Approach 66,000 81,000 CONCLUDED ENTERPRISE VALUE $ 66,000 $ 81,000 Excess Cash(1) 40,000 40,000 Interest-bearing Debt(2) (1,394) (1,394) Value of Net Operating Loss Carryforwards(3) 2,744 2,744 ------------ ------------ AGGREGATE EQUITY VALUE $ 107,350 $ 119,606 Proceeds - "in the money" Options(4) 3,087 3,087 ADJUSTED EQUITY VALUE $ 110,437 $ 122,693 Shares outstanding 20,688,971 20,688,971 Total "in the money" Options Outstanding 1,501,000 1,501,000 ------------ ------------ Fully Diluted Shares Outstanding 22,189,971 22,189,971 INDICATED PRICE PER SHARE $ 4.98 $ 5.53(5)
CONCLUSION Based upon the above analysis, the proposed Transaction at $5.30 per share is fair to the Company's stockholders. NMF Implied valuation not considered meaningful; therefore, indication excluded from valuation conclusion. (1) Excess Cash estimated as follows: Cash on-hand as of December 31, 2001 (per Koffler & Co.) $ 50,000 Less: Cash required for working capital plus litigation liability 10,000 (per management) --------- Excess Cash $ 40,000 =========
(2) Interest-bearing debt as of November 30, 2001 is comprised entirely of certain capital lease obligations. (3) Represents the estimated value of the Company's net operating loss carryforwards; see analysis attached in Appendix. (4) Represents approximately 1.5 million options outstanding with a weighted-average exercise price of $2.06/share. (5) In June 2000, Sid & Jenny Craig, the Company's primary shareholders, offered to purchase the remaining outstanding shares of the Company for $3.75/share. This offer was later withdrawn in August 2000. Houlihan Lokey Howard & Zukin Financial Advisors 24 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS IMPLIED PUBLIC MARKET VALUATION ($ in Thousands)
Current 20 - Day 90 - Day Stock Price Average Average ----------- -------- -------- Fully-diluted Shares Outstanding (in 000's) 22,190 22,190 22,190 Price Per Share $ 3.0000 $ 3.0132 $ 2.7400 -------- -------- -------- Total Equity Market Capitalization $ 66,570 $ 66,863 $ 60,801 Adjustments to Equity Value to Determine Value of Core Operations: Less: "Excess" Cash $(40,000) $(40,000) $(40,000) Less: NOL Value Inherent in Stock Price(1) (2,744) (2,744) (2,744) Add: Interest-bearing Debt 1,394 1,394 1,394 -------- -------- -------- Implied Enterprise Value (Operations) $ 25,220 $ 25,513 $ 19,451 -------- -------- --------
(1) Represents the estimated value of the Company's net operating loss carryforwards; see analysis attached in Appendix. Houlihan Lokey Howard & Zukin Financial Advisors 25 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS MARKET APPROACH - SELECTION OF PUBLICLY-TRADED COMPARABLE COMPANIES - - Houlihan Lokey performed an extensive review of publicly available information and held discussions with the Company for the purpose of determining appropriate public companies (i.e. public companies of similar size, profitability, market capitalization, and line of business). - - Houlihan Lokey's search included both weight loss industry participants as well as food companies with controlled distribution. - - Based on our research, Houlihan Lokey considers the Company to have very unique business characteristics that are difficult to match with other publicly traded companies. - - Nonetheless, Houlihan Lokey selected 9 publicly traded providers of nutritional / weight-management products as comparable companies. - Advantage Marketing Systems, Inc. - Herbalife International, Inc. - Nature's Sunshine Products, Inc. - Usana Health Sciences, Inc. - Weight Watchers International, Inc. - Hain Celestial Group, Inc. - Natrol, Inc. - Reliv International, Inc. - Weider Nutrition International, Inc. Houlihan Lokey Howard & Zukin Financial Advisors 26 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS MARKET APPROACH - MARKET MULTIPLES OF COMPARABLE COMPANIES
ENTERPRISE VALUE / --------------------------------------------------------------------------------------- LTM EBITDA LTM EBIT LTM REVENUE NFY EBITDA NFY +1 EBITDA ---------- -------- ----------- ---------- ------------- ADVANTAGE MARKETING 7.8 18.6 0.48 NA NA HAIN CELESTIAL NMF NMF 1.92 11.1 9.3 HERBALIFE INTERNATIONAL 3.3 4.2 0.31 NA NA NATROL INC NMF NMF 0.53 3.7 NA NATURES SUNSHINE 5.9 7.5 0.58 4.2 NA RELIV INTERNATIONAL NMF NMF 0.33 8.0 4.8 USANA HEALTH SCIENCES 3.0 5.9 0.21 2.6 NA WEIDER NUTRITION 6.6 14.2 0.36 NA NA WEIGHT WATCHERS 6.6 7.1 2.26 NA NA MINIMUM 3.0 4.2 0.2 2.6 4.8 MAXIMUM 7.8 18.6 2.3 11.1 9.3 MEAN 5.5 9.6 0.78 5.9 7.0 MEDIAN 6.2 7.3 0.48 4.2 7.0
LTM Latest twelve months NFY Next fiscal year NMF Multiple not considered meaningful; excluded from analysis. NA Not Available Houlihan Lokey Howard & Zukin Financial Advisors 27 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS WEIGHT WATCHERS, INC. COMPARISON
JENNY CRAIG, INC. WEIGHT WATCHERS INTERNATIONAL, INC. ----------------- ----------------------------------- DESCRIPTION Company provides weight management program through Leading provider of weight-loss services in 27 chain of Company-owned and franchised weight loss countries worldwide. At core of the business are centers. Through these centers, the Company sells weekly meeting promoting weight loss through JENNY CRAIG cuisine to participants in the education and group support in conjunction with program. healthy diet. Meetings held in temporary rented space. Revenues are principally derived from the Revenues are principally derived from the following: following: Food sales: (93%) - food sales under the JENNY'S Meeting Fees: (69%) weekly fee paid by members CUISINE brand name Product Sales: (23%) sale of propriety products Service fees: fixed service fee paid by each including snack bars, books, and CD-ROMs. participant at commencement of program ($200-$300 Franchise Royalties: (6%) franchisees pay each) approximately 10% of meeting fees BUSINESS MODEL Fixed cost, food company, with leases Variable cost, service company, without leases ENTERPRISE VALUE $17.7 million (implied public valuation) $1.2 billion LTM REVENUES $291 million $541 million LTM EBITDA $7.9 million (reported) $185 million EBITDA % 2.7% 34% EV / LTM EBITDA 2.2x 6.5x EMPLOYEES Over 3,500 worldwide Approximately 800 employees full-time; in addition, company employs over 30,000 part-time employees and/or commission based service providers. MEMBERSHIP 89,000 participants worldwide (68,000 - U.S., Over 1 million worldwide; attending 37,000 21,000 - foreign markets). weekly Weight Watcher meetings PROPERTIES / LOCATIONS 657 locations - principally throughout U.S. and 5 leased offices in North America and 26 other Australia Company-owned - 544 (429 - U.S., 115 - leased offices worldwide. Meetings are held in Australia). All 544 locations are leased. third party leased facilities such as shopping malls and civic centers. FRANCHISE OPERATIONS 111 franchise location in U.S. and foreign markets; Represents approximately 33% of worldwide contributed approximate 7.5% of total revenues. attendance. No additional franchises are anticipated in the future. LICENSING Licensing agreement with Kraft Foods, Inc. for a Name licensed to 3(rd) parties for sale of "bar" and drink product. Other opportunities books, apparel, and food products. Heinz, currently being explored previous owner of the Company, receives royalties of approximately $4 million annually through 2004 associated with certain food products. After 2004, such royalties will be payable to the company. MARKETING / PROMOTION Highly marketing intensive; generally 10% of Highly marketing intensive, generally 10%-15% revenues spent on advertising. of revenues spent in marketing BRAND NAME RECOGNITION Jenny Craig has 99% brand awareness. Over $700 Most widely recommended weight loss program by million in vested-to-date. U.S. doctors. Name recognized by 97% of women in U.S. MARKET POSITION Market leader in weight-loss services in nearly every country the company operates STRATEGIC Initiatives New products (incl. Ultimate Choice), re-imaging of brand Entering new markets (in Europe), and increasing penetration in existing markets and centers, & other changes to the Jenny Craig program. OTHER INFORMATION Postured as the "personal trainer" of the weight Discontinued sale of pre-packaged meals several LOSS industry - high level of service. years ago. Postured as a "cheap gym" - with low service yet inexpensive.
Houlihan Lokey Howard & Zukin Financial Advisors 28 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS MARKET APPROACH SUMMARY ($ in Thousands)
Rep Selected Multiple Enterprise Value Level Low High Low High BASED ON LATEST TWELVE MONTHS ENDED 11/30/01 RESULTS EV / EBITDA $ 14,522 4.5 5.5 $ 65,349 $ 79,871 EV / EBIT 8,700 7.0 9.0 60,900 78,300 EV / Revenue 296,713 0.20 0.25 59,343 74,178 PROJECTED FY 2002E RESULTS EV / EBITDA $ 24,472 3.0 3.5 $ 73,416 $ 85,652 EV / EBIT 19,581 3.5 4.0 68,534 78,324 PROJECTED FY 2003E RESULTS EV / EBITDA $ 29,360 2.5 3.0 $ 73,400 $ 88,080 EV / EBIT 24,060 3.0 3.5 72,180 84,210 CONCLUDED ENTERPRISE VALUE $ 69,000 $ 80,000
Houlihan Lokey Howard & Zukin Financial Advisors 29 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS DETERMINATION OF REPRESENTATIVE LEVELS OF EARNINGS ($ in Thousands)
ACTUAL RESULTS - YEAR ENDED ----------------------------------------------------- LTM EST. JUNE 98 JUNE 99 JUNE 00 JUNE 01 NOV 01 JUNE 02 --------- --------- --------- --------- --------- --------- REVENUES $ 352,249 $ 320,952 $ 290,985 $ 283,552 $ 296,713 $ 308,146 Revenue Growth -8.9% -9.3% -2.6% 8.7% Reported Operating Income (EBIT) 2,040 (2,784) (12,871) (2,711) 14,055 19,681 Depreciation / Amortization 7,101 5,854 5,541 6,053 5,822 4,891 --------- --------- --------- --------- --------- --------- Reported EBITDA 9,141 3,070 (7,330) 3,342 19,877 24,572 2.6% 1.0% -2.5% 1.2% 6.7% 8.0% Adjustments Litigation Judgment -- 8,203 1,446 876 (8,649) -- Licensing Revenues 480 480 -- Restructuring Charge -- -- 6,910 -- -- -- Legal Fees - Litigation Judgement -- -- 775 291 274 -- Inventory Write-off ("On-the-Go") -- -- 3,068 -- -- -- Public Company Costs -- -- 500 500 502 -- Normalized Senior Level Compensation -- -- 1,400 1,100 1,100 -- One-time Expenses (Tender Offer) -- -- 141 297 292 -- Non-recurring Marketing Costs (Lewinski P/R Campaign) -- -- 783 25 -- -- Feeling Fine (co-branding agreement) -- -- 475 -- -- -- One-time Expenses (Strategic Alternatives) -- -- -- 303 746 -- Consulting Fees Payable to Sid & Jenny Craig -- -- -- (600) (600) (600) Savings upon Headquarters Move -- -- -- 500 500 500 TOTAL ADJUSTMENTS -- 8,203 15,498 3,772 (5,355) (100) ADJUSTED EBITDA $ 9,141 $ 11,273 $ 8,168 $ 7,114 $ 14,522 $ 24,472 Adjusted EBITDA margins 2.6% 3.5% 2.8% 2.5% 4.9% 7.9% Less: Depreciation / Amortization 7,101 5,854 5,541 6,053 5,822 4,891 ADJUSTED EBIT 2,040 5,419 2,627 1,061 8,700 19,581 Adjusted EBIT margins 0.6% 1.7% 0.9% 0.4% 2.9% 6.4%
Houlihan Lokey Howard & Zukin Financial Advisors 30 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS COMPARABLE TRANSACTIONS - - Houlihan Lokey performed an extensive review of publicly available information regarding the sales of companies with operations similar to that of the Company. - - Based on our research, other than the acquisition of Weight Watchers (discussed below), Houlihan Lokey did not identify any transactions involving companies with sufficiently similar business characteristics. - - Weight Watchers was acquired in September 1999 for approximately $735 million, or 7.3x trailing EBITDA (see appendix for further information). Houlihan Lokey Howard & Zukin Financial Advisors 31 [JENNY CRAIG LOGO] FAIRNESS/VALUATION ANALYSIS INCOME APPROACH ($ in Thousands)
LTM NOV 2001 FY 2002E FY 2002E FY2003E Terminal -------- -------- -------- ------- -------- Revenues $296,713 $308,146 $183,644 $318,860 $334,803 % Growth 3.5% 5.0% Adjusted EBITDA 14,522 24,572 16,865 29,360 EBITDA % 4.9% 8.0% 9.2% 9.2% Depreciation / Amortization (4,891) (2,036) (5,300) ------- -------- -------- Projected EBIT 19,681 14,829 24,060 25,263 EBIT Margins 6.4% 8.1% 7.5% 7.5% Less: Income Tax Expense 40.0% 7,872 5,932 9,624 10,105 ------- -------- -------- -------- Debt-free Earnings $11,809 $ 8,898 $ 14,436 $ 15,158 Depreciation / Amortization 4,891 2,036 5,300 =CAPX Capital Expenditures (6,300) (5,500) (5,000) =DEPR Working Capital (3,600) (2,700) 800 94 Debt-free Cash Flow $ 6,800 $ 2,734 $ 15,536 $ 15,252
ENTERPRISE VALUE Terminal Growth Rate ----------------------------------------------- 3.0% 4.0% 5.0% 6.0% 7.0% Discount Rate(1) 21.00% 74,950 78,492 82,478 86,994 92,156 22.00% 70,811 73,934 77,424 81,351 85,802 23.00% 67,093 69,863 72,940 76,380 80,250 24.00% 63,735 66,205 68,935 71,968 75,359 25.00% 60,688 62,902 65,336 68,027 71,017
Low Mid High -------- -------- -------- Concluded Range $ 66,000 $ 73,000 $ 81,000
NOTE: All projections above based on information furnished by management. (1) Discount rate estimated based on consideration pro-forma capital structure (post-Transaction) and estimated IRR's of various investors. Certain key assumptions include: (1) Senior Debt: 40% LTV, IRR approximately 18%; (ii) Sub Debt, Preferred, Common Stock: assumes strip investments across all securities, 60% LTV, IRR approximately 30% - 35%. Houlihan Lokey Howard & Zukin Financial Advisors 32 APPENDICES COMPARABLE COMPANY DESCRIPTIONS [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS ADVANTAGE MARKETING SYSTEMS, INC. Advantage Marketing Systems, Inc. (AMM) markets a product line consisting of more than 100 products in three categories: weight management, dietary supplement and personal care products. The products are marketed through a network marketing organization in which independent distributors purchase products for resale to retail customers as well as for their own personal use. The number of active distributors has increased from approximately 33,000 at December 31, 1998, and about 61,200 at December 31, 1999, to approximately 86,600 at December 31, 2000. On January 4, 2001, AMM purchased the LifeScience Technologies group of companies for $1.2 million and a five-year payment of $41,667 per month or 5 percent of the gross sales of LifeScience Technologies products, whichever is greater. As a result of this acquisition the company added 14 products and over 5,000 distributors. [DAILY PRICE/VOLUME GRAPH] The company's growth strategy is to expand its product line and network of independent distributors to increase sales. It also seeks to increase sales through initiatives designed to enhance sales in its existing markets. These initiatives include increasing the number of its training and motivational events and teleconferences, hiring additional distributor support personnel and establishing more convenient regional support centers in targeted geographic markets. The principal objective of AMM's acquisition strategy is to acquire other network marketing organizations that can be combined with its network marketing organization, resulting in increased sales volume with minimal additional administrative cost. The company does not consummate an acquisition unless, at the time, it anticipates that such acquisition will contribute to profitability and provide positive cash flows from operations. Houlihan Lokey Howard & Zukin Financial Advisors 35 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS ADVANTAGE MARKETING SYSTEMS, INC. (CONTINUED) AMM believes that the weight management and dietary supplement category is expanding because of heightened public awareness of reports about the positive effects of weight management and dietary supplements on health. During the years ended December 31, 2000 and 1999, 67.6 percent and 70.9 percent respectively, of AMM's net sales were derived from the seven products in the weight management category that were marketed under the Advantage Marketing Systems label. The company also believes that the personal care products market is a mature category that has been historically immune to swings in the economy. With an aging population, the company believes there may be a growing demand for a wide spectrum of new products in the area of skin care. Houlihan Lokey Howard & Zukin Financial Advisors 36 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS HAIN CELESTIAL GROUP, INC. Hain Celestial Group, Inc. (HAIN), formerly Hain Food Group, Inc., is a natural, specialty and snack food company. On May 30, 2000, the company acquired Celestial Seasonings, Inc. with stockholders of Celestial receiving 1.265 Common shares of the company for each Common share of Celestial. [DAILY PRICE/VOLUME GRAPH] The company markets, distributes and sells natural, organic, and specialty food products under brand names. The product categories encompass natural and organic foods, medically- directed foods, weight-loss and portion control foods, snack foods, kosher foods, and specialty teas, including herb, green, black, wellness, and organic. The products are sold primarily to specialty and natural food distributors, and are marketed nationally to supermarkets, natural food stores, and other retail classes of trade. The company also sells specialty gifts. The company believes it is a leader in 13 of the top 15 natural food categories, with such well-known natural food brands as Celestial Seasonings teas, including Sleepytime, Lemon Zinger, Red Zinger, and Tension Tamer varieties, Hain Pure Foods, Westbrae, Westsoy, Arrowhead Mills, Health Valley, Breadshop's, Casbah, Garden of Eatin, Terra Chips, DeBoles, Earth's Best, and Nile Spice. The company's principal specialty product lines include Hollywood cooking oils, Estee sugar-free products, Weight Watchers dry and refrigerated products, Kineret kosher foods, Boston Better Snacks, and Alba Foods. Houlihan Lokey Howard & Zukin Financial Advisors 37 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS HERBALIFE INTERNATIONAL, INC. Herbalife International, Inc. (HERBA) is a network marketing company that sells a wide range of weight management products, food and dietary supplements and personal care products worldwide. As of December 31, 2000, the company conducted business in 49 countries located in Asia/Pacific Rim, Europe and The Americas. Retail sales in those regions represented 41.2 percent, 23.9 percent and 34.9 percent, respectively, of its total retail sales in 2000. Products are made to company specifications by outside manufacturers, and are marketed through a network of independent distributors. HERBA's products are marketed exclusively through a network marketing system that enables its independent distributors to earn profits by selling Herbalife products to retail consumers or other distributors. Distributors may also develop their own distributor downline organizations by sponsoring other distributors to do business in any market where HERBA operates. In doing so, sponsors are entitled to receive royalty overrides (cash incentives, including royalties and bonuses) on product sales within their downline organizations. [DAILY PRICE/VOLUME GRAPH] The company currently markets a total of 179 products which include Formula 1, a protein powder in four different flavors designed as a meal replacement; four Thermojetics weight management tablets; Thermojetics Herbal Concentrate, an herbal beverage; and a variety of other nutritional products. Houlihan Lokey Howard & Zukin Financial Advisors 38 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS HERBALIFE INTERNATIONAL, INC. (CONTINUED) All personal care products are grouped under the name Dermajetics, which was initiated in 1995. Products include the Skin Survival Kit, which has four skin care products, Parfums Vitessence, made up of six eau de toilettes, and other specialty care products. Food and dietary supplements include a variety of products, each containing herbs, vitamins, minerals and other natural ingredients. The company also sells products for nutrition and weight management as part of a Health & Fitness Program and Bulk & Muscle Program. The programs consist of a protein powder, multivitamin- mineral, herbal tablet and cell activator. Houlihan Lokey Howard & Zukin Financial Advisors 39 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS NATROL, INC. Natrol, Inc. (NTOL) manufactures and markets branded, high- quality dietary supplements, herbal teas, nutraceutical ingredients, and more recently, through its acquisition of Prolab Nutrition, Inc., sports nutrition products. [DAILY PRICE/VOLUME GRAPH] Supplements are sold primarily under the NTOL's Natrol brand. These supplements include vitamins, minerals, hormonal supplements, herbal products, and specialty combination formulas that contribute to an individual's mental or physical well-being. The company sells its products through multiple distribution channels throughout the United States. These channels include domestic health food stores and mass market drug, retail, and grocery store chains. NTOL also sells its products through independent catalogs, Internet shopping sites, and, to a limited degree, within select foreign countries. The company's strategy emphasizes building strong recognition of the Natrol brand across multiple distribution channels through a widespread multi-media marketing and advertising strategy. Herbal teas are sold under its Laci Le Beau brand name. The company uses essentially the same sales people and brokers to sell teas as it does supplements. The company's recently acquired Prolab sports nutrition line of products is targeted to body builders and health minded individuals seeking a high degree of physical fitness. The company also sells nutraceutical grade ingredients, primarily garlic, vegetable powders, kava, melatonin and cetyl myristoleate complex to other manufacturers. Houlihan Lokey Howard & Zukin Financial Advisors 40 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS NATURE'S SUNSHINE PRODUCTS, INC. Nature's Sunshine Products, Inc. (NATR) primarily manufactures and distributes nutritional and personal care products. The company's extensive product line includes herbs, vitamins, mineral supplements, and homeopathic remedies, as well as natural skin, hair and beauty care products. [DAILY PRICE/VOLUME GRAPH] The company's herbal products (approximately 69 percent of sales in 2000) are sold in the form of tablets, capsules or liquid extracts. NATR manufactures a wide variety of single vitamins, which are sold in the form of chewable or non- chewable tablets, and also manufactures several multiple vitamins and mineral supplements, including a line containing natural antioxidants. Combined sales of vitamins and mineral supplements were about 23 percent of total sales in 2000. NATR manufactures or contracts with independent manufacturers to supply a variety of personal care products for external use. Sales of personal care products accounted for approximately 2 percent of the company's total sales in 2000. NATR markets a line of more than 40 distinctive homeopathic products designed for the treatment of certain common ailments, including various allergies. NATR buys herbs and other raw materials in bulk, and, after quality control testing, encapsulates, tabulates or concentrates them, and then packages them for shipment. Most products are manufactured at the company's headquarters in Spanish Fork, Utah. Certain personal care and homeopathic products are manufactured for the company by contract manufacturers in accordance with company specifications. NATR also operates regional warehouses in Columbus, Ohio, Dallas, Texas, and Atlanta, Georgia. Houlihan Lokey Howard & Zukin Financial Advisors 41 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS NATURE'S SUNSHINE PRODUCTS, INC. (CONTINUED) The company sells its products primarily through an independent sales force of managers and distributors. Managers resell the products to the distributors in their sales group or to consumers, or use the products themselves. Demand for the products is created largely by the number of active members of the independent distributor sales force. Synergy Worldwide, Inc., acquired in 2000, is a direct marketer involved in the distribution and sale of nutritional, personal care and other products with an emphasis on the Asian markets. Houlihan Lokey Howard & Zukin Financial Advisors 42 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS RELIV INTERNATIONAL, INC. Reliv International, Inc. produces a line of food products including nutritional supplements, diet management products, functional foods, a line of granola bars and a sports drink mix. Functional foods are products designed to influence specific functions of the body. The company also distributes a line of premium skin care products. These products are sold by subsidiaries of the company to a sales force of independent distributors who sell products directly to consumers. Reliv and its subsidiaries sell products to distributors throughout the United States and in Australia, Canada, New Zealand, Mexico and the United Kingdom. [DAILY PRICE/VOLUME GRAPH] The nutritional supplements include Reliv NOW and Reliv Classic. Both products are designed to provide a balanced nutritional supplement for an individual's diet and contain a variety of vitamins and minerals, soy and other protein sources and various herbs. The products are in powdered form to be mixed with juice or other beverages. The Reliv Classic formula has a United States patent and the Reliv NOW formula is a no-yeast derivative of the Reliv Classic formula. Reliv NOW is available with all natural flavoring or in the original formula. The company also markets a line of skin care products which is based on compounds found only in the avocado. The products are designed to be used individually or in combination with each other. The product line includes: Reliv Face and Body Bar, a mild face and body soap; Reliv Pathway, a skin cleanser and primer which contains a variety of avocado based ingredients; Reliv Reavo, a skin care cream designed to reduce the appearance of aging in the skin caused by natural and environmental causes; and Reliv R.P. 1.5, a skin care cream having the active ingredient retinyl palmitate is designed to reduce the appearance of aging caused by environmental causes such as exposure to the sun. The company's skin care line also includes toners, moisturizers, sunless tanning lotions and related items. Houlihan Lokey Howard & Zukin Financial Advisors 43 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS RELIV INTERNATIONAL, INC. (CONTINUED) In January 2000, Reliv International, Inc. announced the launch of two new products and the reformulation of two existing products, each focused on meeting the specific nutritional needs of particular sets of consumers. The new products include Reliv NOW for Kids, a supplement designed to provide important vitamins, minerals and other nutrients for growing bodies; and Reliv SoySense, a new supplement that provides a significant source of soy protein, a nutrient proven to lower the risk of heart disease. Houlihan Lokey Howard & Zukin Financial Advisors 44 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS USANA HEALTH SCIENCES, INC. USANA Health Sciences, Inc. (USNA) is a Utah corporation that develops and manufactures high-quality nutritional, personal care and weight management products. USNA distributes its products through a network marketing system. As of December 30, 2000, the company had approximately 93,000 Independent distributors or Associates in the United States, Canada, Australia, New Zealand, Hong Kong, Japan and the United Kingdom. [DAILY PRICE/VOLUME GRAPH] USNA also offers a Preferred Customer program specifically designed for customers who desire to purchase USANA's products for personal use and do not desire to resell or distribute products. At December 30, 2000, the company had approximately 76,000 Preferred Customers worldwide. The company defines a current Associate and a current Preferred Customer as one that has purchased product from USNA at any time during the most recent twelve-month period. During 2000, Preferred Customer purchases accounted for approximately 17 percent of net sales. USNA's three primary product lines consist of USANA Nutritionals (approximately 69 percent of net sales in 2000), LEAN Lifelong (12 percent) and Sens# (9 percent). The company's top-selling products are USANA Essentials (32 percent) and Proflavanol (13 percent). Sens# is a completely new line, introduced in June 2000, of scientifically developed natural products designed to support healthy skin and hair by providing protection and nourishment on both the inside and outside of the dermal layers of skin. Houlihan Lokey Howard & Zukin Financial Advisors 45 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS USANA HEALTH SCIENCES, INC. (CONTINUED) The strategic shift in USNA's customer base continued during 2000. In February 2000, USANA introduced a value initiative that decreased prices on its products by an average of approximately 24 percent. The value initiative reduced the price of its top selling product, the Essentials, by 35 percent and offers a 10 percent discount for all customers who are active on the USANA Autoship (standing monthly order) program. These pricing changes were made in an effort to better attract and retain customers. North America is the primary market for the company's products. Sales in the United States and Canada collectively represented approximately 79.3 percent of net sales in 2000. Sales in the Australia-New Zealand market represented approximately 15.4 percent of net sales in 2000. Hong Kong, the company's first market in Asia, accounted for 5.3 percent of net sales in 2000. Houlihan Lokey Howard & Zukin Financial Advisors 46 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS WEIDER NUTRITION INTERNATIONAL, INC. Weider Nutrition International, Inc. (WNI) began as the nutritional products division of its parent, Weider Health and Fitness, whose predecessor was formed by Joe Weider in 1940. The division, along with the parent's publications and exercise equipment divisions, established the Weider name as a leading brand in the health and fitness industry. WNI now produces capsules and tablets, powdered drink mixes, bottled beverages and nutrition bars. It markets its branded products in four principal categories: sports nutrition; vitamins, minerals and herbs; diet; and healthy snacks. WNI makes and markets some 1,400 products. [DAILY PRICE/VOLUME GRAPH] The company's products are sold in over 48,000 retail outlets in all 50 states. Customers in the mass volume retail channel include mass merchandisers, drug stores, warehouse clubs and supermarkets. The company services the health food market by distributing its products to General Nutrition Center and the leading health food distributors. It also sells through other distribution channels, including its network of exclusive distributors to health clubs and gyms, international markets and private-label manufacturing for other nutritional supplement companies and certain retail customers. WNI also distributes products to major markets worldwide. As part of its multi-brand, multi-channel strategy, WNI has created a portfolio of brands designed for specific distribution channels. The positioning of WNI's brand names is supported by significant advertising and marketing expenditures, as well as the company's historical association with the Weider name. As a result, WNI believes that it has many of the leading brands in the nutritional supplement industry, including Great American Nutrition, Joe Weider Signature, Tiger's Milk, Fi-Bar, and Schiff. Houlihan Lokey Howard & Zukin Financial Advisors 47 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS WEIDER NUTRITION INTERNATIONAL, INC. (CONTINUED) In July 1998, WNI acquired Germany-based Haleko Hanseatisches Lebensmittel Kontor GmbH ($65 million in annual sales), the largest sports nutrition company in Europe, for $25 million in cash, stock, assumption of debt, and other costs, as well as contingency payments. Houlihan Lokey Howard & Zukin Financial Advisors 48 [JENNY CRAIG LOGO] COMPARABLE COMPANY DESCRIPTIONS WEIGHT WATCHERS INTERNATIONAL, INC. Weight Watchers International, Inc. is the largest provider of weight control programs in the world and operates in 30 countries through a network of Company-owned and franchise operations. At the core of the business are weekly meetings, in which is presented a scientifically designed program, incorporating group support and education about healthy eating patterns, behavior modification and physical activity. The Company has developed the Weight Watchers program through continuous improvement over its 37-year history and the brand name is recognized globally today as the standard for healthy, safe and drug free weight control. Careful management of the brand identity and reputation is a fundamental element of the Company's long-term success. The Company believes that the combination of its brand recognition, extensive global network and 8,600 classroom leaders in Company-owned operations provide a significant competitive advantage.. [DAILY PRICE/VOLUME GRAPH] Throughout its history, the Company has based its program on four core elements: group support, behavior modification, diet and exercise. The group support system remains the cornerstone method of presenting the program. Group support assists members in dealing with issues such as depression-eating and habitual eating behaviors. This support is offered through meetings that are interactive and encourage learning through group activities and discussions. Members learn strategies from leaders who have learned how to lose weight and maintain their weight loss on the program. These leaders are trained to respond to member needs by using internally developed techniques and actively modeling the Company's principles. The group support system continues throughout the maintenance period of the program when members learn how to stay within their appropriate weight range. Houlihan Lokey Howard & Zukin Financial Advisors 49 COMPARABLE COMPANY FINANCIAL INFORMATION [JENNY CRAIG LOGO] COMPARABLE COMPANY FINANCIAL INFORMATION COMPARABLE COMPANY FINANCIAL ANALYSIS (Figures in millions, except per share data)
WEIDER ADVANTAGE HAIN HERBALIFE NATURES RELIV USANA NUTRITION WEIGHT CRAIG MARKETING CELESTIAL INTL NATROL SUNSHINE INTERNATIO HEALTH INTL WATCHERS (JENNY) SYS INC GROUP INC INC -CL A INC PRODS INC NAL INC SCIENCES -CL A INTL INC INC General Market Information Ticker Symbol AMM HAIN HERBA NTOL NATR RELV USNA WNI WTW JCGI Exchange AMEX NASDAQ NASDAQ NASDAQ NASDAQ NASDAQ NASDAQ NYSE NYSE OTC Fiscal Year End 12/2000 06/2001 12/2000 12/2000 12/2000 12/2000 12/2000 05/2001 12/01/00 06/2001 Latest Financial Information 09/2001 09/2001 09/2001 09/2001 09/2001 09/2001 09/2001 08/2001 09/01/01 09/2001 Closing Price as of Valuation Date $ 2.44 $ 23.59 $ 14.01 $ 2.70 $ 12.31 $ 1.37 $ 1.44 $ 2.01 $ 33.15 $ 2.95 20-Day Average Stock Price $ 2.80 $ 23.06 $ 12.85 $ 3.05 $ 12.43 $ 1.21 $ 1.47 $ 1.53 $ 30.61 $ 2.70 52 Week Price Range High $ 3.50 $ 36.38 $ 13.90 $ 4.40 $ 14.75 $ 1.75 $ 3.06 $ 3.05 $ 31.70 $ 3.28 Low $ 2.00 $ 17.80 $ 6.88 $ 0.95 $ 5.69 $ 0.89 $ 0.88 $ 1.35 $ 29.50 $ 0.17 52 Week Return -18.7% -18.1% 75.1% 35.0% 77.4% -12.6% -30.2% -26.9% NA 105.2% Market Valuation Information Fully Diluted Shares 4.754 34.586 32.223 13.843 17.091 9.724 9.752 26.251 22.743 23.151 Closing Price as of Valuation Date $ 2.44 $ 23.59 $ 14.01 $ 2.70 $ 12.31 $ 1.37 $ 1.44 $ 2.01 $ 33.15 $ 2.95 Market Value of Equity (MVE) $11.600 $815.887 $451.445 $37.377 $210.385 $13.273 $14.043 $ 52.764 $ 753.914 $ 68.295 plus: Total Debt (book) 3.331 13.284 11.571 8.428 0.000 6.100 13.808 74.732 480.786 1.508 less: Converted Debt 0.000 0.023 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 plus: Preferred Stock Redemption/Market/Liq Value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 25.621 0.000 less: Converted Preferred 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 less: Cash & Cash Equivalents (book) 2.078 13.990 195.290 3.535 26.447 1.357 4.105 2.603 37.904 52.078 plus: Minority Interest in Subsidiaries 0.000 0.000 1.761 0.000 0.000 0.000 0.000 0.000 0.000 0.000 ------- -------- -------- ------- -------- ------- ------- -------- ---------- ------- Enterprise Value $12.853 $815.158 $269.487 $42.270 $183.938 $18.016 $23.746 $124.893 $1,221.417 $17.725 ------- -------- -------- ------- -------- ------- ------- -------- ---------- -------
Houlihan Lokey Howard & Zukin Financial Advisors 51 [JENNY CRAIG LOGO] COMPARABLE COMPANY FINANCIAL INFORMATION COMPARABLE COMPANY DEBT-FREE MULTIPLES ($ in Millions)
EV / EBITDA ---------------------------------------------- 3-YR EV Avg. FYE LTM NFY NFY + 1 -------- ------ ------ ------ ------ ------- Advantage Marketing Sys Inc(1) $ 12.9 8.1x 8.5x 7.8x NA NA Hain Celestial Group Inc(2) 815.2 NMF NMF NMF 11.1x 9.3x Herbalife Intl Inc -Cl A(1) 269.5 2.8x 3.1x 3.3x NA NA Natrol Inc(3) 42.3 4.6x NMF NMF 3.7x NA Natures Sunshine Prods Inc(3) 183.9 5.1x 5.5x 5.9x 4.2x NA Reliv International Inc(4) 18.0 13.6x NMF NMF 8.0x 4.8x Usana Health Sciences Inc(3) 23.7 1.5x 2.5x 3.0x 2.6x NA Weider Nutrition Intl -Cl A(1) 124.9 5.2x 6.1x 6.6x NA NA Weight Watchers Intl Inc(1) 1,221.4 11.4x 10.0x 6.6x NA NA Low 1.5x 2.5x 3.0x 2.6x 4.8x High 13.6x 10.0x 7.8x 11.1x 9.3x Median 5.2x 5.8x 6.2x 4.2x 7.0x Mean 6.6x 5.9x 5.5x 5.9x 7.0x JENNY CRAIG 81.2 9.2X 11.4X 5.6X 3.3X NA
EV / REVENUE ----------------------------------------------- 3-YR EV Avg. FYE LTM NFY NFY + 1 -------- ------ ------ ------ ------ ------- Advantage Marketing Sys Inc(1) $ 12.9 0.62x 0.48x 0.48x NA NA Hain Celestial Group Inc(2) 815.2 2.16x 1.97x 1.92x 1.97x NA Herbalife Intl Inc -Cl A(1) 269.5 0.29x 0.29x 0.31x NA NA Natrol Inc(3) 42.3 0.54x 0.49x 0.53x NA NA Natures Sunshine Prods Inc(3) 183.9 0.61x 0.58x 0.58x NA NA Reliv International Inc(4) 18.0 0.29x 0.29x 0.33x 0.33x 0.30x Usana Health Sciences Inc(3) 23.7 0.19x 0.19x 0.21x NA NA Weider Nutrition Intl -Cl A(1) 124.9 0.36x 0.35x 0.36x NA NA Weight Watchers Intl Inc(1) 1,221.4 3.13x 3.01x 2.26x NA NA Low 0.19x 0.19x 0.21x 0.33x 0.30x High 3.13x 3.01x 2.26x 1.97x 0.30x Median 0.54x 0.48x 0.48x 1.15x 0.30x Mean 0.91x 0.85x 0.78x 1.15x 0.30x JENNY CRAIG 81.2 0.27X 0.29X 0.27X 0.26X NA
EV / EBIT ----------------------------------------------- 3-YR EV Avg. FYE LTM NFY NFY + 1 -------- ------ ------ ------ ------ ------- Advantage Marketing Sys Inc(1) $ 12.9 12.7x 17.9x 18.6x NA NA Hain Celestial Group Inc(2) 815.2 NMF NMF NMF 13.2x 10.7x Herbalife Intl Inc -Cl A(1) 269.5 3.3x 3.8x 4.2x NA NA Natrol Inc(3) 42.3 6.4x NMF NMF 5.5x NA Natures Sunshine Prods Inc(3) 183.9 6.1x 6.9x 7.5x 5.0x NA Reliv International Inc(4) 18.0 NMF NMF NMF 11.9x 5.9x Usana Health Sciences Inc(3) 23.7 2.1x 4.4x 5.9x 4.7x NA Weider Nutrition Intl -Cl A(1) 124.9 10.6x 13.2x 14.2x NA NA Weight Watchers Intl Inc(1) 1,221.4 12.6x 11.0x 7.1x NA NA Low 2.1x 3.8x 4.2x 4.7x 5.9x High 12.7x 17.9x 18.6x 13.2x 10.7x Median 6.4x 9.0x 7.3x 5.5x 8.3x Mean 7.7x 9.5x 9.6x 8.1x 8.3x JENNY CRAIG 81.2 NMF NMF 9.3x 4.1x NA
EV / TOTAL ASSETS (NET OF CASH) ----------------------------------------------- 3-YR EV Avg. FYE LTM NFY NFY + 1 -------- ------ ------ ------ ------ ------- Advantage Marketing Sys Inc(1) $ 12.9 1.81x 1.58x 0.98x NA NA Hain Celestial Group Inc(2) 815.2 2.08x 1.87x 1.80x NA NA Herbalife Intl Inc -Cl A(1) 269.5 1.02x 0.97x 1.00x NA NA Natrol Inc(3) 42.3 0.56x 0.50x 0.52x NA NA Natures Sunshine Prods Inc(3) 183.9 2.12x 2.05x 1.78x NA NA Reliv International Inc(4) 18.0 0.97x 0.94x 1.06x NA NA Usana Health Sciences Inc(3) 23.7 0.68x 0.73x 0.70x NA NA Weider Nutrition Intl -Cl A(1) 124.9 0.55x 0.60x 0.61x NA NA Weight Watchers Intl Inc(1) 1,221.4 3.88x 4.05x 3.17x NA NA Low 0.55x 0.50x 0.52x 0.00x 0.00x High 3.88x 4.05x 3.17x 0.00x 0.00x Median 1.02x 0.97x 1.00x NA NA Mean 1.52x 1.48x 1.29x NA NA JENNY CRAIG 81.2 1.28x 1.72x 2.10x NA NA
Footnotes: (1) No projections available. (2) Projected financial figures are based on the average of several analyst reports. (3) Projected financial figures are based on the Houlihan Lokey Howard & Zukin build-up method. (4) Projected financial figures are based on a Taglich Brothers, Inc. report dated November 27, 2001. Houlihan Lokey Howard & Zukin Financial Advisors 52 [JENNY CRAIG LOGO] COMPARABLE COMPANY FINANCIAL INFORMATION COMPARABLE COMPANY DEBT-FREE MULTIPLES (CONT.) ($ in Millions)
PRICE / EARNINGS ----------------------------------------------- 3-YR MVE AVG. FYE LTM NFY NFY + 1 ------ ------ ------ ------ ------ ------- Advantage Marketing Sys Inc(1) $ 11.6 14.3x 23.5x 32.4x NA NA Hain Celestial Group Inc(2) 815.9 NMF 33.7x 36.1x 22.4x 18.0x Herbalife Intl Inc -Cl A(1) 451.4 9.1x 10.6x 11.2x NA NA Natrol Inc(3) 37.4 9.8x NMF NMF 9.0x NA Natures Sunshine Prods Inc(3) 210.4 10.7x 12.0x 12.7x 9.5x NA Reliv International Inc(4) 13.3 NMF NMF NMF 19.5x 8.4x Usana Health Sciences Inc(3) 14.0 2.0x 5.3x 7.3x 5.8x NA Weider Nutrition Intl -Cl A(1) 52.8 NMF NMF NMF NA NA Weight Watchers Intl Inc(1) 753.9 20.0x 33.8x 16.5x NA NA Low 2.0x 5.3x 7.3x 5.8x 8.4x High 20.0x 33.8x 36.1x 22.4x 18.0x Median 10.2x 17.8x 14.6x 9.5x 13.2x Mean 11.0x 19.8x 19.4x 13.2x 13.2x JENNY CRAIG 122.5 NMF NMF NMF NA NA
PRICE / NET BOOK VALUE ----------------------------------------------- 3-YR MVE AVG. FYE LTM NFY NFY + 1 ------ ------ ------ ------ ------ ------- Advantage Marketing Sys Inc(1) $ 11.6 1.47x 1.36x 1.89x NA NA Hain Celestial Group Inc(2) 815.9 10.51x 5.89x 2.04x NA NA Herbalife Intl Inc -Cl A(1) 451.4 2.32x 2.06x 1.80x NA NA Natrol Inc(3) 37.4 1.10x 1.46x 1.24x NA NA Natures Sunshine Prods Inc(3) 210.4 2.86x 2.79x 2.49x NA NA Reliv International Inc(4) 13.3 2.01x 2.35x 2.29x NA NA Usana Health Sciences Inc(3) 14.0 0.75x 1.09x 0.99x NA NA Weider Nutrition Intl -Cl A(1) 52.8 1.33x 1.25x 1.26x NA NA Weight Watchers Intl Inc(1) 753.9 NMF NMF NMF NA NA Low 0.75x 1.09x 0.99x 0.00x 0.00x High 10.51x 5.89x 2.49x 0.00x 0.00x Median 1.74x 1.76x 1.85x NA NA Mean 2.79x 2.28x 1.75x NA NA JENNY CRAIG 122.5 3.25x 6.17x 2.80x NA NA
PRICE / CASH FLOW ---------------------------------------------- 3-YR MVE Avg. FYE LTM NFY NFY + 1 ------ ------ ------ ------ ------ ------- Advantage Marketing Sys Inc(1) $ 11.6 8.4x 9.0x 8.8x NA NA Hain Celestial Group Inc(2) 815.9 33.1x 22.0x 23.7x 16.9x 14.3x Herbalife Intl Inc -Cl A(1) 451.4 7.0x 7.7x 7.9x NA NA Natrol Inc(3) 37.4 5.9x NMF NMF 4.8x NA Natures Sunshine Prods Inc(3) 210.4 8.2x 8.6x 8.9x 7.2x NA Reliv International Inc(4) 13.3 15.5x 27.7x NMF 9.4x 5.8x Usana Health Sciences Inc(3) 14.0 1.3x 2.1x 2.4x 2.2x NA Weider Nutrition Intl -Cl A(1) 52.8 4.2x 5.0x 5.6x NA NA Weight Watchers Intl Inc(1) 753.9 15.6x 22.2x 12.9x NA NA Low 1.3x 2.1x 2.4x 2.2x 5.8x High 33.1x 27.7x 23.7x 16.9x 14.3x Median 8.2x 8.8x 8.8x 7.2x 10.1x Mean 11.0x 13.0x 10.0x 8.1x 10.1x JENNY CRAIG 122.5 NMF NMF NMF NA NA
Footnotes: (1) No projections available. (2) Projected financial figures are based on the average of several analyst reports. (3) No projections available. (4) Projected financial figures are based on a Taglich Brothers, Inc. report dated November 27, 2001. Houlihan Lokey Howard & Zukin Financial Advisors 53 [JENNY CRAIG LOGO] COMPARABLE COMPANY FINANCIAL INFORMATION RISK ANALYSIS RANKINGS SIZE (Revenue, millions) HERBALIFE INTL INC -CL A $ 881.5 WEIGHT WATCHERS INTL INC $ 540.7 HAIN CELESTIAL GROUP INC $ 424.1 WEIDER NUTRITION INTL -CL A $ 348.7 NATURES SUNSHINE PRODS INC $ 318.0 JENNY CRAIG $ 291.1 USANA HEALTH SCIENCES INC $ 115.3 NATROL INC $ 79.3 RELIV INTERNATIONAL INC $ 53.8 ADVANTAGE MARKETING SYS INC $ 26.7
HISTORICAL GROWTH (2-Year EBITDA) JENNY CRAIG 57.5% HAIN CELESTIAL GROUP INC 17.3% ADVANTAGE MARKETING SYS INC 16.1% WEIGHT WATCHERS INTL INC 14.5% HERBALIFE INTL INC -CL A -4.4% WEIDER NUTRITION INTL -CL A -4.6% NATURES SUNSHINE PRODS INC -9.4% USANA HEALTH SCIENCES INC -28.0% RELIV INTERNATIONAL INC -50.1% NATROL INC NMF
PROFITABILITY (EBITDA to Revenue) WEIGHT WATCHERS INTL INC 34.3% HAIN CELESTIAL GROUP INC 11.5% NATURES SUNSHINE PRODS INC 9.9% HERBALIFE INTL INC -CL A 9.2% USANA HEALTH SCIENCES INC 7.0% ADVANTAGE MARKETING SYS INC 6.2% WEIDER NUTRITION INTL -CL A 5.5% JENNY CRAIG 5.0% RELIV INTERNATIONAL INC 0.7% NATROL INC -5.1%
SIZE (Enterprise Value, millions) WEIGHT WATCHERS INTL INC $1,221.4 HAIN CELESTIAL GROUP INC $ 815.2 HERBALIFE INTL INC -CL A $ 269.5 NATURES SUNSHINE PRODS INC $ 183.9 WEIDER NUTRITION INTL -CL A $ 124.9 JENNY CRAIG $ 81.2 NATROL INC $ 42.3 USANA HEALTH SCIENCES INC $ 23.7 RELIV INTERNATIONAL INC $ 18.0 ADVANTAGE MARKETING SYS INC $ 12.9
HISTORICAL GROWTH (1-Year EBITDA) HAIN CELESTIAL GROUP INC 56.4% WEIGHT WATCHERS INTL INC 15.3% NATURES SUNSHINE PRODS INC 1.2% JENNY CRAIG -11.7% HERBALIFE INTL INC -CL A -19.2% ADVANTAGE MARKETING SYS INC -27.9% WEIDER NUTRITION INTL -CL A -29.2% USANA HEALTH SCIENCES INC -47.9% RELIV INTERNATIONAL INC -249.0% NATROL INC NMF
RELATIVE DEPRECIATION (Depreciation to EBITDA) RELIV INTERNATIONAL INC 235.2% ADVANTAGE MARKETING SYS INC 58.2% WEIDER NUTRITION INTL -CL A 53.8% USANA HEALTH SCIENCES INC 50.4% JENNY CRAIG 40.1% HAIN CELESTIAL GROUP INC 24.1% NATURES SUNSHINE PRODS INC 22.1% HERBALIFE INTL INC -CL A 21.0% WEIGHT WATCHERS INTL INC 6.9% NATROL INC -91.2%
HISTORICAL GROWTH (2-Year Revenue) ADVANTAGE MARKETING SYS INC 41.8% HAIN CELESTIAL GROUP INC 14.3% NATROL INC 13.0% RELIV INTERNATIONAL INC 7.1% WEIGHT WATCHERS INTL INC 5.5% HERBALIFE INTL INC -CL A 4.4% WEIDER NUTRITION INTL -CL A 2.5% NATURES SUNSHINE PRODS INC 2.2% USANA HEALTH SCIENCES INC -1.2% JENNY CRAIG -6.0%
PROJECTED GROWTH (1-Year EBITDA) JENNY CRAIG 206.3% RELIV INTERNATIONAL INC 145.8% HAIN CELESTIAL GROUP INC 40.3% NATURES SUNSHINE PRODS INC 31.1% USANA HEALTH SCIENCES INC -5.7% NATROL INC NMF ADVANTAGE MARKETING SYS INC NA HERBALIFE INTL INC -CL A NA WEIDER NUTRITION INTL -CL A NA WEIGHT WATCHERS INTL INC NA
INTERNAL INVESTMENT (Capital Expenditures to Revenue) ADVANTAGE MARKETING SYS INC 7.6% USANA HEALTH SCIENCES INC 6.7% NATURES SUNSHINE PRODS INC 4.8% HAIN CELESTIAL GROUP INC 4.6% HERBALIFE INTL INC -CL A 1.2% WEIDER NUTRITION INTL -CL A 1.0% WEIGHT WATCHERS INTL INC 0.9% JENNY CRAIG 0.9% RELIV INTERNATIONAL INC 0.6% NATROL INC 0.4%
HISTORICAL GROWTH (1-Year Revenue) ADVANTAGE MARKETING SYS INC 19.1% NATURES SUNSHINE PRODS INC 6.8% NATROL INC 6.7% HAIN CELESTIAL GROUP INC 2.3% WEIGHT WATCHERS INTL INC 1.6% HERBALIFE INTL INC -CL A -1.3% JENNY CRAIG -2.6% WEIDER NUTRITION INTL -CL A -3.3% USANA HEALTH SCIENCES INC -8.3% RELIV INTERNATIONAL INC -11.5%
PROJECTED GROWTH (5-Year EPS) ADVANTAGE MARKETING SYS INC NA HAIN CELESTIAL GROUP INC NA HERBALIFE INTL INC -CL A NA NATROL INC NA NATURES SUNSHINE PRODS INC NA RELIV INTERNATIONAL INC NA USANA HEALTH SCIENCES INC NA WEIDER NUTRITION INTL -CL A NA WEIGHT WATCHERS INTL INC NA CRAIG (JENNY) INC NA JENNY CRAIG NA
LIQUIDITY (Current Ratio) ADVANTAGE MARKETING SYS INC 2.9 NATROL INC 2.9 HAIN CELESTIAL GROUP INC 2.8 NATURES SUNSHINE PRODS INC 2.2 HERBALIFE INTL INC -CL A 2.0 JENNY CRAIG 1.8 WEIDER NUTRITION INTL -CL A 1.7 RELIV INTERNATIONAL INC 1.1 USANA HEALTH SCIENCES INC 1.0 WEIGHT WATCHERS INTL INC 0.7
PROJECTED GROWTH (1-Year Revenue) JENNY CRAIG 7.1% HAIN CELESTIAL GROUP INC 0.0% RELIV INTERNATIONAL INC -11.2% ADVANTAGE MARKETING SYS INC NA HERBALIFE INTL INC -CL A NA NATROL INC NA NATURES SUNSHINE PRODS INC NA USANA HEALTH SCIENCES INC NA WEIDER NUTRITION INTL -CL A NA WEIGHT WATCHERS INTL INC NA
PROFITABILITY (EBIT to Revenue) WEIGHT WATCHERS INTL INC 31.9% HAIN CELESTIAL GROUP INC 8.7% NATURES SUNSHINE PRODS INC 7.7% HERBALIFE INTL INC -CL A 7.3% USANA HEALTH SCIENCES INC 3.5% JENNY CRAIG 3.0% ADVANTAGE MARKETING SYS INC 2.6% WEIDER NUTRITION INTL -CL A 2.5% RELIV INTERNATIONAL INC -0.9% NATROL INC -9.8%
LEVERAGE (Debt to EV) NATURES SUNSHINE PRODS INC 0.0% HAIN CELESTIAL GROUP INC 1.6% JENNY CRAIG 1.7% HERBALIFE INTL INC -CL A 4.3% NATROL INC 19.9% ADVANTAGE MARKETING SYS INC 25.9% RELIV INTERNATIONAL INC 33.9% WEIGHT WATCHERS INTL INC 39.4% USANA HEALTH SCIENCES INC 58.1% WEIDER NUTRITION INTL -CL A 59.8%
Houlihan Lokey Howard & Zukin Financial Advisors 54 [JENNY CRAIG LOGO] COMPARABLE COMPANY FINANCIAL INFORMATION OPERATING PERFORMANCE PARAMETERS (figures in millions)
LTM OPERATING INDICATIONS LTM MARGINS -------------------------------------------------- ---------------------------------------------- ADJUSTED ADJUSTED ADJUSTED ADJUSTED GROSS ADJUSTED ADJUSTED CASH NET GROSS ADJUSTED ADJUSTED CASH NET REVENUE PROFIT EBITDA EBIT FLOW INCOME PROFIT EBITDA EBIT FLOW INCOME ------- ------ -------- -------- -------- -------- ------ -------- -------- -------- -------- ADVANTAGE MARKETING SYS INC $ 26.7 $ 9.0 $ 1.7 $ 0.7 $ 1.3 $ 0.4 33.8% 6.2% 2.6% 4.9% 1.3% HAIN CELESTIAL GROUP INC 424.1 172.8 48.7 37.0 34.4 22.6 40.7% 11.5% 8.7% 8.1% 5.3% HERBALIFE INTL INC -CL A 881.5 411.1 81.2 64.2 57.2 40.2 46.6% 9.2% 7.3% 6.5% 4.6% NATROL INC 79.3 26.5 (4.1) (7.7) (5.3) (9.0) 33.5% -5.1%* -9.8%* -6.7%* -11.3%* NATURES SUNSHINE PRODS INC 318.0 261.0 31.4 24.4 23.5 16.6 82.1% 9.9% 7.7% 7.4% 5.2% RELIV INTERNATIONAL INC 53.8 20.3 0.4 (0.5) 0.1 (0.8) 37.7% 0.7% -0.9%* 0.2% -1.4%* USANA HEALTH SCIENCES INC 115.3 80.9 8.0 4.0 6.0 1.9 70.2% 7.0% 3.5% 5.2% 1.7% WEIDER NUTRITION INTL -CL A 348.7 131.1 19.0 8.8 9.5 (0.8) 37.6% 5.5% 2.5% 2.7% -0.2%* WEIGHT WATCHERS INTL INC 540.7 285.9 185.3 172.6 58.3 45.6 52.9% 34.3%* 31.9%* 10.8%* 8.4%* Low $ 26.7 $ 9.0 $ (4.1) $ (7.7) $ (5.3) $ (9.0) 33.5% 0.7% 2.5% 0.2% 1.3% High $881.5 $411.1 $185.3 $172.6 $ 58.3 $ 45.6 82.1% 11.5% 8.7% 8.1% 5.3% Median $318.0 $131.1 $ 19.0 $ 8.8 $ 9.5 $ 1.9 40.7% 7.0% 5.4% 5.2% 4.6% Mean $309.8 $155.4 $ 41.3 $ 33.7 $ 20.6 $ 13.0 48.4% 7.1% 5.4% 5.0% 3.6% Jenny Craig $296.7 $ 24.7 $ 14.5 $ 8.7 $ 11.0 $ 5.2 8.3% 4.9% 2.9% 3.7% 1.8%
2-YEAR COMPOUND ANNUAL GROWTH RATES ------------------------------------ ADJUSTED ADJUSTED ADJUSTED NET REVENUE EBITDA EBIT INCOME ------- -------- -------- -------- ADVANTAGE MARKETING SYS INC 41.8% 16.1% -1.4% -14.1% HAIN CELESTIAL GROUP INC 14.3% 17.3% 14.4% 30.4% HERBALIFE INTL INC -CL A 4.4% -4.4% -5.2% -6.3% NATROL INC 13.0% NMF* NMF* NMF* NATURES SUNSHINE PRODS INC 2.2% -9.4% -14.1% -13.4% RELIV INTERNATIONAL INC 7.1% -50.1% NMF* NMF* USANA HEALTH SCIENCES INC -1.2% -28.0% -40.1% -47.4% WEIDER NUTRITION INTL -CL A 2.5% -4.6% 7.1% NMF* WEIGHT WATCHERS INTL INC 5.5% 14.5% 15.0% -31.8% Low -1.2% -50.1% -40.1% -47.4% High 41.8% 17.3% 15.0% 30.4% Median 5.5% -4.5% -1.4% -13.7% Mean 10.0% -6.1% -3.5% -13.8% Jenny Craig -6.0% 57.5% NMF NMF
* Excluded from range. Houlihan Lokey Howard & Zukin Financial Advisors 55 [JENNY CRAIG LOGO] COMPARABLE COMPANY FINANCIAL INFORMATION BALANCE SHEET RATIOS (figures in millions)
NET NET NET TOTAL INCOME INCOME CURRENT QUICK INVENTORY A/R A/P WORKING ASSETS ROA ROE RATIO RATIO TURNOVER DAYS DAYS CAPITAL ------ ------ ------ ------- ------ --------- ------ ------ --------- ADVANTAGE MARKETING SYS INC $ 15.2 2.7% 2.0% 2.9 1.7 14.2 14.1 6.4 $ 2.156 HAIN CELESTIAL GROUP INC 467.4 5.0% 5.9% 2.8 1.4 4.9 43.2 67.7 $ 77.138 HERBALIFE INTL INC -CL A 465.4 9.1% 16.9% 2.0 1.3 5.0 13.3 15.9 ($ 10.950) NATROL INC 84.9 -10.0% -13.7% 2.9 1.4 3.9 56.9 47.2 $ 17.146 NATURES SUNSHINE PRODS INC 129.8 13.2% 18.1% 2.2 1.0 2.0 9.6 36.5 $ 13.310 RELIV INTERNATIONAL INC 18.3 -3.6% -15.8% 1.1 0.3 6.5 15.6 57.3 $ 0.453 USANA HEALTH SCIENCES INC 38.3 4.9% 16.2% 1.0 0.3 3.0 1.4 48.3 $ 2.430 WEIDER NUTRITION INTL -CL A 206.4 -0.4% -2.4% 1.7 0.7 4.1 51.9 52.2 $ 64.349 WEIGHT WATCHERS INTL INC 423.4 11.9% -21.9% 0.7 0.4 16.9 8.6 11.2 ($ 56.966) Low $ 15.2 -10.0% -21.9% 0.7 0.3 2.0 1.4 6.4 ($ 56.966) High $467.4 13.2% 18.1% 2.9 1.7 16.9 56.9 67.7 $ 77.138 Median $129.8 4.9% 2.0% 2.0 1.0 4.9 14.1 47.2 $ 2.430 Mean $205.5 3.7% 0.6% 1.9 0.9 6.7 23.8 38.1 $ 12.118 Jenny Craig $ 90.7 11.5% 10.2% 1.8 1.4 48.6 1.4 9.3 ($ 21.397)
LEVERAGE -------------------------------------------- OTHER LT DEBT/ DEBT/ DEBT/ INTEREST LIAB/EV EBITDA MVE (1) EV COVERAGE (2) -------- ------ ------- ------ ------------ ADVANTAGE MARKETING SYS INC 0.5% 2.0x 28.7% 0.3x 4.8x HAIN CELESTIAL GROUP INC 1.0% 0.3x 1.6% 0.0x 35.5x HERBALIFE INTL INC -CL A 15.2% 0.1x 2.6% 0.0x NMF* NATROL INC 0.5% NMF* 22.5% 0.2x NMF* NATURES SUNSHINE PRODS INC 1.1% 0.0x 0.0% 0.0x NMF* RELIV INTERNATIONAL INC 2.1% 16.8x 46.0% 0.3x 0.8x USANA HEALTH SCIENCES INC 0.0% 1.7x 98.3% 0.6x 9.8x WEIDER NUTRITION INTL -CL A 0.0% 3.9x 141.6% 0.6x 2.0x WEIGHT WATCHERS INTL INC 0.3% 2.6x 63.8% 0.4x 3.4x Low 0.0% 0.0x 0.0% 0.0x 0.8x High 15.2% 16.8x 141.6% 0.6x 35.5x Median 0.5% 1.9x 28.7% 0.3x 4.1x Mean 2.3% 3.4x 45.0% 0.3x 9.4x Jenny Craig NA 0.1x NA NA NA
* Excluded from range. Houlihan Lokey Howard & Zukin Financial Advisors 56 SELECTED COMPARABLE TRANSACTIONS [JENNY CRAIG LOGO] SELECTED COMPARABLE TRANSACTIONS TRANSACTION ANALYSIS - WEIGHT WATCHERS ($ in Millions) Announce Date: 7/22/99 Close Date; 9/29/99 Target: H.J. HEINZ CO. Unit Sold: WEIGHT WATCHERS BUSINESS Business Line: Provides dieting classes and sells prepackaged food products Buyer: ARTAL LUXEMBOURG SA Transaction Value: $ 735.0 Terms: - Weight Watchers redeemed shares of common stock from Heinz for $349.5 million, paying $324.5 million in cash and $25 million in preferred stock issues to Heinz. - Artal bought 94% of the remaining common stock from Heinz for $223.7 in cash. - Heinz used $14.3 million of the proceeds to retain a 6 percent stake in Weight Watchers. - Senior lenders provided $239 million under new, secured bank credit facilities which provide for borrowings of up to $267 million. - Weight Watchers International issues $255 million worth of high yield bonds. - The notes and the senior borrowings together were used to finance the purchase of shares from Heinz and to refinance the existing debt of the company. FINANCIAL ANALYSIS 12 months to 2Q FY00 (a) Revenue $ 406.0 EV/Revenue 1.8 x EBIT $ 96.1 EV/EBIT 7.6 x EBITDA $ 101.0 EV/EBITDA 7.3 x
OPERATIONAL ANALYSIS - - Acquisition allows Heinz to use the savings to boost marketing of its ketchup, Ore-Ida frozen potatoes and other food products. - - Acquisition gives Heinz the opportunity to focus on its long-term food growth strategy, including Weight Watchers foods and other global food businesses. - - With Artal's strong track record of success in consumer branded goods and services, the acquiring company believes that it can strengthen the Weight Watchers brand in weight loss services and work with Heinz to grow the Weight Watchers branded food businesses. (a) Per ING Barings High-Yield Research Paper dated January 10, 2000, without adjustments. Houlihan Lokey Howard & Zukin Financial Advisors 58 NET OPERATING LOSS ANALYSIS [JENNY CRAIG LOGO] NET OPERATING LOSS ANALYSIS NET OPERATING LOSS ANALYSIS ($ IN MILLIONS) ASSUMPTIONS: Growth Rate (pre-tax income) 0.0% NOL usage Limitation (% of pre-tax)(2) 90.00% Federal Tax Rate 35.00% State Tax Rate 9.30% Cost of Equity 25.0% Federal NOL - Beginning Balance 10.000 State NOL - Beginning Balance 0.000 State NOL usage limitation(4) 100.0%
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 1 2 3 4 5 6 7 8 9 10 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ PRE-TAX INCOME(1) 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 Maximum NOL Usage, if change of control 10.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 FEDERAL TAX SAVINGS: Potential Federal NOL Usage(2) 9.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Allowed Federal NOL Usage(2) 9.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Federal Tax Savings at 35 percent 3.150 0.350 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 STATE TAX SAVINGS State NOL Usage(2) 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 State NOL Usage(2) 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 State Tax Savings at 6.045 percent.(3) 6.05% 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 TOTAL TAX SAVINGS (FEDERAL AND STATE) 3.150 0.350 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Number of Years(4) 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 Present Value Factor 0.8000 0.6400 0.5120 0.4096 0.3277 0.2621 0.2097 0.1678 0.1342 0.1074 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ PRESENT VALUE OF TAX SAVING 2.520 0.224 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 SUM OF PRESENT VALUE OF TAX SAVING 2.744 FEDERAL NOL Beginning Balance 10.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Usage 9.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Additions 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ Ending Balance 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 STATE NOL Beginning Balance 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Usage 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Additions(5) 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ Ending Balance 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
NOTES: (1) Projected pre-tax income assumes $10 million in pre-tax income in FY 2002 (annualized results for quarter ended 9/30/01) with an assumed growth rate equal to 0 percent thereafter. (2) Assumes Federal and State NOL's can be used to offset 90 percent of taxable income. In addition, annual NOL usage is limited under a 'change of control' scenario to the Company's equity value multiplied by the Fed Funds Rate. (3) The state tax rate of 9.3 percent is adjusted by 65 percent or (1-Federal tax rate) to reflect the federal tax benefit received if the Company had paid state taxes. (4) Assumes tax benefit associated with the usage of NOL to be received at end of each year. (5) Assumes that additions to the State NOL are limited to 100 percent of the pre-tax loss, if any, in a given year. Houlihan Lokey Howard & Zukin Financial Advisors 60 TERMINATION FEE STUDY [JENNY CRAIG LOGO] TERMINATION FEE STUDY SUMMARY OF ANALYSIS - - This study includes 144 announced M&A transactions in 2000 involving U.S. publicly traded target companies with an aggregate Transaction Value of at least $50.0 million in which there was a disclosed Termination Fee. - - The magnitude of each Termination Fee was measured as a percentage of "Transaction Value." Transaction Value is defined as the total amount of consideration payable in the transaction, excluding transaction fees and expenses. Liabilities and preferred stock were included in Transaction Value only if they were publicly disclosed as part of the consideration. - - Transaction Value was determined to be a more appropriate reference point than Equity Value for determining the magnitude of a Termination Fee because, unlike Equity Value, Transaction Value is not affected by the target company's capital structure. - - Based on the 144 transactions analyzed, Termination Fees in 2000 as a percent of Transaction Value ranged from a high of 6.6 percent to a low of 0.7 percent, with a median of 2.9 percent. TRANSACTION TERMINATION FEE STUDY SUMMARY(1) ($ IN MILLIONS)
TERMINATION FEE AS A PERCENTAGE OF TRANSACTION TERMINATION TRANSACTION VALUE FEE VALUE ----------- ----------- ------------------ High $172,494.0 $3,900.0 6.6% Low $ 55.7 $ 1.8 0.7% Mean $ 3,483.4 $ 88.1 3.0% Median $ 685.3 $ 20.7 2.9%
- ---------- (1) High, low, mean and median summary results are exclusive of each other. Results shown for transaction value, termination fee and termination fee as a percentage of transaction value may be from different transactions. Houlihan Lokey Howard & Zukin Financial Advisors 62 [JENNY CRAIG LOGO] TERMINATION FEE STUDY - - Illustrated below is an analysis of 2000 and 1999 Termination Fees relative to transaction size and form of consideration. TERMINATION FEE STUDY BY TRANSACTION SIZE AND FORM OF CONSIDERATION ($ IN MILLIONS)
MEDIAN TERMINATION NUMBER MEDIAN MEDIAN FEE AS A PERCENTAGE OF OF TRANSACTIONS TRANSACTION VALUE TERMINATION FEE TRANSACTION VALUE ---------------- -------------------- ---------------- ---------------------- 2000 1999 2000 1999 2000 1999 2000 1999 ------ ------ -------- -------- ------ ------ ------ ------ MEDIAN TERMINATION FEES BY TRANSACTION SIZE $50 million to $250 million 37 110 $ 153.6 $ 115.3 $ 5.0 $ 4.0 3.3% 3.4% $250 million to $500 million 28 61 $ 387.9 $ 389.6 $ 10.3 $ 12.0 2.7% 3.1% $500 million to $1 billion 18 52 $ 732.2 $ 707.2 $ 23.8 $ 15.3 3.6% 2.5% $1 billion and greater 61 99 $2,559.1 $2,327.9 $ 85.0 $ 54.0 2.8% 2.5% ------ ------ -------- -------- ------ ------ ------ ------ TOTAL 144 322 $ 730.4 $ 450.4 $ 20.0 $ 12.5 2.9% 2.9% MEDIAN TERMINATION FEES BY TRANSACTION CONSIDERATION All Stock 62 133 $1,475.4 $ 569.3 $ 45.0 $ 20.0 3.0% 2.9% All Cash 77 164 $ 412.0 $ 295.9 $ 10.0 $ 9.0 2.8% 2.8% Cash and Stock 5 25 $1,755.6 $1,291.7 $ 65.0 $ 30.0 2.6% 2.6% ------ ------ -------- -------- ------ ------ ------ ------ TOTAL 144 322 $ 730.4 $ 450.4 $ 20.0 $ 12.5 2.9% 2.9%
Houlihan Lokey Howard & Zukin Financial Advisors 63 LBO MODEL LBO MODEL LBO MODEL SUMMARY
SOURCES: $000s % TOTAL RATE PIK RATE EQUITY AMORTIZATION ------ ------- ------ -------- ------ -------------- Senior Term A 15,000 19.5% 15.0% 0.0% 0.0% 2.0 in 2.0 Senior Term B 15,000 19.5% 17.0% 0.0% 0.0% 3.0 in 3.0 Revolving Line of Credit 2,000 2.6% 11.0% 0.0% 0.0% -- -- -- Subordinated Debt 25,000 32.5% 17.0% 0.0% 20.0% 5.0 in 5.0 Seller Note -- 0.0% 10.0% 0.0% 0.0% 5.0 in 5.0 Preferred Equity 18,000 23.4% 10.0% 0.0% 57.6% 0.0 in 7.0 Common Equity 2,000 2.6% 0.0% 0.0% 22.4% -- -- -- Other Common -- 0.0% 0.0% 0.0% 0.0% -- -- -- Total Sources 77,000 100.0% 100.0%
USES: $000s % TOTAL -------- ------- Cash Stock Purchase 115,000 149.4% Cash Asset Purchase -- 0.0% Refinance Debt -- 0.0% Seller Note -- 0.0% Reinvested Equity -- 0.0% Transaction Costs 8,000 10.4% Other -- 0.0% Change in Cash (46,000) -59.7% Total Uses 77,000 100.0%
INTERNAL RATES OF RETURN: Exit Multiple (Yr. 5) 4.0x 5.0x 6.0x Subordinated Debt 24.8% 27.1% 29.3% Pref. & Comm Eqty 42.2% 48.1% 53.1%
PROJECTED AS OF JUNE 30 DEBT BALANCE: OPENING AT ------------------------------------------------------------ 11/30/01 2002 2003 2004 2005 2006 ---------- -------- -------- -------- -------- -------- Senior Term A 15,000 13,250 9,550 -- -- -- Senior Term B 15,000 12,083 7,083 -- -- -- Revolving Line of Credit 2,000 3,302 2,422 5,000 -- 5,000 Subordinated Debt 25,000 25,000 25,000 25,000 25,000 -- Seller Note -- -- -- -- -- -- Total Debt 57,000 53,635 44,055 30,000 25,000 5,000 Less: Cash (7,665) (5,000) (5,000) (2,506) (10,332) (4,811) Net Debt 49,335 48,635 39,055 27,494 14,668 189 EQUITY: Preferred Equity 18,000 18,000 18,000 18,000 18,000 18,000 Common Equity 73,622 73,622 73,622 73,622 73,622 73,622 Paid in Capital (58,499) (58,499) (58,499) (58,499) (58,499) (58,499) Retained Earnings 201 2,361 11,941 22,993 35,296 49,239 Treasury Stock (74,762) (74,762) (74,762) (74,762) (74,762) (74,762) -------- -------- -------- -------- -------- -------- Total Stockholder' Equity (41,438) (39,278) (29,698) (18,646) (6,343) 7,600 -------- -------- -------- -------- -------- --------
OPERATING SUMM: ACTUAL FYE JUNE 30, PROJECTED FYE JUNE 30, ----------------------------------------- LTM 7 MOS. ----------------------------------------- 1998 1999 2000 2001 NOV-01 6/30/02 2003 2004 2005 2006 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- Revenue 352,249 320,952 290,985 283,552 296,713 183,644 318,860 326,832 335,002 343,377 % Growth NA -8.9% -9.3% -2.6% 4.6% NA 3.5% 2.5% 2.5% 2.5% Gross Profit 28,617 30,856 20,346 20,396 28,642 26,186 45,432 46,568 47,732 48,925 % of Sales 8.1% 9.6% 7.0% 7.2% 9.7% 14.3% 14.2% 14.2% 14.2% 14.2% Adjusted EBITA 2,040 5,419 2,627 481 20,235 16,856 25,532 26,089 26,657 27,236 % of Sales 0.6% 1.7% 0.9% 0.2% 6.8% 9.2% 8.0% 8.0% 8.0% 7.9% Adjusted EBITDA 9,141 11,273 8,168 6,534 26,057 17,639 28,760 29,017 29,585 30,164 % of Sales 2.6% 3.5% 2.8% 2.3% 8.8% 9.6% 9.0% 8.9% 8.8% 8.8% CAPX 4,678 5,073 4,747 1,961 800 5,500 5,000 5,000 5,000 5,000 % of Sales 1.3% 1.6% 1.6% 0.7% 0.3% 3.0% 1.6% 1.5% 1.5% 1.5% Adj. EBITDA - CAPX 4,463 6,200 3,421 4,573 25,257 12,139 23,760 24,017 24,585 25,164 % of Sales 1.3% 1.9% 1.2% 1.6% 8.5% 6.6% 7.5% 7.3% 7.3% 7.3%
COVERAGE & LIQUIDITY: PROJECTED FYE JUNE 30, OPENING AT EST. FYE 7 MOS. --------------------------------------- 11/30/01 2002 2002 2003 2004 2005 2006 ---------- -------- ------ ------ ------ ------ ------ EBITDA - CAPX - Taxes/ Cash Interest+Sch. Prin+Cash Div 1.15x 0.75x 0.73x 0.93x 0.67x 2.54x 0.53x EBITDA - CAPX/Cash Interest NMF 1.97x 2.32x 3.01x 4.02x 5.43x 10.48x EBITDA/Cash Interest NMF 2.67x 3.37x 3.64x 4.86x 6.54x 12.57x Financing/EBITDA NA 6.1x 8.2x 4.7x 4.2x 3.9x 3.2x Total Debt/EBITDA 2.19x 2.24x 3.04x 1.53x 1.03x 0.85x 0.17x Senior Debt/EBITDA 1.23x 1.10x 1.62x 0.66x 0.17x 0.00x 0.17x Financing/EBITDA - CAPX 5.9x 8.2x 12.0x 5.7x 5.1x 4.7x 3.8x Total Debt/EBITDA - CAPX 2.3x 3.0x 4.4x 1.9x 1.2x 1.0x 0.2x Senior Debt/EBITDA - CAPX 1.3x 1.6x 2.4x 0.8x 0.2x 0.0x 0.2x
PROJECTED FYE JUNE 30, REVOLVER AVAILABILITY: OPENING AT -------------------------------------------------- 11/30/01 2002 2003 2004 2005 2006 ---------- ------ ------ ------ ------ ------ Actual Revolver Balance 2,000 3,302 2,422 5,000 -- 5,000 Eligible Accounts Receivable @ 75% 1,792 1,800 2,175 2,229 2,285 2,342 Eligible Inventory @ 50% 5,013 6,050 6,400 6,560 6,724 6,892 ------ ------ ------ ------ ------ ------ Maximum Availability 5,000 5,000 5,000 5,000 5,000 5,000 Revolver Availability 3,000 1,698 2,578 -- 5,000 --
Houlihan Lokey Howard & Zukin Financial Advisors 65 VALUATION SUMMARY VALUATION SUMMARY ($ in Thousands, except per share information)
MARKET APPROACH DCF APPROACH IMPLIED PUBLIC MARKET ---------------------------- ---------------------------- --------------------- Low High Low High Low High ENTERPRISE VALUE $ 69,000 $ 80,000 $ 66,000 $ 81,000 ------------ ------------ ------------ ------------ Excess Cash $ 40,000 $ 40,000 $ 40,000 $ 40,000 Interest-bearing Debt (1,394) (1,394) (1,394) (1,394) Value of Net Operating Loss Carryforwards 2,744 2,744 2,744 2,744 ------------ ------------ ------------ ------------ Aggregate Equity Value $ 110,350 $ 121,350 $ 107,350 $ 122,350 Proceeds - "in the money" Options 3,087 3,087 3,087 3,087 ------------ ------------ ------------ ------------ Adjusted Equity Value $ 113,437 $ 124,437 $ 110,437 $ 125,437 ============ ============ ============ ============ Shares outstanding 20,688,971 20,688,971 20,688,971 20,688,971 Total "in the money" Options Outstanding 1,501,000 1,501,000 1,501,000 1,501,000 ------------ ------------ ------------ ------------ Fully Diluted Shares Outstanding 22,189,971 22,189,971 22,189,971 22,189,971 Indicated Price Per Share $ 5.11 $ 5.61 $ 4.98 $ 5.65 $ 2.74 $ 3.00
Houlihan Lokey Howard & Zukin Financial Advisors 67
EX-99.(D)(2) 7 v79145orex99-d2.txt EXHIBIT (D)(2) EXHIBIT (d)(2) ================================================================================ JENNY CRAIG, INC. STOCKHOLDERS' AGREEMENT DATED ------------------ ================================================================================ TABLE OF CONTENTS
Page ---- Section 1. Definitions ............................................................................1 Section 4. Action by Stockholders; Irrevocable Proxy..............................................12 Section 5. Other Arrangements.....................................................................13 Section 6. Preemptive Rights .....................................................................15 Section 7. Restrictions on Transfer...............................................................15 Section 8. Right of First Refusal.................................................................16 Section 9. Rights and Obligations of Inclusion (Tag-Along and Drag-Along Rights)..................17 Section 10. Share Certificates.....................................................................19 Section 11. After-Acquired Shares..................................................................20 Section 12. Severability ..........................................................................20 Section 13. Governing Law .........................................................................20 Section 14. Assignment ............................................................................20 Section 15. Notices ...............................................................................20 Section 16. Termination ...........................................................................21 Section 17. Section and Other Headings.............................................................21 Section 18. Remedies ..............................................................................21 Section 19. Entire Agreement ......................................................................21 Section 20. Amendment; Waiver .....................................................................21 Section 21. Counterparts ..........................................................................21 Section 22. Fees and Expenses .....................................................................21 Section 23. Affiliate Transactions.................................................................21
STOCKHOLDERS' AGREEMENT STOCKHOLDERS' AGREEMENT, dated as of ___________, 2002 (this "Agreement"), among J Holdings Corp., a Delaware corporation (the "Company"), DB Capital Investors, L.P., a Delaware limited partnership (collectively with its Affiliates who shall, from time to time, own, beneficially or of record, securities of the Company "DBCP"), [ACI Capital Co., Inc. on behalf of ACI Entities] (collectively with its Affiliates who shall, from time to time, own, beneficially or of record, securities of the Company, "ACI") and _____________, and __________, each an individual (each, a "Management Stockholder"), SJF Enterprises, Inc., a Delaware corporation ("SJF"), Craig Enterprises, Inc., a __________ corporation ("CEI"), and Sidney Craig and Jenny Craig, each an individual (collectively the "Craigs", and together with SJF and CEI, the "Craig Group"). W I T N E S S E T H: WHEREAS, the Major Investors, the Management Stockholders and SJF own the shares of common stock of the Company (the "Common Stock") and other securities of the Company listed on Exhibit A attached hereto and desire to enter into this Stockholders' Agreement; NOW, THEREFORE, in consideration of the agreements, premises and mutual covenants contained in this Agreement, the parties to this Agreement, intending to be legally bound, hereby agree as follows: Section 1. Definitions. (a) The following terms have the meanings set forth below: "Accepting Offeree" has the meaning set forth in Section 9. "ACI" has the meaning set forth in the recitals. "ACI Director" has the meaning set forth in Section 2(b)(ii). "Acquisition Notice" has the meaning set forth in Section 9(b). "Acquisition Proposal" has the meaning set forth in Section 9(b). "Affiliate" shall mean, with respect to any Person, any Person directly or indirectly controlling, controlled by, or under direct or indirect common control with such other Person (by contract or otherwise, including any entity to which such other Person is the exclusive provider of management or other investment advisory services). "Agreement" has the meaning set forth in the recitals. "Annual Budget" has the meaning set forth in Section 3(a)(i)(xvii). "Board" has the meaning set forth in Section 2. "Business Day" means any day (other than a Saturday or Sunday) on which banks in New York City are open for business. "Capital Expenditures" means all commitments to pay or payments for any fixed assets or improvements or for replacements, substitutions or additions thereto, that have a useful life of more than one year and which are required to be capitalized under GAAP. "CEI" has the meaning set forth in the preamble. "Common Stock" means the common stock, par value $.01 per share, of the Company, of which there are ________ shares issued and outstanding (all of which are voting shares) as of the date of this Agreement. "Company" has the meaning set forth in the recitals. "Convertible Securities" means any option, warrant or share of preferred stock of the Company or any other security, in any case, which is convertible into or exercisable or exchangeable for Common Stock, either immediately or upon the occurrence of a specified date or a specified event. "Craigs" has the meaning set forth in the preamble. "Craig Director" has the meaning set forth in Section 2(b). "Craig Group" has the meaning set forth in the preamble. "DAH" has the meaning set forth in the preamble. "DBCP Director" has the meaning set forth in Section 2(b)(i). "DBCP" has the meaning set forth in the preamble. "Excess New Securities" has the meaning set forth in Section 6. "Fiscal Year" has the meaning set forth in Section 3(a)(ii)(B)(iii). "GAAP" means United States generally accepted accounting principles. "Initial Public Offering Date" means the first date on which the Common Stock shall have been registered pursuant to an effective registration statement on Form S-1 (or any equivalent general registration form) under the Securities Act. "Joint Director" has the meaning set forth in Section 2. "Lien" means any pledge, claim, lien, charge, encumbrance or security interest of any kind or nature whatsoever. "Major Investor Directors" has the meaning set forth in Section 2(b)(ii). "Major Investors" means each of DBCP and ACI. "Management Stockholder" has the meaning set forth in the preamble. "New Securities" means any authorized but unissued shares, and any treasury shares, of capital stock of the Company and all rights, options or warrants to purchase capital stock, or securities of any type whatsoever that are, or may become, convertible into capital stock. "New Securities Notice" has the meaning set forth in Section 6. "Notice" has the meaning set forth in Section 9. 2 "Obligated Party" has the meaning set forth in Section 3(c)(vii). "Offer" has the meaning set forth in Section 8. "Offeree" has the meaning set forth in Section 9. "Option Period" has the meaning set forth in Section 8. "Parent" means any entity that has beneficial ownership or the right to control, directly or indirectly, the voting of more than 50% of the voting securities of any other entity. "Permitted Transferees" means (i) in the case of an individual, his estate or legal representative and trusts solely for the benefit of him, his spouse or his children, (ii) in the case of a partnership, (A) any of its partners (limited or general) who are partners as of the date of this Agreement, (B) any individual or entity who becomes a partner after the date of this Agreement (except that if Shares constituting more than 5% of the outstanding shares of Common Stock (on a fully diluted basis) are Transferred to any individual or entity who becomes a partner after the date of this Agreement, such transferee shall not qualify as a Permitted Transferee), (C) the estates of such partners and (D) any Affiliate of such partnership or any of its partners (limited or general) who are partners as of the date of this Agreement (but shall not include any Person to whom Shares or other Stock are sold); (iii) in the case of a corporation, any Subsidiary, any Parent corporation and any Subsidiary of a Parent corporation; provided that any Transfer to such a transferee was not consummated (and, in the case of clause (ii)(B), such transferee was not made a partner) in contemplation of a transaction intended to circumvent the restrictions on Transfer of Shares set forth in this Agreement; and (iv) in the case of SJF, a member of the Craig Family (defined below) or a Craig Entity (defined below), any one or more of the following shall (subject to the proviso to this sentence) be a Permitted Transferee, (A) Sidney Craig or Jenny Craig or (B) any lineal descendant of either of the Craigs (with the Craigs, collectively the "Craig Family") or (C) any trust solely for the benefit of a member or members of the Craig Family or (D) any partnership, limited liability company, corporation or other entity more than 75% of the equity securities of which are beneficially owned directly or indirectly by a member or members of the Craig Family (a "Craig Entity") (the Persons listed in this subparagraph each being a "Craig Stockholder" and collectively the "Craig Stockholders"); provided, however, and not withstanding the foregoing, a Permitted Transferee may not effect a further transfer, directly or indirectly (other than a transfer in accordance with clause (i) above) of his, her or its Securities to any Person unless such Person is both a Permitted Transferee of (x) the original holder of such Securities being transferred and (y) the Permitted Transferee who is transferring such Securities; provided further, that in the discretion of Deutsche Bank AG, unlimited transfers may be made by itself or by any of its direct or indirect majority owned subsidiaries, to itself or to any of its direct or indirect majority owned subsidiaries which is also a Permitted Transferee. In addition, the Small Business Administration (the "SBA"), or any Person designated by the SBA in accordance with applicable SBA regulations, shall be deemed a Permitted Transferee of ACI for the purposes of this Agreement. After a Permitted Transferee becomes a party to this Agreement pursuant to Section 7(b), each reference in this Agreement to a party to this Agreement shall be deemed to include such Permitted Transferee of such party and such Permitted Transferee shall have all the rights of the transferring party hereunder, subject to the limitations on such rights contained herein, including but not limited to limitations based on ownership of required minimum amounts of Stock. "Person" shall mean a corporation, limited liability company, partnership or other entity or person. 3 "Preferred Stock" means the Senior Preferred Stock, par value $_____ per share, of the Company, having an aggregate liquidation preference of $18,000,000 of which _____ shares having a liquidation preference of $_____ per share are issued and outstanding as of the date of this Agreement. "Prohibited Payment" has the meaning set forth in Section 3. "Registrable Securities" shall mean (1) any Common Stock now or hereafter owned by the Stockholders, (2) any Common Stock issuable or issued upon conversion or exercise of any warrant, right or other security now or hereafter owned by the Stockholders, and (3) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a distribution with respect to, or in exchange for or in replacement of, or upon conversion of, such Common Stock, warrants, rights or other securities. "Sale Notice" has the meaning set forth in Section 8. "Securities" means Common Stock, Preferred Stock, Warrants or other Stock, provided that, for purposes of Sections 7, 8 and 9, the term "Securities" shall not include the Warrants if the same are being Transferred together with the Transfer of the Subordinated Debt. "Securities Act" means the Securities Act of 1933, as amended, and the rules and regulations thereunder. "Selling Stockholder" has the meaning set forth in Section 8. "Shares" means the shares of Common Stock held by any of the Stockholders on the date of this Agreement and any other shares of Common Stock hereafter acquired by any Stockholder, including shares issued upon conversion or exercise of any Convertible Security. "Stock" means any and all shares, interests, participations or other equivalents (however designated) of the Company's capital stock (or equivalent ownership interests or membership interests) whether now outstanding or hereafter issued, including, without limitation, the Common Stock and the Preferred Stock, all common or preferred stock of any other class issued after the date of this Agreement, any convertible securities and rights, warrants (including the Warrants) or options to purchase the Company's capital stock. "Stockholders" means, collectively, the Major Investors, the Management Stockholders, SJF and any Permitted Transferees of such parties which become party to this Agreement pursuant to Section 7(b). "Subordinated Debt" means the junior subordinated debt of J Acquisition Corp., a Delaware corporation, and its successors and assigns, due _________, 2007. "Subsidiary" means any entity, more than 50% of whose voting securities are beneficially owned or controlled, directly or indirectly, by any other entity. "Third Party Offeror" has the meaning set forth in Section 9(b). "Transfer" means any direct or indirect transfer, sale, assignment, pledge, encumbrance, hypothecation or other disposition, whether with or without consideration and whether voluntary or involuntary or by operation of law. 4 "Warrants" means warrants exercisable for _____________ shares of Common Stock of the Company, subject to adjustment as respectively provided therein, at a price of $_____ per share, which may be exercised at any time from _____, 200_ to _______, 200_. As of the date of this Agreement the Warrants are held as follows: DBCP holds Warrants for ____ shares, ACI holds Warrants for _______ shares, and the Management Stockholders collectively hold Warrants for ________ shares. (b) Dilution Calculations. Whenever in this Agreement it is specified that a calculation based on a percentage of outstanding shares of Common Stock is to be done on a "fully diluted basis" the denominator of the fractional equivalent of such percentage shall be the aggregate of (i) all shares of outstanding Common Stock, plus (ii) the shares of Common Stock issuable upon exercise of all options granted to employees and management of the Company plus (iii) the shares of Common Stock issuable upon exercise of conversion or exchange rights under all other Convertible Securities including, without limitation, the Warrants. Section 2. Election and Removal of Directors. Each Stockholder shall vote all of its Shares and any other voting securities of the Company over which such Stockholder has voting control and shall take all other necessary or desirable actions within its control (including, without limitation, attendance at meetings in person or by proxy for purposes of obtaining a quorum and execution of written consents in lieu of meetings), and the Company shall take all necessary or desirable actions within its control (including, without limitation, calling special board and stockholder meetings), so that: (a) Number of Directors. The authorized number of directors on the Board of Directors of the Company (the "Board") shall be nine directors. (b) Nominations Prior to the Initial Public Offering Date. Immediately after the date of this Agreement, the Board shall consist of (i) three nominees designated by DBCP (each a "DBCP Director"), who shall initially be __________________; (ii) three nominees designated by ACI (each an "ACI Director," and collectively with the DBCP Directors, the "Major Investor Directors"), who shall initially be ____________________; (iii) one designee of SJF (the "Craig Director"), who shall at all times be either Sidney Craig or Jenny Craig; and (iv) up to two members designated by mutual consent of the Major Investors or the Major Investor Directors designated by them, who shall initially be Kent Kreh and Patricia Larchet (for purposes of this Section 2, each a "Joint Director"). If (x) both Sidney Craig and Jenny Craig shall be unable to serve as director or (y) SJF fails to designate either of them as director, the number of Joint Directors shall be increased to three. In addition, DBCP and ACI shall each have the right to appoint an observer (each, an "Observer") to attend all meetings of the Board and all committees (whether in person, telephonic or other) in a non-voting, observer capacity and the Company shall provide to each Observer, concurrently with the members of the Board and each such committee, and in the same manner, notice of such meeting and a copy of all materials provided to such members, provided that each such Observer shall execute a confidentiality agreement with respect to such materials and information on standard terms. On the first date a Major Investor owns less than seven percent (7%) of the outstanding Common Stock, calculated on a fully diluted basis, such Major Investor shall immediately lose, from and after such date, (i) its rights under this Agreement to appoint, remove or fill vacancies with respect to two of its designated Major Investor Directors and any Observer, but shall retain such rights under this Section 2 with respect to one member of the Board, but such director shall no longer be considered a Major Investor Director and (ii) its rights under Section 3. At the discretion of the Board, either or both of the directors formerly designated by such Major Investor may thereafter be nominated by a majority of the then current directors for reelection in accordance with the Company's by-laws and applicable law, but such director(s) shall no longer be considered Major Investor Director(s), or the size of the Board may be reduced accordingly (in which case such Major Investor shall cause such director(s) to resign from the Board). On the first date SJF owns less than seven percent (7%) of the outstanding Common Stock, calculated on a fully diluted basis, SJF shall immediately lose, from and after such date, its rights under 5 this Agreement to appoint, remove or fill vacancies with respect to the Craig Director. At the discretion of the Board, the director formerly designated by SJF may thereafter be nominated by a majority of the then current directors for reelection in accordance with the Company's by-laws and applicable law, but such director shall no longer be considered a Craig Director, or the size of the Board may be reduced accordingly (in which case SJF shall cause such director to resign from the Board). (c) Removal. DBCP and ACI shall each be entitled at any time and for any reason (or for no reason) to designate any of its respective nominees for removal from the Board as a director. Each of DBCP and ACI, by mutual consent, shall be entitled at any time and for any reason (or for no reason) to designate any of the Joint Directors for removal from the Board as a director. SJF shall be entitled at any time and for any reason (or for no reason) to designate its nominee for removal from the Board as a director. The Stockholders agree to take such action, and to cause the remaining directors to take such action, as promptly as practicable but no later than twenty (20) days after such designation, as is necessary to remove such directors from the Board. (d) Filling Vacancies. If at any time a vacancy is created on the Board by reason of the death, removal or resignation of any director, the Stockholders agree to take such action, and to cause the remaining directors to take such action, within twenty (20) days after such occurrence, to approve and elect an individual to fill such vacancy, which individual shall be designated for election as a director by (i) DBCP, if the individual who has ceased to be a director was a nominee designated by DBCP, (ii) ACI, if the individual who has ceased to be a director was a nominee designated by ACI, or (iii) subject to Section 2(b), SJF, if the individual who has ceased to be a director was Sidney Craig or Jenny Craig, or (iv) mutual consent of the Major Investors or the Major Investor Directors. If both Sidney Craig and Jenny Craig are unable to serve on the Board or SJF does not designate either of them to serve on the Board, then such vacancy shall be filled by the mutual consent of the Major Investors or the Major Investor Directors. (e) Failure to Designate. If any Major Investor fails to designate a nominee to fill a vacancy in a directorship controlled by it or the Major Investors fail to designate a nominee to fill a vacancy for a Joint Director, in each case within twenty (20) days of the occurrence of such vacancy , the election of an individual to such directorship shall be accomplished in accordance with the Company's by-laws and applicable law. (f) Subsidiary Boards. The identity of the directors, managing members, general partners, or similar office holders, depending on the structure thereof, as the case may be, of each Subsidiary of the Company shall be identical to the directors of the Company unless otherwise agreed to by the Major Investors, and if not identical to the directors of the Company, SJF shall be entitled to designate one director, managing member, general partner or similar office holder, as applicable, to such Subsidiary of the Company. (g) Meetings. The Board shall meet at least quarterly. (h) Committees. At all times a DBCP Director and an ACI Director shall serve on the following committees of the Board if and when created: (i) the Executive Committee, (ii) the Audit Committee and (iii) the Compensation Committee. No committee of the Board shall be created, and the powers and duties thereof determined, except with the mutual consent of each of the Major Investors. At least one Major Investor Director and, at the discretion of DBCP and ACI, at least one DBCP Director and one ACI Director, shall serve on each additional committee of the Board. 6 (i) Quorum. At all times this Agreement is in effect and DBCP and ACI are Major Investors, a quorum of the Board shall consist of a majority of the entire Board and must include at least two DBCP Directors and two ACI Directors. Section 3. Certain Corporate Actions. (a) Each Stockholder shall vote all of its Shares and any other voting securities of the Company over which such Stockholder has voting control and shall take all other necessary or desirable actions within its control (including, without limitation, attendance at meetings in person or by proxy for purposes of obtaining a quorum and execution of written consents in lieu of meetings), and the Company shall take all necessary or desirable actions within its control (including, without limitation, calling special board and stockholder meetings), so that at all times the charter documents of the Company, including but not limited to the by-laws and the certificate of incorporation, shall provide, subject to the provisions of Section 3(b), that the affirmative vote of a majority of the Directors then in office, including the affirmative vote of all Major Investor Directors designated by each of DBCP and ACI, shall be required in order for the Company or any Subsidiary to take any of the following actions (or series of actions that, on a cumulative basis, produce the same result) and the Company shall not (and shall cause its Subsidiaries not to) take any such action (or series of actions) without such consent: (i) declare or pay any dividends or authorize or make any distribution upon or with respect to any Stock (except for dividends or distributions by any wholly-owned Subsidiary to another wholly-owned Subsidiary); (ii) enter into a merger, consolidation or other business combination involving the Company or any Subsidiary (whether or not the Company would be the surviving entity of such merger, consolidation or other business combination); (iii) approve the acquisition, or a related series of acquisitions, of any material properties or assets of any Person (regardless of the type of consideration used in connection therewith) (1) either not provided therefor or exceeding by $50,000 or more the amount approved therefor, in the Annual Budget, (2) in excess of $500,000 notwithstanding whether such acquisition has been approved in the Annual Budget or (3) in excess of $1,000,000 in the aggregate for all such transactions (regardless of the size of any one such transaction), in each case other than the purchase of inventory in the ordinary course of business; (iv) approve the assignment, transfer, conveyance, lease or other disposition of any of the material properties or assets of the Company and its Subsidiaries, or a related series of such transactions (1) exceeding by $50,000 or more in value the amount approved therefor in the Annual Budget, (2) in excess of $500,000 in value notwithstanding whether any such disposition has been approved in the Annual Budget or (3) in excess of $1,000,000 in value in the aggregate for all such transactions (regardless of the size of any one such transaction), in each case other than sales of inventory in the ordinary course of business; (v) during any Fiscal Year, make any investment in another Person whether in the form of equity or debt (including in connection with a joint venture) in an amount that exceeds $50,000 in the aggregate; (vi) adopt any plan of recapitalization, liquidation, voluntary bankruptcy or dissolution of the Company, unless otherwise required by law; 7 (vii) redeem or repurchase any Stock or rights to purchase Stock of the Company other than pursuant to employee or management stock option or purchase plans approved by the Major Investor Directors.; (viii) borrow any money or incur any indebtedness, including purchase money indebtedness, in excess of $100,000 in the aggregate; (ix) waive a right or debt owed to the Company or its Subsidiaries exceeding $50,000 individually or $500,000 in the aggregate; (x) satisfy or discharge any indebtedness or make payment of any obligation of the Company or its Subsidiaries in excess of $50,000, other than in the ordinary course of business consistent with past practice; (xi) permit or allow any assets of the Company or its Subsidiaries to be subjected to any material Lien in excess of $50,000, other than Liens on equipment in the ordinary course of business consistent with past practices; (xii) make any material change in any method of accounting or accounting practice or appoint auditors; (xiii) enter into transactions with Affiliates of the Company in excess of $50,000, including, without limitation, financial advisory or other services agreements; (xiv) issue or sell any shares of Stock, rights to acquire Stock (by conversion, exercise of a warrant or option or otherwise) or debt securities of the Company or any Subsidiary (provided that the Company may issue such securities pursuant to a stock incentive plan previously approved by the Major Investor Directors), or authorize a Transfer of Stock or rights to purchase Stock of any Subsidiary where approval of the Board is required; (xv) adopt any stockholder rights plan or amend the certificate of incorporation or by-laws of the Company; (xvi) appoint, elect or terminate the chairman of the Board or any executive officer and member of senior management; (xvii) with respect to any fiscal year, approve an annual business plan, budget and any long range strategic plan therefor (collectively, the "Annual Budget"); provided that in the event the Major Investor Directors do not approve an Annual Budget for any fiscal year, the officers shall operate the company consistent with past practice and the prior Annual Budget; (xviii) approve any individual or series of related capital expenditures (1) either not provided therefor or exceeding by $50,000 or more the amount approved therefor, in the Annual Budget, (2) in excess of $500,000 notwithstanding whether such expenditure has been approved in the Annual Budget other than as approved by the Executive Committee or (3) in excess of $1,000,000 in the aggregate for all such expenditures (regardless of the size of any one such expenditure); 8 (xix) approve or adopt any compensation, incentive, benefit, pension or similar plan for senior management or other employees in excess of $50,000, including any equity or equity-based plan; (xx) approve contracts having a value that exceeds $50,000 (other than contracts regarding the purchase of inventory) or that contain any covenants or other terms restricting the business of the Company; (xxi) prepare to register Common Stock pursuant to a registration statement on Form S-1 (or any equivalent general registration form) under the Securities Act; (xxii) assume, guarantee, endorse or otherwise become liable or responsible (whether directly, contingently or otherwise) for the material obligations of any other Person or make any loans, advances or capital contributions to any other Person; or (xxiii) materially change, add to, or eliminate any of the Company's lines of business other than as approved in the Annual Budget. (xxiv) provided, a motion to take such action with respect to any of the foregoing may be made by any Major Investor Director and such motion shall thereafter be voted upon, with or without a second or any other additional requirement, by the Board no later than at its next regularly scheduled meeting. For avoidance of doubt, the foregoing actions shall not require the approval of all Major Investor Directors of a Major Investor if such Major Investor has lost its designation rights under Section 2(b). (b) If at any time after the fourth anniversary of the date of this Agreement the Major Investor Directors do not agree with respect to any of the items brought to a vote pursuant to Sections 3(a)(i), 3(a)(ii), 3(a)(vi), 3(a)(xvi) or 3(a)(xvii) hereof, and such disagreement continues after such initial vote until the later of (A) the six month anniversary thereof or (B) the conclusion of the second consecutive Board meeting held thereafter, each of the Stockholders (other than SJF and its Permitted Transferees) shall, and shall cause members of the Board designated by them to cooperate to cause the Company to sell its assets and liquidate or to arrange a transaction for the sale of all outstanding Stock (through a merger or otherwise) as promptly as commercially practicable thereafter. The sale shall be supervised and directed by a representative of each of the Major Investors, in consultation and cooperation to the extent practicable with the Company, in a manner (including use of an investment banking firm of recognized standing selected by mutual consent of such representatives) structured, in the reasonable judgment of such representatives, to achieve the highest available price. It is understood and agreed that each Stockholder (other than, subject to the provisions of Section 9(b) hereof, SJF and its Permitted Transferees) shall vote its Shares and shall take all other necessary or desirable actions within its control (including, without limitation, attendance at meetings in person or by proxy for purposes of obtaining a quorum and execution of written consents in lieu of meetings) and, if applicable, shall direct its Board nominee(s) to take all necessary or desirable actions to approve and consummate any sale pursuant to this Section 3(b), including exercise of the proxy granted under Section 4(c) in the event of any failure to vote in accordance with the preceding sentence. SJF and its Permitted Transferees shall cooperate with the reasonable joint requests of the Major Investors in furtherance of the foregoing. Without the written consent of the Major Investors, no Stockholder or Affiliate of any Stockholder shall be eligible to purchase assets or Stock pursuant to such a sale. Any such sale or transaction shall be on terms and conditions that are identical for all Stockholders. (c) The Company covenants and agrees that from and after the date hereof (except as otherwise provided herein), until termination of this Agreement: 9 (i) Books and Records. The Company shall, and shall cause its Subsidiaries to, keep adequate records and books of account and prepare periodic statements of accounts with respect to their business activities in which proper entries reflecting all of their financial transactions are made in accordance with accounting practices and procedures established by the Company, which shall be in accordance with GAAP and applicable law. These practices and procedures shall provide that the Company shall (x) make and keep books, records, and accounts, which, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company and (y) devise and maintain a system of internal accounting controls sufficient to provide reasonable assurances that (1) transactions are executed and access to assets is given only in accordance with management's general or specific authorization, (2) transactions are recorded as necessary to permit preparation of periodic financial statements and to maintain accountability for assets and (3) recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. (ii) Financial and Business Information. The Company will deliver as soon as practicable (x) to each Major Investor and, for so long as SJF holds at least seven percent (7%) of the outstanding Common Stock, calculated on a fully diluted basis, SJF, the information listed in A, B, C, D and E below and (y) to each Stockholder, the information listed in C below: (A) Monthly Information. Commencing with the month ending _____________, after the end of each month, but in any event within 30 days thereafter: (x) an unaudited consolidated balance sheet of the Company and its Subsidiaries as of the end of such month; and (y) unaudited consolidated statements of income, retained earnings and cash flows of the Company and its Subsidiaries, for such month and for the portion of such year ending with such month. (B) Quarterly Information. After the end of each of the first three quarterly fiscal periods in each Fiscal Year of the Company, but in any event within 45 days thereafter, (x) an unaudited consolidated balance sheet of the Company and its Subsidiaries as of the end of such quarter, and (y) unaudited consolidated statements of income, retained earnings and cash flows of the Company and its Subsidiaries for such quarter and (in the case of the second and third quarters) for the portion of the Fiscal Year ending with such quarter, setting forth in each case in comparative form the projected consolidated figures for such period and the actual consolidated figures for the comparable period of the prior Fiscal Year. Such statements shall be (i) prepared in accordance with GAAP consistently applied, (ii) in reasonable detail and (iii) certified by the principal financial or accounting officer of the Company. (C) Annual Information. After the end of each fiscal year of the Company (each a "Fiscal Year"), but in any event within 90 days thereafter, (x) an audited consolidated balance sheet of the Company and its Subsidiaries as of the end of such Fiscal Year, and (y) audited consolidated statements of income, retained earnings and cash flows of the Company and its Subsidiaries for such year Fiscal Year, setting forth in each case in comparative form the figures for the previous year. Such statements shall be (i) prepared in accordance with 10 GAAP consistently applied, (ii) in reasonable detail and (iii) certified by KPMG or such other auditor selected in accordance with Section 3(a)(xii) hereof (D) Projections. Not less than thirty (30) days prior to the beginning of each Fiscal Year: (x) projected consolidated balance sheets of the Company and its Subsidiaries, if any, for such Fiscal Year, on a monthly basis; (y) projected consolidated cash flow statements of the Company and its Subsidiaries, if any, including summary details of cash disbursements (including for Capital Expenditures), for such Fiscal Year, on a monthly basis; and (z) projected consolidated income statements of the Company and its Subsidiaries, if any, for such Fiscal Year, on a monthly basis; in each case, approved by the Board of Directors of the Company, together with appropriate supporting details. (E) Supplemental Information. Concurrently and in connection with the supply of any historical financial information by the Company pursuant to subsections (A), (B) and (C) above, the Company will, but only to the extent it prepares such reports, provide reports containing comparisons and analyses of any variances between budgeted amounts and actual performance by the Company for the period of time covered by any such historical financial information. (iii) Tax Compliance. The Company shall pay all transfer, excise or similar taxes (not including income or franchise taxes) in connection with the issuance, sale, delivery or transfer by the Company to each Major Investor and SJF of Stock, and shall indemnify and save each Major Investor and SJF harmless without limitation as to time against any and all liabilities with respect to such taxes. The Company shall not be responsible for any taxes in connection with the transfer of Common Stock by the holder thereof. The obligations of the Company under this paragraph (iii) shall survive the termination or expiration of this Agreement. (iv) Access. The Company shall permit representatives of each Major Investor to visit and inspect any of the properties of the Company and its Subsidiaries, to examine the corporate books and make copies or extracts therefrom and to discuss the affairs, finances and accounts of the Company and its Subsidiaries with the principal officers of the Company, at such times and as often as each Major Investor may reasonably request upon prior notice. In addition, for so long as Sidney Craig, Jenny Craig and their respective Affiliates own at least seven percent (7%) of the Company's Common Stock calculated on a fully diluted basis, Sidney Craig, or a representative thereof, shall have access to the Chief Executive Officer and the Chief Financial Officer once each quarter for two (2) hours to discuss the status of the Company. (v) Restrictive Trade Practices; Boycotts. The Company will avoid any role in restrictive trade practices or boycotts prohibited or penalized under U.S. law. (vi) Prohibited Payments. The Company, its Subsidiaries and the officers, directors, employees, or representatives of the Company and its Subsidiaries shall use only legitimate practices in commercial operations and in promoting the Company's position on issues before governmental authorities. No officer, director, employee, or representative of the Company or its Subsidiaries shall pay, offer, promise or authorize the payment, directly or indirectly through any other Person, of any monies or anything 11 of value to (x) any Person employed by or acting for or on behalf of any customer, whether private or governmental, or (y) any government official or employee or any political party or candidate for political office or any or employee of, or any person acting on behalf of, a public international organization, for the purpose of inducing or rewarding any favorable action by the customer in any commercial transaction or in any governmental matter (any such act being a "Prohibited Payment"). A Prohibited Payment shall not include the payment of reasonable and bona fide expenditures, such as travel and lodging expenses, which are directly related to the promotion, demonstration or explanation of products or services, or the execution or performance of a contract with a foreign government or agency thereof; provided such payments are permissible under local law and customer guidelines. (vii) Confidentiality. Each party hereto or made a party hereto agrees to keep (A) this Agreement and the terms hereof and (B) any non-public information about the Company received pursuant to rights under this Agreement ((A) and (B) collectively, the "Confidential Information"), strictly confidential and to disclose such Confidential Information only to those Persons who have a need to know such terms in order to allow such party to properly perform their obligations hereunder and who are themselves bound by confidentiality obligations with respect thereto; provided (x) ACI may disclose Confidential Information to its limited partners (who shall be advised of the confidential nature of such information) and to the SBA and (y) that if a party (the "Obligated Party") is requested to, or required by, applicable law, rule, regulation or by court order, subpoena, other legal process, to disclose any of the Confidential Information, such party shall provide the Company with prompt written notice of the request or requirement so that the Company may seek a protective order or other appropriate remedy or, in the absence of seeking such protective order or other remedy, waive compliance by such party with the provisions of this Agreement; provided that, in the case of DBCP, upon the request of any government or regulatory or self-regulatory body having or claiming authority to regulate or oversee any aspect of its business or that of its Affiliates, DBCP may disclose such Confidential Information upon advising such requesting party of the confidential nature of such information. In the absence of a protective order or other remedy or the receipt of a waiver from the Company, if the Obligated Party is, in its good faith determination, legally compelled to disclose any of the Confidential Information, it may, without liability hereunder, disclose only such portion of the Confidential Information that it determines is legally required to be disclosed, provided that in that connection the Obligated Party shall use its reasonable best efforts to preserve the confidentiality thereof, including cooperating with the Company to obtain an appropriate protective order or other reliable assurance that confidential treatment will be accorded that portion of the Confidential Information disclosed. For avoidance of doubt, the marketing or transfer of Stock by any Stockholder is subject to the terms of this subsection (vii). Section 4. Action by Stockholders; Irrevocable Proxy. (a) Action by Written Consent. Any action required or permitted to be taken by the Stockholders under this Agreement, including any action with respect to the designation of members of the Board, may be taken pursuant to a written consent setting forth the action so taken and signed by the holders of the requisite percentage of the Shares then held by the Stockholders. (b) Special Meetings. In the event that the holders of the requisite percentage of the outstanding Shares have not consented in writing to any action required to be taken by the Stockholders 12 within ten days after such action is required to be taken, then the Chairman of the Board shall call a stockholders meeting for the purpose of determining the decision of stockholders in accordance with the By-Laws, the Certificate of Incorporation and applicable law. (c) Irrevocable Proxy. If any Stockholder fails for any reason to vote its Shares in accordance with the requirements of this Agreement, then the applicable proxy holder (as hereinafter determined) shall have the right to vote such Shares. Each Major Investor hereby constitutes and appoints the other Major Investor, with full power of substitution, its true and lawful proxy and attorney-in-fact, to vote, or to give a written consent with respect to, all of the Shares owned by the appointing Major Investor for the election to or the removal from the Board of the other Major Investor's nominee(s), or to vote upon any other matter upon any failure by such appointing Major Investor to vote its Shares in accordance with this Agreement. Each non-Major Investor Stockholder hereby constitutes and appoints each of the Major Investors, with full power of substitution, its true and lawful proxy and attorney-in-fact, to vote, or to give a written consent with respect to, all of the Shares owned by each such Stockholder for the election to or the removal of directors from the Board or to vote upon any other matter, upon any failure by such non-Major Investor to vote its Shares in accordance with this Agreement; provided that the Major Investor that first gives notice to the other Major Investor of its intent to exercise the proxy of any non-Major Investor Stockholder with respect to the votes taken at a particular stockholders meeting or with respect to a particular consent shall be the only Major Investor entitled to exercise such proxy with respect to such vote or consent. Any proxy granted hereunder shall only be valid to the extent that the holder thereof uses such proxy to vote the shares relating thereto in accordance with the terms of this Agreement. Each such appointment shall terminate at such time as the grantor no longer is obligated to vote his, her or its Shares in accordance with the requirements of this Agreement and, in all events, with respect to particular Shares upon the sale of such Shares by such grantor pursuant to an effective registration statement or Rule 144 under the Securities Act. The proxy granted hereby shall be binding on any transferee that acquires Shares in a transaction permitted pursuant to Section 7(b). EACH STOCKHOLDER ACKNOWLEDGES THAT THE PROXY GRANTED HEREBY IS COUPLED WITH AN INTEREST AND IS IRREVOCABLE TO THE FULL EXTENT PERMITTED BY THE GENERAL CORPORATION LAW OF THE STATE OF DELAWARE. Section 5. Other Arrangements. (a) No Stockholder shall grant any proxy or enter into or agree to be bound by any voting trust with respect to any of its Shares nor shall any Stockholder enter into any stockholder agreement or arrangement of any kind with any Person with respect to any of its Shares or other Stock, in each case inconsistent with the provisions of this Agreement (whether or not such agreement and arrangement is with other Stockholders or holders of shares of other Stock that are not bound by this Agreement), including, but not limited to, agreements or arrangements with respect to the acquisition, disposition or voting of Shares or other Stock, or act, for any reason, as a member of a group or in concert with any other Persons in connection with the acquisition, disposition or voting of its Shares or other Stock in any manner which is inconsistent with the provisions of this Agreement. (b) The Company shall, as a condition to grants of additional Stock to executive officers or employees of the Company or its Subsidiaries, require such employees to enter into an agreement with the Company restricting the Transfer of the Stock so acquired and other Stock, except with the consent of the Board, and imposing such other restrictions required by the Board and allowing the Company to repurchase such Stock at fair market value, as determined in good faith by the Board, or other price acceptable to the Board in the event that such employees cease to be employed by the Company. 13 (c) SJF shall be entitled to the following registration rights in respect of its Registrable Securities: (i) If the Company at any time proposes to register (including for this purpose a registration effected by the Company in connection with its initial public offering, only if shares are being sold in such offering for the account of a Major Investor or with respect to the shares transferred to any transferee of such Major Investor) any of its equity Securities under the Securities Act in connection with the public offering of such securities solely for cash (other than a registration on Form S-8 relating solely to the sale of securities to participants in a Company stock plan or to other compensatory arrangements to the extent includable on Form S-8, or a registration on Form S-4), the Company shall, at such time, promptly give SJF written notice of such registration at least thirty (30) days before the initial filing of such registration statement. Upon the written request of SJF given within twenty (20) days after mailing of such notice by the Company, the Company shall use its reasonable best efforts to cause to be registered under the Securities Act all of the Registrable Securities that SJF has requested to be registered. Notwithstanding anything to the contrary contained in this Section 5(c), if in connection with any offering described in this Section 5(c) involving an underwriting of securities (whether solely for Company's own account or for the account of others), the managing underwriter or the underwriters shall impose a limitation on the number of shares of Common Stock which may be included in the registration statement, then, in the discretion of such managing underwriter or underwriters, the Company shall include in such registration statement only such portion of the Registrable Securities with respect to which SJF shall have requested inclusion pursuant hereto as such limitation permits after the inclusion of all shares of Securities to be registered by Company for its own account or the account of others, other than the Major Investors or with respect to any of the shares transferred to any such Major Investor's transferees; provided, however, that if the offering is being made for the account of other persons as well as the Company, then the aggregate number of Registrable Securities that may be included in the underwriting shall be allocated (as nearly as practicable) among all holders of Registrable Securities participating in such registration in proportion to the amount of Registrable Securities owned by each such holder. The Company shall have no obligation under this Section 5(c) to make any offering of its securities, or to complete an offering of its securities that it proposes to make, and shall incur no liability to SJF for its failure to do so. (ii) At the time and in connection with any registered offering, the Company and SJF shall provide customary indemnification to one another in connection with its obligations under this Section 5(c). The Company shall furnish to SJF such number of copies of a summary prospectus or other prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents, as SJF may reasonably request. In connection with an underwritten registered offering of Registrable Securities, SJF will enter into an underwriting agreement in customary form and (whether or not SJF participates in such offering) will enter into a market standoff agreement in customary form and not more restrictive than comparable agreements entered into by any other holders of Registrable Securities. (iii) All expenses incident to the Company's performance of or compliance with the provisions of this Section 5(c), including, without limitation, all registration and filing fees, fees and expenses of compliance with securities or "blue sky" laws, printing expenses and reasonable fees and disbursements of counsel for the Company and of all independent certified public accountants of the Company, underwriters, securities acts 14 liability insurance if the Company so desires and fees and expenses of other Persons retained by the Company (all such expenses being herein called "Registration Expenses") will be borne by the Company, regardless of whether the registration statement becomes effective. SJF is liable for any (X) fees, discounts or commissions to any underwriter in respect of the Securities sold by SJF and (Y) any fees, expenses or disbursements of counsel and other legal and financial advisors to SJF. (iv) The rights under this Section 5(c) shall expire immediately as to any Registrable Securities owned by SJF when (i) a registration statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities have been disposed of in accordance with such registration statement, (ii) such securities shall have been distributed or sold to the public pursuant to Rule 144 promulgated under the Securities Act (or any successor rule thereto or any complementary rule thereto) or they shall become eligible for sale under Rule 144(k) provided such Registrable Securities represent less than one percent (1%) of the issued and outstanding Common Stock or (iii) they shall have ceased to be issued and outstanding for any reason. Section 6. Preemptive Rights. In case the Company proposes to issue or sell any New Securities to either ACI and/or DBCP or their respective Affiliates, the Company shall, no later than thirty (30) Business Days prior to the consummation of such transaction, give notice in writing (the "New Securities Notice") to SJF of such proposed issuance of New Securities. The New Securities Notice shall describe the proposed issuance of New Securities (including the amount and price of such New Securities), identify the proposed purchaser(s), and contain an offer (the "Preemptive Rights Offer") to sell to SJF at the same price and for the same consideration to be paid by the proposed purchaser(s), all or part of SJF's pro rata portion of the New Securities to be issued to ACI and/or DBCP. Following receipt of such notice, SJF shall have twenty (20) Business Days during which it may elect to purchase a pro rata portion of the New Securities proposed to be issued to ACI and/or DBCP, determined by dividing the number of Shares held by SJF by the aggregate number of Shares held by all Stockholders before the proposed issuance of New Securities. If the Company does not effectuate such sale within ninety (90) days after the expiration of such twenty (20) Business Day period, the Company shall be required to again comply with this Section 6 prior to effectuating any such sale. Notwithstanding the foregoing, this Section 6 shall not apply to (i) shares of Common Stock issued to ACI and/or DBCP upon their exercise of any Convertible Securities, including, without limitation, the Warrants; (ii) any payment-in-kind interest payable to ACI and/or DBCP pursuant to that certain Junior Subordinated Debt Facility, dated as of _____________, among _________________; (iii) dividends payable in kind, if and when declared, on the Preferred Stock; (iv) dividends or distributions on its Securities payable in shares of its Common Stock or other equity interests of the Company, (v) a subdivision of the Company's outstanding shares of Common Stock into a larger number of shares of Common Stock, (vi) a combination of the Company's outstanding shares of Common Stock into a smaller number of shares of Common Stock or (vii) an increase or decrease in the number of shares of Common Stock outstanding by reclassification of the Company's Common Stock. Section 7. Restrictions on Transfer. (a) Transfer Restricted. No Stockholder may Transfer any interest in any of the Securities held by such Stockholder except in accordance with Section 7(b). No Transfer of Securities in violation of this Agreement shall be made or recorded on the books of the Company. 15 (b) Permitted Transfers by Stockholders. The parties acknowledge and agree that any of the following Transfers of Securities are deemed to be in compliance with this Agreement: (i) a Transfer by any Stockholder in compliance with Section 8 and/or Section 9; and (ii) a Transfer by any Stockholder to a Permitted Transferee of such Stockholder. (c) Additional Restrictions on Shares Owned by Major Investors. On or prior to the fourth (4th) anniversary of the date hereof, none of the Major Investors may Transfer, pursuant to Section 7(b)(i) hereof, more than forty nine percent (49%) in the aggregate of any class of Securities owned by such Major Investor as of the date of this Agreement without the consent of the non-transferring Major Investor, such consent not to be unreasonably withheld; provided that notwithstanding the foregoing, in the case of DB Capital, if Deutsche Bank AG, in its good faith, reasonably determines that such Transfer is required in order to comply with any law, regulation or order applicable to DB Capital Partners or its Affiliates, such Transfer shall be permitted. (d) Restrictions on Certain Transferees. Without the mutual consent of the Major Investors, no transferee of Shares from a Major Investor pursuant to a Transfer approved under this Section 7 shall have any of the rights of a Major Investor hereunder including rights deriving from the number of shares of Common Stock owned by such transferee; provided, that in the event that Deutsche Bank AG transfers or causes all or substantially all of the Shares owned by DBCP to be transferred to itself or to one or more of its direct or indirect subsidiaries, Deutsche Bank AG may designate, at its discretion, which of itself or any such subsidiary shall succeed to the rights and obligations of DBCP as a Major Investor hereunder. provided, however, that, except for Transfers to the Company or Stockholders in accordance with this Agreement, no Transfer pursuant to this Section 7 shall be permitted unless and until each transferee delivers to the Company an executed copy of this Agreement, in which it agrees to be bound by and take the Securities so transferred subject to all the terms of this Agreement. (e) Transfers by the Craig Group. Notwithstanding anything herein to the contrary, so long as CEI or any Subsidiary of CEI beneficially owns, directly or indirectly, Stock representing more than seven percent (7%) of the Common Stock of the Company on a fully diluted basis, the Craigs will not Transfer more than fifty percent (50%) of the voting securities of CEI or any Subsidiary of CEI owning such Stock or any Person owning more than fifty percent (50%) of the voting securities of such Subsidiary to any Person other than a Permitted Transferee of the Craigs. Section 8. Right of First Refusal. (a) Except for Transfers to Permitted Transferees or Transfers pursuant to Section 9, if any Stockholder (a "Selling Stockholder") desires to dispose of any or all of its Securities, (i) such proposed Transfer must be pursuant to a bona fide written offer received from a proposed third party purchaser who is not an Affiliate of the Selling Stockholder (the "Offer"), (ii) such Stockholder shall give written notice (the "Sale Notice") to the Company and each non-selling Major Investor not fewer than thirty (30) Business Days before the date of the proposed disposition, which notice shall specify the terms and conditions of the Offer and the identity of the offeror and (iii) each non-selling Major Investor shall have the option, but not the obligation, by providing written notice to the Selling Stockholder within thirty (30) Business Days following the receipt of the Sale Notice (the "Option Period"), to purchase in the aggregate, all, but not less than all, of the Securities for which the Offer was made at the price and 16 upon the terms and conditions set forth in the Offer. Such option shall be exercisable by each non-selling Major Investor on a pro-rata basis with a right to purchase the full allotment of Securities unsubscribed for by any other non-selling Major Investor. Subject to the compliance with the tag-along right provisions of Section 9(a) hereof, such purchase will close, unless otherwise agreed to by the Selling Stockholder and the non-Selling Major Investor, on the thirtieth (30th) Business Day after the latest day on which a Sale Notice was received by any of the purchasing Major Investors. (b) If, for any reason, the non-selling Major Investors fail to exercise the option to purchase all of the Securities of the Selling Stockholders for which the Offer was made provided for in Section 8(a) within the thirty (30) Business Day period described in Section 8(a), it shall be deemed to be a waiver of such non-Selling Major Investors' option and the option shall expire and the Selling Stockholder shall have the right, subject to Section 9(a), for a period of ninety (90) days following the expiration of such option, to sell all of the Securities subject to the Offer; provided, that such sale may only be to the original offeror and on the same terms and conditions of the Offer, and provided, further, that such third party purchaser shall agree in writing to be bound by all of the terms and conditions of this Agreement which apply to the Selling Stockholder. Section 9. Rights and Obligations of Inclusion (Tag-Along and Drag-Along Rights). (a) Tag Along Rights. (i) Except for Transfers to Permitted Transferees, no Selling Stockholder or group of Selling Stockholders shall, individually or collectively, in any one transaction or any series of transactions, Transfer to any third party or group of third parties any or all of such Stockholder's or Stockholders' Securities unless the Major Investors have not exercised their rights of first refusal with respect to such Securities under Section 8. If any Selling Stockholder or group of Selling Stockholders receives and intends to accept a bona fide offer from a third party to purchase or otherwise acquire a number of Securities, then such Selling Stockholder or group of Selling Stockholders shall cause the third party's offer to be reduced to writing (which writing shall include an offer to purchase or otherwise acquire Securities from each non-selling Stockholder (each an "Offeree") according to the terms and conditions of this Section 9(a)) and shall send written notice of the third party's offer (the "Notice") to each Offeree, which notice may be the same notice and given at the same time as the Sale Notice under Section 8. The Notice shall be accompanied by a true and correct copy of the third party's offer. At any time within thirty (30) Business Days after receipt of the Notice, each Offeree may accept the offer included in the Notice (an "Accepting Offeree") for up to such number of Securities as is determined in accordance with the provisions of Section 9(b) by furnishing written notice of such acceptance to the Selling Stockholders and delivering to the Selling Stockholders the certificate or certificates representing the maximum number of Securities that may be sold or otherwise disposed of pursuant to such offer by such Offerees, together with a limited power-of-attorney authorizing the Selling Stockholders to sell or otherwise dispose of such Securities pursuant to the terms of such third party's offer. (ii) Each Offeree shall have the right, pursuant to Section 9(a)(i) above, to sell, at the price and upon the terms and conditions set forth in the Notice, a number of any class of equity Securities (rounded down to the nearest whole number of Securities) equal to the product of (A) the total number of such class of equity Securities to be acquired by the third party, times (B) a fraction, the numerator of which shall be the total number of such class of equity Securities owned by such Offeree, and the denominator of 17 which shall be the total number of such class of equity Securities owned by the Selling Stockholders and each participating Offeree. The Selling Stockholders shall reduce the number of such class of equity Securities they are to sell accordingly to allow for that amount of Securities of such class owned by the Accepting Offerees to be sold. (iii) The purchase from each Accepting Offeree pursuant to this Section 9(a) shall be on the same terms and conditions, including the price per unit and the date of sale or other disposition, as are received by the Selling Stockholders and stated in the Notice provided to the Offerees by the Selling Stockholders. (iv) Simultaneously with the consummation of the sale or other disposition of the Securities of the Selling Stockholders and the Accepting Offerees to the third party pursuant to the third party's offer, the Selling Stockholders shall notify the Accepting Offerees of the consummation of such sale or other disposition, shall cause the third party purchaser to remit to each Accepting Offeree the total sale price of the Securities of such Accepting Offeree sold or otherwise disposed of pursuant to such sale or other disposition and shall furnish such other evidence of the completion and time of completion of such sale or other disposition and the terms of such sale or other disposition as may be reasonably requested by the Accepting Offeree. The Selling Stockholders may deduct from the sales price payable to each Accepting Offeree pursuant to this Section 9(a) such Accepting Offeree's pro rata portion of the reasonable out-of-pocket fees and expenses payable in respect of the completion of such sale, including, without limitation, brokers', legal and accounting fees and expenses. (v) If within thirty (30) Business Days after the receipt of the Notice, any Offeree has not accepted the offer contained in the Notice, such Offeree will be deemed to have waived any and all rights with respect to the sale or other disposition of the Securities described in the Notice and the Selling Stockholders shall have ninety (90) days from the expiration of the tag-along option provided by this Section 9 in which to sell or otherwise dispose of not more than the amount of Securities described in the Notice, to the offeror named in the Notice and on terms not more favorable to the Selling Stockholders than were set forth in the Notice. If, at the end of such ninety (90) days following the receipt of the Notice, the Selling Stockholders have not completed the sale or other disposition of the Securities of the Selling Stockholders and any Accepting Offeree in accordance with the terms of the third party's offer, the Selling Stockholders shall return to each Accepting Offeree all certificates representing the Securities which such Accepting Offeree delivered for sale or other disposition pursuant to this Section 9(a), and all the restrictions on sale or other disposition contained in this Agreement with respect to the Securities owned by the Selling Stockholders shall again be in effect. (b) Drag-Along Obligations. If any Stockholder or the Company shall receive an offer in writing from a third party which is not an Affiliate of such Stockholder or the Company (a "Third-Party Offeror") to purchase all of the Common Stock of the Company, on a fully diluted basis, to effect a business combination of the Company with such Third Party Offeror or an Affiliate thereof or to purchase all or substantially all the assets of the Company (any such proposal, including any subsequent amendments thereto accepted by the Third Party Offeror and the Major Investors, an "Acquisition Proposal"), such Stockholder or the Company, as the case may be, shall deliver a notice (an "Acquisition Notice") to the Major Investors within three (3) Business Days of receipt thereof. Such Acquisition Notice shall contain a copy of such Acquisition Proposal, including the name and address of the Third-Party Offeror and the terms of the Acquisition Proposal. In the event that the Major Investors send 18 written notice (a "Joint Acceptance Notice") to the Company and the other Stockholders within thirty (30) Business Days after receipt of the Acquisition Notice of their acceptance of the terms of the Acquisition Proposal (which notice shall include a description of any changes to the terms of the Acquisition Proposal accepted by the Major Investors that differ from the terms of the Acquisition Proposal distributed as part of the initial Acquisition Notice), and provided that pursuant to the terms of the Acquisition Proposal as accepted by the Major Investors, the Securities held by Management Stockholders and SJF will receive the same consideration as the corresponding Securities if held by DBCP or ACI, the other Stockholders severally agree that, upon receipt of such Joint Acceptance Notice, they shall be obligated to sell, at the same time as the Major Investors sell, all of their Securities to the Third-Party Offeror upon the terms and conditions set forth in the Acquisition Proposal, or, as the case may be, to vote all of their Securities entitled to vote in favor of the merger or sale of all or substantially all of the assets of the Company as described in the Acquisition Proposal, and otherwise to take all actions reasonably necessary or appropriate to cause the Company to consummate the proposed transaction. Section 10. Share Certificates. (a) Each certificate or other instrument representing the Securities or Subordinated Debt now or hereafter held by a Stockholder shall be stamped with a legend in substantially the following form: "THE [SECURITIES][DEBT] EVIDENCED BY THIS [CERTIFICATE] [INSTRUMENT] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT OR COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY TO COMPANY STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT. (b) Each instrument representing the Securities now or hereafter held by a Stockholder shall be stamped with a legend substantially in the following form: THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A STOCKHOLDERS AGREEMENT, DATED ______________, A COPY OF WHICH IS ON FILE AT THE OFFICE OF COMPANY AND WILL BE FURNISHED TO ANY PROSPECTIVE PURCHASER ON REQUEST. SUCH STOCKHOLDERS AGREEMENT PROVIDES, AMONG OTHER THINGS, FOR CERTAIN RESTRICTIONS ON THE SALE, TRANSFER, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SHARES REPRESENTED BY THIS CERTIFICATE AND THAT UNDER CERTAIN CIRCUMSTANCES THE HOLDER THEREOF MAY BE REQUIRED TO SELL THE SHARES REPRESENTED BY THIS CERTIFICATE. BY ACCEPTANCE OF THIS CERTIFICATE, EACH HOLDER HEREOF AGREES TO BE BOUND BY THE PROVISIONS OF THE STOCKHOLDERS AGREEMENT" Each Stockholder agrees that he or it will deliver all certificates for or other instruments evidencing Securities or Subordinated Debt owned by him to the Company for the purpose of affixing such legend to such certificates or instruments. 19 Section 11. After-Acquired Shares. All of the provisions of this Agreement shall apply to all of the Securities now owned or hereafter issued or transferred to a Stockholder or to his or its Permitted Transferees in consequence of any additional issuance, purchase, exchange, exercise of conversion rights or reclassification of Securities, corporate reorganization, or any other form or recapitalization, or consolidation, or merger, or share split, or share dividend, or which are acquired by a Stockholder in any other manner. Section 12. Severability. If one or more provisions of this Agreement are held to be unenforceable to any extent under applicable law, such provision shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted by law so as to effectuate the parties' intent to the maximum extent, and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms to the maximum extent permitted by law. Section 13. Governing Law. This Agreement shall be governed by, and construed and enforced in accordance with the laws of the State of Delaware without regard to the conflict of law principles of such state to the extent that they would apply the law of a different jurisdiction. Each of the parties irrevocably elects as the sole judicial forum for, and consents to the jurisdiction of, the courts of the United States of America located in Delaware and of the State of Delaware in connection with the adjudication of any matter arising under or in connection with this Agreement, and waives any objection to such jurisdiction or venue that it may have. Service of process on the parties in any action arising out of or relating to this Agreement shall be effective if mailed to the parties in accordance with Section 15. The parties waive all right to trial by jury in any action, suit or proceeding to enforce or defend any rights or remedies under this Agreement. Section 14. Assignment. Neither this Agreement nor any right or obligation arising under this Agreement may be assigned by any party without the prior written consent of the other parties, other than to a Permitted Transferee of the assignor and except that each Major Investor may assign its rights in whole or in part to an Affiliate of such Major Investor without the prior written consent of any other party, provided such assignor or Major Investor shall remain liable for all of its respective obligations under this Agreement. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns, and no other Person shall have any right, benefit or obligation under this Agreement. Section 15. Notices. All notices and communications to be given or made by any party under this Agreement shall be in writing and delivered by hand-delivery, registered first class mail (return receipt requested), facsimile, or air courier guaranteeing overnight delivery, addressed as follows, or to such other Person or address as the party named below may designate by notice: (a) If to the Company: (b) If to DBCP: (c) If to ACI: (d) If to the Management Stockholder: (e) If to SJF: Each such notice or other communication shall be deemed to have been duly given or served on the date on which personally delivered, with receipt acknowledged, telecopied and confirmed by telecopy answerback, or three Business Days after the same shall have been deposited with the United States mail. 20 Section 16. Termination. This Agreement shall terminate and be of no further force or effect with respect to any Stockholder (i) upon such Stockholder's Transfer of all of such Stockholder's Securities in accordance with the terms of this Agreement or (ii) upon the Initial Public Offering Date; provided, however, that no such termination shall relieve any Stockholder from any liability arising from any breach of this Agreement by such Stockholder prior to such termination. Section 17. Section and Other Headings. The section and other headings in this Agreement are for convenience only and shall not affect the meaning or interpretation of this Agreement. Section 18. Remedies. Each party, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. Each party agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Agreement and hereby agrees to waive the defense in any action for specific performance that a remedy at law would be adequate. In any action or proceeding brought to enforce any provision of this Agreement or where any provision of this Agreement is validly asserted as a defense, the successful party shall be entitled to recover reasonable attorneys' fees in addition to any other available remedy. Section 19. Entire Agreement. This Agreement constitutes the entire understanding of the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, of the parties with respect to the subject matter hereof. Section 20. Amendment; Waiver. (a) Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by each Major Investor, or in the case of a waiver, by the party against whom the waiver is to be effective; provided that no amendment may impair the rights of, or impose any additional liability or obligation on, any Stockholder without such Stockholder's consent. (b) No failure or delay by any party in exercising any right, power or privilege under this Agreement shall operate as a waiver of such right, power or privilege nor shall any single or partial exercise of any right, power or privilege preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege. Except as otherwise provided in this Agreement, the rights and remedies provided under this Agreement shall be cumulative and not exclusive of any rights or remedies provided by law. Section 21. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which together shall be deemed to be one and the same document. Section 22. Fees and Expenses. Except as otherwise provided in this Agreement, each party shall bear its own costs and expenses incurred in connection with this Agreement, including the fees and expenses of their respective accountants and counsel. Section 23. Affiliate Transactions. Except for the transactions contemplated by (a) the Agreement and Plan of Merger, dated as of January ___, 2002 ("Merger Agreement"), among J Holdings Corp., J Acquisition Corp. and Jenny Craig, Inc., (b) the Fee Letter, dated the date hereof, among J Holdings Corp., J Acquisition Corp., DBCP and ACI, (c) this Agreement and (d) the equity and debt commitment letters of ACI and DBCP executed in connection with the Merger Agreement, the Company 21 shall not enter into any transaction with a Major Investor or Affiliate thereof without the consent of the other Major Investor. [SIGNATURES BEGIN ON NEXT PAGE] 22 IN WITNESS WHEREOF, the parties have executed this Agreement on the date first above written. J HOLDINGS CORP. By: ------------------------------------------------ Name: Title: DB CAPITAL INVESTORS, L.P. By: DB Capital Partners, L.P., its general partner By: DB Capital Partners, Inc., its general partner By: ------------------------------------------------ Name: Title: [ACI CAPITAL CO., INC.], on behalf of ACI Entities By: ------------------------------------------------ Name: Title: [MANAGEMENT STOCKHOLDER] By: ------------------------------------------------ Name: Title: SJF ENTERPRISES, INC. By: ------------------------------------------------ Name: Title: --------------------------------------------------- SID CRAIG [Only with respect to Section 7(e) hereof] --------------------------------------------------- JENNY CRAIG [Only with respect to Section 7(e) hereof] CRAIG ENTERPRISES, INC. By: ------------------------------------------------ Name: Title: [Only with respect to Section 7(e) hereof] 2 EXHIBIT A SECURITIES OWNED BY MAJOR INVESTORS, MANAGEMENT STOCKHOLDERS AND SJF 3
EX-99.(D)(4) 8 v79145orex99-d4.txt EXHIBIT (D)(4) EXHIBIT (d)(4) January 27, 2002 J Holdings Corp. 900 Third Avenue 26th Floor New York, New York 10022 Re: Equity Capital Commitment Gentlemen: Reference is made to that certain Agreement and Plan of Merger (the "Agreement"), dated as of the date hereof, by and among J Holdings Corp., a Delaware corporation ("Parent"), J Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (the "Purchaser"), and Jenny Craig, Inc., a Delaware corporation (the "Company"), which agreement contemplates the acquisition by Parent of 100% of the outstanding shares of the Company (such acquisition, together with agreements related thereto or contemplated thereby, representing the "Transaction"). In connection therewith and in order to finance, in part, the Transaction, ACI Capital Co., Inc. (the "Investor") is pleased to advise you that it hereby commits to provide Parent with $6 million of equity capital (the "Investment"), to be allocated between preferred stock (the "Senior Preferred") and common stock of Parent on a nine-to-one basis. The Investor's commitment to provide the Investment is subject in all respects to satisfaction of the terms and conditions contained in this commitment letter and in the Outline of Terms and Conditions attached hereto as Exhibit A (the "Term Sheet"). The Investor's commitment to provide the Investment is subject to (i) the negotiation, execution and delivery of definitive documentation thereof, including, without limitation, a Certificate of Designations of the Senior Preferred, in form and substance satisfactory to the Investor, Parent and their respective counsel, (ii) the satisfaction of the conditions precedent to the closing of the Transaction set forth in Sections 6.1 and 6.3 (other than Section 6.3(c) of the Agreement), (iii) all conditions precedent to the obligation of the Senior Lender (as defined in the Agreement) to consummate the Senior Financing (as defined in the Agreement) having been met and the Senior Lender shall intend to and shall be willing and prepared to consummate the Senior Financing, in each case other than with respect to any conditions relating to the equity capital investment contemplated by this commitment letter, the equity commitment letter of each of DB Capital Investors, L.P. ("DBCI") and SJF Enterprises, Inc., of even date herewith, and the subordinated debt facility commitment letter of each of ACI and DBCI, each of even date herewith, and (iv) satisfaction of the conditions set forth in the Term Sheet attached hereto. The offer made by the Investor in this commitment letter is contingent upon execution of the Agreement, and should the Agreement be executed, the commitment by the Investor to provide the Investment shall expire immediately upon the earlier of (i) the termination of the Agreement and (ii) the Expiration Date (as defined in the Agreement), as may be extended in accordance with the terms of the Agreement. Should the terms and conditions of the offer contained herein meet with your approval, please indicate your acceptance by signing and returning a copy of this commitment letter to the Investor. This commitment letter, including the attached Term Sheet (i) supersedes all prior discussions, agreements, commitments, arrangements, negotiations or understandings, whether oral or written, of the parties with respect to the subject matter hereof and thereof, (ii) shall be governed by the law of the State of New York, (iii) shall be binding upon the parties and their respective successors and assigns, (iv) may not be relied upon or enforced by any other person or entity other than the parties hereto and Purchaser, and (v) may be signed in multiple counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. If this commitment letter becomes the subject of a dispute, each of the parties hereto hereby waives trial by jury. This commitment letter may be amended, modified or waived only in a writing signed by the parties hereto. 2 Please confirm that the foregoing is in accordance with your understanding by signing and returning to the Investor the enclosed copy of this Commitment Letter on or before the close of business on the date hereof, whereupon this Commitment Letter shall become a binding agreement between us. Very truly yours, ACI CAPITAL CO., INC. By: /s/ KEVIN S. PENN -------------------------------- Name: Kevin S. Penn Title: Managing Director Agreed and accepted on this 27th day of January, 2002: J HOLDINGS CORP. By: /s/ KEVIN S. PENN ---------------------------- Name: Kevin S. Penn Title: President 3 EXHIBIT A OUTLINE OF TERMS AND CONDITIONS FOR PROPOSED EQUITY FINANCING This Outline of Terms and Conditions is part of the Commitment Letter, dated January __, 2002 (the "Commitment Letter"), addressed to J Holdings Corp. by ACI Capital Co., Inc. (the "Investor") and is subject to the terms and conditions of the Commitment Letter. Capitalized terms used herein shall have the meanings set forth in the Commitment Letter unless otherwise defined herein. ISSUER: J Holdings Corp. TOTAL ISSUANCE OF PREFERRED: $18 million TOTAL ISSUANCE OF COMMON: $2 million COMMITMENT BY INVESTOR: $5.4 million in senior preferred stock (the "Preferred"), having an aggregate liquidation preference of $5.4 million, and $600,000 in shares of Common Stock (the "Common"), at a price of $0.10 per share. MANDATORY REDEMPTION OF PREFERRED: Five years. PREFERRED DIVIDENDS: Cumulative undeclared dividends (declarable only in cash), payable at the rate of 15% per annum, or such lower rate as would ensure for any time in which ACI remains a holder of the Preferred that the combined interest + dividend rate payable on the Issuer's capital (which shall be an amount equal to the sum of the Purchaser Debt Financing (as defined in the Agreement), Preferred and Common (which includes paid in capital and additional paid in capital)) does not exceed 15% for any annual period (the applicable rate at any time being the "Base Rate"); provided, however, that the foregoing limitation shall only apply to the extent that ACI remains subject to applicable limitations prescribed by the Small Business Administration ("SBA"). The rate paid on the Issuer's capital shall be calculated in a manner consistent with applicable regulations of the SBA. USE OF PROCEEDS: To finance the Transaction and the general working capital needs of the Issuer. 4 OPTIONAL REDEMPTION: At the option of the Issuer, with no penalty. TRANSFERABILITY: Subject to restrictions contained in the Stockholders' Agreement. COVENANTS: Standard for this type of security, including, but not limited to, reporting requirements, change of control restrictions, approval of mergers, acquisitions, equity issuances, payment of dividends, debt incurrence, redemption of equity or debt, amendments to the preferred stock, amendments of equity rights, amendments to the Issuer's charter and bylaws, changes in the Issuer's management, material changes in business strategy, increase in size of Board, etc. Such covenants will not restrict the Issuer's ability to incur debt for the sole purpose of prepaying Preferred. CONDITIONS: Customary conditions precedent, including, without limitation: 1) Negotiation, execution, delivery of definitive documentation. 2) Closing of the Transaction contemplated by the Agreement. 5 EX-99.(D)(5) 9 v79145orex99-d5.txt EXHIBIT (D)(5) EXHIBIT (d)(5) DB CAPITAL INVESTORS, L.P. 31 WEST 52ND STREET 26TH FLOOR NEW YORK, NEW YORK 10019 EQUITY COMMITMENT LETTER January 27, 2002 J Holdings Corp. J Acquisition Corp. ACI Capital Co., Inc. c/o ACI Capital Co., Inc. 900 Third Avenue 26th Floor New York, New York 10022 Ladies and Gentlemen: We are pleased to confirm the arrangements under which DB Capital Investors, L.P. ("DBCI") is committed to provide equity capital in connection with the transactions described herein in the amount, on the terms and subject to the conditions set forth in this letter (together, the "COMMITMENT LETTER") and the Fee Letter (as defined below). We understand that J Holdings Corp., a Delaware company ("PARENT", which is a newly formed, wholly owned subsidiary of ACI Capital Co., Inc. ("ACI")), and J Acquisition Corp., a Delaware company and a wholly owned subsidiary of Parent ("PURCHASER"), will sign, concurrently herewith, a merger agreement, dated the date hereof, and in the form attached hereto as EXHIBIT A (along with any other agreements or documents entered into in connection therewith or delivered pursuant thereto, the "ACQUISITION AGREEMENT") to acquire (the "ACQUISITION") all of the issued and outstanding common stock of Jenny Craig, Inc., a Delaware corporation (the "COMPANY"). In addition, in connection with the Acquisition, Parent, Purchaser, Sidney Craig, Jenny Craig, SJF Enterprises, Inc., DA Holdings, Inc., Craig Enterprises, Inc. and the Company will enter into a Stockholders' Voting Agreement, dated the date hereof and substantially in the form attached hereto as EXHIBIT B (along with any other agreements or documents entered into in connection therewith or delivered pursuant thereto, the "VOTING AGREEMENT"). We have confirmed that the total purchase price and financing requirements (including equity financing January 27, 2002 Page 2 being provided by ACI, Company stockholders and management) for the Acquisition will be financed as set forth on EXHIBIT C hereto (the "FINANCINGS"). 1. Commitment. DBCI is pleased to confirm its commitment (the "COMMITMENT") to invest $10 million in the equity capital of Parent, of which $9 million shall be invested in the preferred stock of Parent and $1 million shall be invested in the common stock of Parent, on the terms and subject to the conditions contained in this Commitment Letter and in the outline of terms and conditions attached hereto as Exhibit D (the "TERM SHEET"). DBCI's Commitment is subject, in its discretion, to the conditions set forth in this Commitment Letter and in the Term Sheet and to the negotiation, execution and delivery of definitive documentation evidencing the Financings (along with any other agreements or documents entered into in connection therewith or delivered pursuant thereto, the "FINANCING Agreements"), satisfactory to DBCI and its counsel and the satisfaction of the terms, conditions and covenants contained therein. 2. Fees and Expenses. The fees for these services, among others, are to be set forth in a separate letter (the "FEE LETTER"), to be entered into prior to the closing of the Acquisition by and among ACI, DBCI, Parent and Purchaser. 3. Conditions Precedent. DBCI's obligations hereunder are conditioned on the following: a. The transactions contemplated by the Acquisition Agreement and the Voting Agreement shall have been consummated concurrently with, or shall be ready for consummation immediately after, DBCI's equity financing hereunder on the terms and conditions set forth in such agreements without modification, amendment or waiver, except as previously consented to in writing by DBCI. All conditions precedent to the obligations of Parent and Purchaser under such agreements (other than Section 6.3(c) of the Acquisition Agreement) shall have been satisfied without modification, amendment or waiver, except as previously consented to in writing by DBCI. b. The transactions contemplated by the Financing Agreements shall have been consummated prior to or concurrently with DBCI's equity financing hereunder in accordance with their terms, without modification, amendment or waiver, except as previously consented to in writing by DBCI. All conditions precedent to the obligations of the lenders or investors under the Financing Agreements shall have been satisfied, other than any conditions relating to the equity capital contemplated by this letter, the equity capital commitment letters from SJF Enterprises, Inc. and ACI and the junior subordinated debt commitment letter from ACI and DBCI, each of even date herewith. c. ACI, Parent and Purchaser shall have complied with their obligations hereunder. 4. Covenants. DBCI, ACI, Parent and Purchaser agree as follows: a. DBCI shall, and shall be permitted to, consummate the investment contemplated by the Commitment in accordance with the terms hereof. 2 January 27, 2002 Page 3 b. Parent and Purchaser shall, and ACI shall cause them to, consummate the transactions contemplated by the Acquisition Agreement and the Voting Agreement and satisfy their obligations thereunder, without amendment, modification or waiver except as previously consented to in writing by DBCI. c. ACI, Parent and Purchaser shall, and ACI shall cause Parent and Purchaser to, consummate the transactions contemplated by the Financing Agreements without amendment, modification or waiver, except as previously consented to in writing by DBCI. Without limiting the generality of the foregoing, there shall be no equity, debt or other financing of any type other than as set forth on EXHIBIT C hereto, without the prior written consent of DBCI. d. Parent and Purchaser shall, and ACI shall cause them to, to the extent commercially reasonable, enforce their respective rights and the obligations of the Company and other parties to the Acquisition Agreement or Voting Agreement (such other parties to the Voting Agreement, the "JC PARTIES"), including any rights to compensation or payments of any kind from any of the Company or the JC Parties whether or not the Acquisition is consummated, whether in respect of damages for breach, payments of termination fees, payments of expenses, gains owing under the Voting Agreement or otherwise. e. ACI, Parent and Purchaser shall promptly keep DBCI informed of, consult and confer with DBCI on all matters relating to the Acquisition, Acquisition Agreement, Voting Agreement, Financing and Financing Agreements and any discussions, communications or negotiations by and between ACI, Parent and Purchaser on the one hand and any of the Company or the JC Parties on the other hand in respect thereof. Such obligation shall include provision of copies of material correspondence, documents and other information and adequate notice and opportunity to attend conferences and meetings in respect thereof. In addition ACI, Parent and Purchaser shall apprise DBCI of, and consult with DBCI concerning all actions they may take or consider pursuant to or as contemplated by the Acquisition Agreement, Voting Agreement and Financing Agreements including exercise of rights thereunder regarding termination, information, further assurances, covenants, conditions, rights upon breach, enforcement of nonsolicitation and other rights. f. Without limiting DBCI's other rights in this Commitment Letter, in the event that an alternate bidder for the Company emerges or for some other reason an altered or improved bid for the Company is necessary or contemplated, DBCI will be given the opportunity, but will not be obligated, to participate in any transactions contemplated in order to improve the terms of the Acquisition Agreement or make an alternative offer for the Company on the same percentage basis relative to ACI as the percentage resulting from dividing DBCI's original commitment to purchase debt and equity capital in Parent hereunder by ACI's original commitment to purchase debt and equity capital in Parent. 3 January 27, 2002 Page 4 5. Acknowledgment. Each of ACI and DBCI has, independently and without reliance on the other party, based on such information and due diligence it has conducted as it has deemed appropriate, made its own analysis and decision to enter into its commitment to invest in Parent and to enter into the other documents and transactions contemplated by the Acquisition and the Acquisition Agreement. Each of ACI and DBCI will independently and without reliance upon the other party, continue to make its own decisions and to conduct its own due diligence with respect to the operation of the Company and the matters, transactions and any related agreements contemplated by the Acquisition and the Acquisition Agreement. ACI represents and warrants that it has made available to DBCI all the due diligence materials which ACI has received from the Company. 6. Confidentiality. Please note that this Commitment Letter, the Fee Letter, the transactions contemplated hereby and any written or oral information provided by DBCI in connection with this arrangement is exclusively for the information of ACI, Parent, Purchaser and the Company and may not be disclosed to any other party or circulated or referred to publicly without DBCI's prior written consent, except that you may disclose such information to your and the Company's officers, directors, agents and advisors who are directly involved in the consideration of the transactions contemplated hereby to the extent such persons are obligated to hold such advice in confidence or if otherwise required by law or in the event such information or documents are made public through no fault of ACI, Parent or Purchaser. 7. Assignment. None of DBCI, ACI, Parent or Purchaser may assign any of their respective rights or be relieved of any of their respective obligations hereunder without the prior written consent of the other parties hereto. 8. Termination. The Commitment will terminate upon the first to occur of (i) the closing of the Acquisition, (ii) the abandonment or termination of the Acquisition Agreement, (iii) a material breach by ACI, Parent or Purchaser under this Commitment Letter or the Fee Letter, provided, however, that DBCI shall notify ACI in writing of such breach, whereupon ACI shall have a commercially reasonable period of time (not to exceed twenty (20) calendar days) after ACI's receipt of such notice to cure such breach or (iv) the Expiration Date (as defined in the Acquisition Agreement), as may be extended in accordance with the terms of the Acquisition Agreement. 4 January 27, 2002 Page 5 Please confirm that the foregoing is in accordance with your understanding by signing and returning to DBCI the enclosed copy of this Commitment Letter on or before the close of business on the date hereof, whereupon this Commitment Letter shall become a binding agreement among us. Very truly yours, DB CAPITAL INVESTORS, L.P. By: /s/ ROBERT SHARP ------------------------------ Authorized Signatory Confirmed as of the date above: ACI CAPITAL CO., INC. By:/s/ KEVIN S. PENN ---------------------------- Name: Kevin S. Penn Title: Managing Director Confirmed as of the date above: J HOLDINGS CORP. By:/s/ KEVIN S. PENN ---------------------------- Name: Kevin S. Penn Title: President 5 January 27, 2002 Page 6 Confirmed as of the date above: J ACQUISITION CORP. By: /s/ KEVIN S. PENN ----------------- Name: Kevin S. Penn Title: President 6 January 27, 2002 Page 10 EXHIBIT D OUTLINE OF TERMS AND CONDITIONS FOR PROPOSED EQUITY FINANCING This Outline of Terms and Conditions is part of the Equity Commitment Letter, dated January 27, 2002 (the "Commitment Letter"), addressed to J Holdings Corp., J Acquisition Corp. and ACI Capital Co., Inc. ("ACI") by DB Capital Investors, L.P. (the "Investor"), and is subject to the terms and conditions of the Commitment Letter. Capitalized terms used herein shall have the meanings set forth in the Commitment Letter unless otherwise defined herein. ISSUER: J Holdings Corp. TOTAL ISSUANCE OF PREFERRED: $18 million TOTAL ISSUANCE OF COMMON: $2 million COMMITMENT BY INVESTOR: $9 million in senior preferred stock (the "Preferred"), having an aggregate liquidation preference of $9 million, and $1 million in shares of Common Stock (the "Common"), at a price of $0.10 per share. MANDATORY REDEMPTION OF PREFERRED: Five years. PREFERRED Cumulative undeclared dividends (declarable only in cash), DIVIDENDS: payable at the rate of 15% per annum, or such lower rate as would ensure for any time in which ACI remains a holder of the Preferred that the combined interest + dividend rate payable on the Issuer's capital (which shall be an amount equal to the sum of the Purchaser Debt Financing (as defined in the Acquisition Agreement), Preferred and Common (which includes paid in capital and additional paid in capital)) does not exceed 15% for any annual period (the applicable rate at any time being the "Base Rate"); provided, however, that the foregoing limitation shall only apply to the extent that ACI remains subject to applicable limitations prescribed by the Small Business Administration ("SBA"). The rate paid on the Issuer's capital shall be calculated in a manner consistent with applicable regulations of the SBA. USE OF PROCEEDS: To finance the Acquisition and the general working capital needs of the Issuer. OPTIONAL At the option of the Issuer, with no penalty. REDEMPTION: TRANSFERABILITY: Subject to restrictions contained in the Stockholders' Agreement. 1 January 27, 2002 Page 11 COVENANTS: Standard for this type of security, including, but not limited to, reporting requirements, change of control restrictions, approval of mergers, acquisitions, equity issuances, payment of dividends, debt incurrence, redemption of equity or debt, amendments to the preferred stock, amendments of equity rights, amendments to the Issuer's charter and bylaws, changes in the Issuer's management, material changes in business strategy, increase in size of Board, etc. Such covenants will not restrict the Issuer's ability to incur debt for the sole purpose of prepaying Preferred. CONDITIONS: Customary conditions precedent, including, without limitation: 1) Negotiation, execution, delivery of definitive documentation. 2) Closing of the Acquisition contemplated by the Acquisition Agreement. 2
-----END PRIVACY-ENHANCED MESSAGE-----